APRIL 2019
CURRICULUM VITAE
Charles Stephen Foster, M.D., F.A.C.S., F.A.C.R. Founder and President
Massachusetts Eye Research and Surgery Institution (MERSI) Ocular Immunology & Uveitis Foundation 1440 Main St. Suite 201 Waltham, MA, 02451
EDUCATION:
1965 Duke University, B.S. Chemistry, with Distinction 9/67 – 6/68 Duke University, Graduate School of Arts & Sciences: Immunology/Biochemistry 9/65 – 6/69 Duke University School of Medicine, M.D.
POSTDOCTORAL TRAINING:
Internships and Residencies:
7/69 – 6/70 Intern in Medicine Duke University Medical Center 7/70 - 6/72 Internal Medicine National Institutes of Health National Heart & Lung Institute: Blood, Vasculitis Branch 7/72 – 6/75 Resident in Ophthalmology Washington University of St. Louis School of Medicine, Barnes Hospital
FELLOWSHIPS:
7/75 – 6/77 Research Fellow Department of Cornea Research Eye Research Institute of Retina Foundation 7/75 – 6/76 Clinical Fellow, Cornea Service Massachusetts Eye and Ear Infirmary 7/76 – 6/77 Chief Clinical Fellow, Cornea Service Massachusetts Eye and Ear Infirmary 7/76 – 6/77 Fellow in Ocular Immunology Harvard Medical School
LICENSURE AND CERTIFICATION:
1969 North Carolina Board of Medical Examiners 1970 National Board of Medical Examiners 1970 Maryland Board of Medical Examiners 1970 District of Columbia Medical Examiners 1972 Missouri Board of Medical Examiners 1975 Massachusetts Board of Medical Examiners 1976 American Board of Ophthalmology, Diplomat 1981 American College of Surgeons 1995 American College of Rheumatology
ACADEMIC APPOINTMENTS:
10/70 – 7/72 Instructor in Medicine, George Washington University Medical Center 7/76 – 6/79 Instructor in Ophthalmology, Harvard Medical School 7/77 – 1/81 Clinical Assistant Scientist, Department of Cornea Research Director, Immunopathology Laboratory Eye Research Institute of Retina Foundation 7/79 – 6/82 Assistant Professor of Ophthalmology, Harvard Medical School 1/81 – 1/84 Clinical Associate Scientist, Department of Cornea Research Eye Research Institute of Retina Foundation 7/82 – 2/94 Associate Professor of Ophthalmology, Harvard Medical School 3/94 – 3/05 Professor of Ophthalmology, Harvard Medical School 4/05 – 6/15 Clinical Professor of Ophthalmology, Harvard Medical School 7/05 – Present Adjunct Professor of Allergy and Immunology, Harvard Medical School 7/15 – Present Professor of Ophthalmology, part-time, Harvard Medical School
HOSPITAL APPOINTMENTS:
7/76 – 5/81 Director, Residency Training (Ophthalmology) Massachusetts Eye and Ear Infirmary 7/77 – 5/82 Assistant in Ophthalmology Massachusetts Eye and Ear Infirmary 5/82 – 7/85 Assistant Surgeon of Ophthalmology Massachusetts Eye and Ear Infirmary 7/85 – 6/87 Associate Surgeon of Ophthalmology Massachusetts Eye and Ear Infirmary 7/87 – Present Surgeon in Ophthalmology Massachusetts Eye and Ear Infirmary 6/81 – 3/05 Founder and Director, Ocular Immunology and Uveitis Service Massachusetts Eye and Ear Infirmary
2 1/84 – 3/05 Founder and Director, Hilles Immunology Laboratory Massachusetts Eye and Ear Infirmary 1/88 – 3/05 Founder and Director, Rhoads Molecular Immunology Laboratory Massachusetts Eye and Ear Infirmary 1/93 – 5/96 Board of Surgeons, Massachusetts Eye and Ear Infirmary 4/94 – 2/05 Executive Committee, Department of Ophthalmology Harvard Medical School 8/96 – 5/14 Clinical Associate in Surgery, Massachusetts General Hospital 4/15– Present Clinical Associate in Surgery, Massachusetts General Hospital 9/08 – Present Surgeon, Mount Auburn Hospital, Cambridge, MA 7/05 – Present Surgeon and Shareholder, West Suburban Eye Surgery Center
VISITING APPOINTMENTS AND SPECIAL LECTURES:
1979 Wills Eye Hospital, Visiting Professor 1979 University of Paris, Visiting Professor 1980 National Eye Institute Task Force: Autoimmune Phenomena and Ocular Disorders 1980 National Eye Institute Task Force: Infection, Inflammation, and Allergy 1980 Moorefield's Eye Hospital, London, Visiting Professor 1980 University of Paris, Visiting Professor 1981 University of Paris, Visiting Professor 1981 National Institutes of Health, Maryland, Ad Hoc Review Study Section 1981 Wills Eye Hospital, Visiting Professor 1982 Washington University of St. Louis, Visiting Professor 1982 University of Paris, Visiting Professor 1982 Brookdale Hospital, New York, Visiting Professor 1982 Georgetown University, Visiting Professor 1982 Eye Research Institute Symposium, Palm Beach, FL, Guest Lecturer 1982 Lenox Hill Hospital New York, Visiting Professor 1982 New York Eye and Ear Infirmary, Visiting Professor 1982 Symposium and Satellite Telecast on "Radial Keratotomy and Extended Wear Contact Lenses," San Francisco, CA, Guest Speaker 1982 University of Maryland School of Medicine, Advances of Ophthalmology, Guest Lecturer 1983 Brigham and Women's Hospital, Boston, MA, Guest Lecturer at Grand Rounds 1983 University Hospitals of Cleveland, Guest Lecturer at Grand Rounds of Cleveland Ophthalmological Society 1983 Fisons Corp. Cromolyn Symposium, Guest Lecturer 1983 St. Luke's-Roosevelt Hospital, New York, Guest Lecturer at Grand Rounds 1983 Southend General Hospital, London, Visiting Professor 1983 University of Paris, Guest Lecturer 1983 National Institutes of Health, Maryland, Visiting Professor 1983 University of South Carolina in Columbia, Guest Lecturer 1984 North Shore University Hospital New York, Guest Lecturer 1984 Manhattan Eye & Ear Institute New York, Visiting Professor 1984 International Corneal Society, Cannes, France, Lecturer 1984 Miami Ophthalmological Society, Visiting Professor
3 1984 International Symposium on Herpetic Eye Disease, Keynote Speaker 1985 Symposium on Ocular Immunology, Uppsala, Sweden, Keynote Speaker 1985 First International Allergy Symposium, St. Petersburg, FL, Invited Lecturer 1985 University of Michigan, Visiting Professor, Keynote Speaker 1985 First International Allergy Symposium, St. Petersburg, FL, Invited Lecturer 1985 Guest of Honor, Recipient of Hippocrates Medal, Swedish Royal Academy of Medicine, Stockholm, Sweden 1986 Ocular Immunology Symposium, St. Petersburg, FL, Keynote Speaker 1986 Ocular Allergy Symposium, St. Petersburg, FL, Keynote Speaker 1986 Ocular Immunology, Tubingin, Germany, Invited Lecturer 1986 International Symposium on Herpes Diseases of the Eye, Lake Tahoe, CA, Invited Lecturer 1986 American Academy of Ophthalmology, Regional Update Course, Washington, DC, Lecturer 1986 Connecticut Ophthalmological Society, Guest of Honor 1986 American Rheumatism Association, Invited Lecturer 1986 University of Florida, Visiting Professor 1987 Swedish Ophthalmological Society, Guest of Honor 1987 Problem Solving in Corneal Disease, San Juan, Puerto Rico, Invited Lecturer 1987 Cooperation Between the Ophthalmologist and Non-Ophthalmologist, San Juan, Puerto Rico, Invited Lecturer 1987 New York City Immunology Course, Manhattan Eye, Ear and Throat Hospital, Invited Lecturer 1987 Arthritis Grand Rounds, Massachusetts General Hospital, Boston, MA, Invited Lecturer 1987 Department of Allergy, New England Medical Center, Boston, MA, Invited Lecturer 1987 Corneal Problems Solving Course, Massachusetts Eye & Ear Infirmary, Boston, MA, Invited Lecturer 1987 Grand Rounds, Sympathetic Ophthalmia, Massachusetts Eye & Ear Infirmary, Boston, MA, Invited Lecturer 1987 Johns Hopkins University, Visiting Professor 1987 Massachusetts Eye & Ear Infirmary, Alumni Meeting, Boston, MA, Invited Speaker 1987 Dupont de Nemours and Co., Wilmington, DE, Visiting Professor 1987 New York University, Division of Rheumatology, Visiting Professor 1987 Manhattan Eye, Ear & Throat Hospital, Visiting Professor 1987 World Cornea Conference, Washington, DC, Invited Speaker 1987 American Ophthalmological Society, Carlsbad, CA, Invited Speaker 1987 Canadian Ophthalmological Society, Montreal, Canada, Invited Speaker 1987 World Congress on Sarcoidosis, Milan, Italy, Invited Speaker 1987 Norwegian Ophthalmological Society, Guest of Honor 1988 American Rheumatism Foundation, San Francisco, CA, Invited Speaker 1988 DalHousie University Faculty Title of Medicine, Halifax, Nova Scotia, Invited Speaker 1988 Lenox Hill Hospital, New York, NY, Invited Speaker 1988 University of Mississippi, Jackson, MS, Invited Speaker 1988 University of Paris, Invited Speaker
4 1988 Cambridge University, Visiting Professor 1988 New England Ophthalmic Society, Boston, MA, Invited Speaker 1988 American Academy of Ophthalmology, Las Vegas, NV, Visiting Professor 1988 Turkish Ophthalmological Society, Istanbul, Turkey, Invited Speaker 1989 Missouri Ophthalmological Society, Kansas City, MO, Invited Speaker 1989 First Annual Cornea and Anterior Segment Symposium, University of New Jersey School of Medicine, Visiting Professor 1989 Long Island Jewish-Hillside Medical Center, Grand Rounds, Invited Speaker 1989 University of Michigan, Detroit, MI 1990 Fifth International Symposium on Immunology and Immunopathology of the Eye. Tokyo, Invited Speaker 1990 Castroviejo Cornea Society, Invited Speaker 1990 International Congress of Ophthalmology, Singapore, Invited Speaker 1990 State University of New York, Dept. of Immunology. Buffalo, NY. "Immunosuppression and the Role of Cyclosporine in Patient Management," Invited Speaker 1990 Manhattan Eye, Ear, & Throat Hospital, Conference on External Eye Disease, Invited Speaker 1990 International Symposium for Ocular Inflammation. Alicante, Spain, Invited Speaker 1990 American Academy of Ophthalmology, Regional Update Course, Cambridge, MA Invited Speaker 1990 First International Symposium on Intermediate Uveitis. Gutersloh, Germany, Visiting Professor 1990 Fourth Workshop on External Eye Disease and Inflammation. Bilesly, England. Invited Speaker 1990 Second Annual University of Illinois, Eye Center Meeting. Chicago, Illinois Ocular Immunology Lecture: Chronic Cicatrizing Conjunctivitis. Invited Speaker. 1990 Massachusetts Eye & Ear Infirmary, Immunology Course. Course Director 1990 Boston University School of Medicine, Resident Lecture Series. Visiting Professor 1990 American Academy of Ophthalmology, Atlanta, GA, Invited Speaker 1990 American Uveitis Society, Course on Uveitis, Atlanta, GA, Instructor 1991 Cullen Memorial Lecture, Ohio State University, Invited Speaker 1991 Manhattan Eye & Ear Hospital, Grand Rounds, Mucous Membrane Disease, Visiting Professor 1991 Massachusetts General Hospital, Grand Rounds, Visiting Professor. 1991 Valladolid, Spain. Guest of Honor. 1991 Spaulding Hospital, Immunologic Diseases of the Eye. Visiting Professor. 1991 Manhattan Eye & Ear Hospital, New York, Visiting Professor. 1991 AAO Update. Lecturer. 1991 American Uveitis Society, Course on Uveitis, Instructor 1991 Cornea Day. New England Ophthalmological Society, Boston Park Plaza Hotel, Fungal Keratitis. Invited Speaker. 1991 University of Maryland, Grand Rounds, Visiting Professor. 1991 Rheumatology Department, SUNY Stoneybrook, Visiting Professor. 1991 Georgetown University, Visiting Professor. 1991 New York City Ophthalmology Course, Ocular Immunology. Visiting Professor. 1992 Long Island Jewish Memorial. Visiting Professor. 1992 Seattle, Washington Academy of Ophthalmology. Featured Speaker.
5 1992 Tubingen, Germany. Guest of Honor. 1992 Chicago Ophthalmologic Society. Featured Speaker. 1992 New Jersey Conference. Invited Speaker. 1992 Brussels International Conference. IXth Congress of Ophthalmology, Keynote Speaker. 1992 Stresa, Italy. International Society for Eye Research. Featured Speaker. 1992 Course on Cornea: Current Problems, Paris, France. Invited Lecturer. 1992 American Uveitis Society, Course on Uveitis, Instructor 1992 Visiting Professor, Grand Rounds, University of Pittsburgh. 1992 2nd Inger Sandstrom Memorial Lecture. Swedish Medical Society Meeting, Stockholm, Sweden. 1993 Visiting Professor, Grand Rounds, McGill University, Montreal. 1993 New Orleans Academy, Featured Speaker 1993 Baltimore, MD, Sinai Hospital, Visiting Professor 1993 American Uveitis Society, Course on Uveitis, Instructor 1993 National Eye Institute, Visiting Professor 1994 Columbia University, Visiting Professor 1994 National Institutes of Health, Visiting Professor 1994 Francisco J. Bajandas Memorial Lecture, University of Texas, San Antonio, Visiting Professor. 1994 University of Berlin Medical College, Visiting Professor 1994 University of California San Francisco, Visiting Professor 1994 University of Michigan, Visiting Professor 1994 University of Utah, Visiting Professor, Grand Rounds 1994 Joint Allergist/Ophthal. Meeting, Buffalo, NY, Featured Speaker 1994 University of South Florida, Visiting Professor, Grand Rounds 1994 Cooperstown, NY, Anterior Segment Conference, Featured Lecturer 1994 Salt Lake City, UT, VanDyk Memorial Lecture 1994 Rhode Island Society of Eye Physicians, Guest Speaker 1994 WV Kanawha Society of Ophthalmologists, Guest Speaker 1994 SUNY Post-Graduate Review, Syracuse, NY, Featured Speaker 1995 Washington University Medical Center, MO, Visiting Professor 1995 Loyola University, Loyola, IL, Visiting Professor 1995 Colorado Ophthalmological Society, CO, Featured Speaker 1995 Escola Paulista de Medicina, São Paulo, Visiting Professor 1995 Brookdale Ophthalmologic Society, NY, Guest Speaker 1995 National Dutch Ophthal. Congress, Amsterdam, Invited Lecturer 1995 Oregon Academy of Ophthalmology, OR, Guest Speaker 1995 Loma Linda Univ. Post-Graduate Convention, CA, Guest Speaker 1995 Calif. Pacific Medical Center, San Francisco, CA, Visiting Professor 1995 Redwood Empire Ophthalmological Society, CA, Guest Speaker 1995 Stanford University, CA, Visiting Professor 1995 Sacramento Kaiser Meeting, Sacramento, CA, Guest Speaker 1995 Northern Calif. Kaiser Quarterly Educ. Mtg., CA, Guest Speaker 1995 Santa Barbara Ophthalmological Society, CA, Guest Speaker 1995 Case-Western Univ. Grand Rounds, Cleveland, Visiting Professor 1995 Xth Congress European Soc. of Ophthal., Milan, Italy, Invited Speaker 1995 Palm Beach Ophthalmological Society, FL, Guest Speaker
6 1995 Northeast Pennsylvania Pediatric Allergy Society, PA, Guest Speaker 1995 S. Illinois Univ. Ophthalmology Residency Program, IL, Visiting Professor 1995 Cincinnati Society of Ophthalmology Grand Rounds, Guest Speaker 1995 LSU-Shreveport Lecture Series, LA, Visiting Professor 1995 Geneva: First International Symposium on Ocular Pharmacotherapeutics (Merck Sharp & Dohme) 1995 University of Gotenburg, Sweden. Visiting Professor 1996 University of Connecticut Grand Rounds, Guest Speaker 1996 Pierce County/Madigan Hospital Resident Society Meeting, Guest Speaker 1996 Wake Forest Eye Center Grand Rounds, Guest Speaker 1996 Indianapolis Ophthalmological Society, IN, Guest Speaker 1996 No. Rhode Island Ophthalmological Society, Providence, RI, Guest Speaker 1996 Tidewater Ophthalmology & Otolaryngology, Norfolk, VA, Guest Speaker 1996 World Congress on the Cornea IV, Orlando, FL, Invited Speaker 1996 UCLA/Jules Stein Eye Institute, Los Angeles, CA, Visiting Professor 1996 New York Hospital-Cornell Medical Center Grand Rounds, Invited Speaker 1996 Delaware Ophthalmological Society 1996 St. Louis Ophthalmological Society 1996 Phoenix Ophthalmological Society 1996 University of Arizona, Visiting Professor 1996 Columbia Ophthalmological Society 1996 Philadelphia Ophthalmological Society 1996 Tacoma Ophthalmological Society, Guest of Honor 1996 University of Arkansas, Visiting Professor 1996 University of Paris, Visiting Professor 1996 Workshop on Ocular Autoimmunity in Skin Disease, Ettal, Germany 1996 Brookdale Ophthalmological Society 1996 Dayton Ophthalmological Society 1996 Raleigh Ophthalmological Society 1996 University of Miami, Visiting Professor 1996 Miami Ophthalmological Society 1996 Guest of Honor, University of Gotland (Sweden) 1996 New Jersey Medical School, Visiting Professor 1996 Grand Rounds, Neurology Department, MGH 1996 Alabama Academy of Ophthalmology 1996 South Western Virginia Ophthalmological Society 1996 Akron Ophthalmological Society 1996 Case Western Reserve, Visiting Professor 1996 University of Washington, Visiting Professor 1996 University of Oregon, Visiting Professor 1996 Alta Society, Sacramento, CA, Guest of Honor 1996 Florida Ophthalmological Society 1996 University of Wisconsin, Visiting Professor 1996 University of Missouri, Visiting Professor 1996 University of Rochester, Visiting Professor, Bujones Memorial Lecture 1996 Keynote Address, Second International Symposium on the Lacrimal Gland, Bermuda 1996 Univeristy of New Mexico, Visiting Professor
7 1996 Santa Barbara Ophthalmological Society 1996 Phoenix Ophthalmological Society 1996 University of Texas, El Paso, Visiting Professor 1996 Martin Luther King Hospital, Los Angeles, CA, Visiting Professor 1996 Fresno Ophthalmological Society, Invited Speaker 1997 King Khalid Eye Hospital, Riyadh, Saudi Arabia, Visiting Professor 1997 University of Colorado, Visiting Professor 1997 Colorado Ophthalmological Society, Guest of Honor 1997 Allegheny General Hospital (Pittsburgh), Visiting Professor 1997 Wilmer Vail Meeting, Faculty 1997 Dallas Academy of Ophthalmology, Guest of Honor 1997 University of Texas, Southwestern, Visiting Professor 1997 Washington University, St. Louis (Barnes Hospital), Visiting Professor 1997 Rush Presbyterian (Chicago), Visiting Professor 1997 Ostler Course, Faculty 1997 New York Eye and Ear Infirmary, Visiting Professor 1997 European Society of Ophthalmology (Budapest), Course Faculty 1997 New England Ophthalmological Society, Invited Speaker 1997 Pittsburgh Eye and Ear Hospital, Visiting Professor 1997 International Symposium on Ocular Pharmacology (Munich), Organizer 1997 University of Oregon, Visiting Professor 1997 American Academy of Ophthalmology, LEO Course, Instructor 1997 East Bay Ophthalmologic al Society (Oakland), Invited Speaker 1997 Minneapolis Ophthalmological Society, Guest of Honor 1997 American College of Rheumatology, Keynote Speaker 1997 Virginia Society of Ophthalmology, Guest of Honor 1997 Baylor University, Visiting Professor 1997 The Proctor Foundation, Invited Speaker 1997 George Washington University, Visiting Professor 1998 Utah Ophthalmological Society – Guest of Honor 1998 Columbia University, Visiting Professor 1998 Aspen Corneal Society, Invited Speaker 1998 Nassau County Grand Rounds, Invited Speaker 1998 New Orleans Academy of Ophthalmology, Guest of Honor 1998 American Academy of Pediatrics, Pediatric Rheumatology, Keynote Speaker 1998 University of Utah-John Moran Eye Center, Visiting Professor 1998 American Osteopathic Colleges, Annual Meeting, Guest of Honor 1998 XIII Annual International Congress of Eye Research, Paris, France – Section Chairman 1998 Seventh Annual Ocular Surgery News Symposium, New York, NY 1998 Empiric Medical Workshop, Rockville, MD 1998 American Academy of Ophthalmology, LEO Course, Instructor 1998 West Virginia Kanawha Meeting, Invited Speaker 1998 Nassau County Grand Rounds, Guest of Honor 1998 Long Island College Hospital, Visiting Professor 1999 The Conrad Behrens Lecture, CLAO 1999 The Jean Lacerte Lecture, Laval University, Quebec 1999 The Canadian Royal College of Surgeons Lecturer
8 1999 Aspen Corneal Society – Speaker 1999 Danish Ophthalmological Society, Annual Meeting, Program Director 1999 Barnet Dulaney Eye Foundation 1999 The Robert Coles Lecture, NY Academy of Medicine 1999 Ocular Inflammatory Disease Update, Mexico City 2000 International Symposium on Ocular Pharmacology and Pharmaceutics, Lisbon, Portugal 2000 International Symposium on Ocular Inflammation, Barcelona, Featured Speaker 2000 Swiss Ophthalmological Society, Bern, Switzerland – Guest of Honor 2001 Illinois Association of Ophthalmologists – Invited Speaker 2001 The Harvey Thorpe Lecture – Pittsburgh Ophthalmological Society 2001 Greek Congress of Ophthalmology – Keynote Lecture 2001 Schepens Lecture – Schepens Eye Research Institute 2001 Adamantiades-Behçet's Disease Congress – Keynote Lecture 2002 Pediatric Uveitis Symposium, UCLA – Invited Speaker 2002 The Torrence Makley, Jr. Lecture – Ohio State University 2002 NYC Rheumatology Society – Guest of Honor 2002 Philippine Alumni Meeting, Washington, DC – Invited Speaker 2002 Yale Eye Clinic Symposium – Visiting Professor 2002 Columbia University Rounds – Visiting Professor 2002 Medical Society of New Jersey – Invited Speaker 2002 Opinion Leaders’ Conference, Washington, DC – Invited Speaker – IVIg and the Blistering Dermatoses 2002 Cleveland Clinic – Visiting Professor 2003 Co-originator and organizer of the first Uveitis Subspecialty Day, American Academy of Ophthalmology 2003 La Escuela de Medicina Ignacio A. Santos de la Division Ciencias de la Salud del Insituto Tecnologico y de Estudios Superiores de Monterrey, Monterrey Mexico – Visiting Professor 2003 The Diaz Caneja Lecture, University of Valladolid, Spain 2003 Hospital for Special Surgery, New York City – Grand Rounds, Rheumatology 2004 The Mahlon Barlow Lecture - Johns Hopkins University School of Medicine, Wilmer Eye Institute 2004 University of Medicine and Dentistry of New Jersey – Grand Rounds 2004 International Society of Ocular Pharmacology and Therapuetics – Monaco (Monte Carlo) – Organizer of and Speaker in two sessions 2004 West Virginia University, Visiting Professor 2004 Massachusetts General Hospital Medical Grand Rounds – Speaker 2004 Congress on New Therapies in Retinal Disease, Rome – Invited Speaker 2004 The Kevin Hill Course, Colby College – Speaker 2004 Evidence-based Model for Diagnosis and Therapy of Uveitis, Symposium Director, Massachusetts Eye and Ear Infirmary, Boston 2004 AUS Uveitis Symposium, American Academy of Ophthalmology 2005 Joseph M. Bryan Research Lecture, Duke University, Durham NC 2005 The Richard D. Richards Lectureship, University of Maryland 2005 Brigham and Women’s Hospital, Ocular Allergy, Resident Grand Rounds, Invited Speaker 2005 American Behcet’s Disease Association – Guest of Honor, New York
9 2005 AAO Uveitis Subspeciality Day – Organizer and Speaker 2005 Massachusetts General Hospital Grand Rounds 2005 Massachusetts General Hospital Dermatology Department Grand Rounds 2005 Massachusetts Eye and Ear Infirmary Resident Lecture Series 2005 Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course, Guest Lecturer 2006 Visiting Professor, SUNY, Brooklyn 2006 Visiting Professor, New England Eye Institute 2006 Allergy Conference, Children’s Hospital, Boston 2006 Harvard Course in Allergy & Immunology, Brigham & Women’s Hospital – Invited Speaker 2006 2nd American-European Ophthalmology Symposium, New York 2006 New England Ophthalmological Society – Invited Speaker 2006 Massachusetts Eye and Ear Infirmary Resident Lecture Series 2006 Lancaster Course in Ophthalmology, Lecturer 2006 Visiting Professor, Grand Rounds, University of Texas Health Sciences Center, Houston 2006 Visiting Professor, Grand Rounds, Baylor University, Houston 2006 Houston Ophthalmological Society – Invited Speaker 2006 Guest Speaker, Vermont Optometric Association Annual Meeting 2006 The First Annual Ocular Immunology & Uveitis Foundation Physician Education Conference: What’s New in Anterior Segment Disorders, Syposium Director, Massachusetts Eye Research & Surgery Institute, Cambridge 2006 The Ocular Microbiology Interest Group, American Academy of Ophthalmology, Las Vegas 2006 Visiting Professor, Grand Rounds, University of Rochester 2006 International Ocular Inflammation Society, Italy, Recipient of Biannual Award for achievements in Ocular Immunology 2006 Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course, Guest Lecturer 2007 Guest Speaker and Visiting Professor, Long Island Rheumatological Association 2007 The Glover Lisman Lectureship: Manhattan Eye, Ear & Throat Hospital 2007 Visiting Professor, Rheumatology Grand Rounds, Emory University, Atlanta 2007 Lancaster Course in Ophthalmology, Lecturer 2007 The Second Annual Ocular Immunology & Uveitis Foundation Physician Education Conference: What’s New in Posterior Segment Disorders, Syposium Director, Marriot, Cambridge 2007 French-American symposium, New York, New York 2007 International Ocular Inflammation Society, Paris 2007 Massachusetts Eye and Ear Infirmary Resident Lecture Series 2007 Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course, Guest Lecturer 2008 Lancaster Course in Ophthalmology, Lecturer 2008 Visiting Professor, University of Louisville, Kentucky 2008 KURE, JIA associated Uveitis Conference, Mt Sinai School of Medicine, NY, NY 2008 Massachusetts Eye and Ear Infirmary Resident Lecture Series 2008 French-American symposium, Boston
10 2008 The Third Annual Ocular Immunology & Uveitis Foundation Physician Education Conference: What’s New in Anterior Segment Disorders, Syposium Director, Marriot, Cambridge 2008 Ocular Immunology & Uveitis Foundation Physician Education Conference: Birdshot Conference, Symposium Director, Speaker 2008 India, Multisite Simulcast teleconference, featured speaker 2008 Visiting Professor, University of Louisville, Residents Day 2008 Rochester, New York, Multisite Simulcast teleconference, featured speaker 2008 Visiting Professor Named Lecture, Case Western Reserve, Bruner Lecture 2008 International Society of Ocular Pharmacology and Therapuetics – Budapest, Hungry – Organizer and Speaker 2008 Neurology Grand Rounds, Massachusetts General Hospital, Invited Lecturer 2008 Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course, Guest Lecturer 2009 Massachusetts Eye and Ear Infirmary Resident Lecture Series 2009 McLean Medal Lecturer, Weill Cornell University School of Medicine 2009 International Ocular Inflammation Society, Prague, Honary President, Course and Symposium Organizer 2009 French-American symposium, New York, New York, Honary President 2009 Lancaster Course in Ophthalmology, Lecturer 2009 SECO Internal, Atlanta, Georgia, featured lecturer 2009 Visiting Professor, New England College of Optometry, Boston 2009 The Fourth Annual Ocular Immunology and Uveitis Foundation Physician Education Conference; Posterior Segment Disease 2009 Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course, Guest Lecturer 2010 Visiting professorship to University of North Carolina 2010 Visiting professorship to University of New Jersey School of Medicine and Dentistry 2010 Gresham Lecturer, Gresham College, London 2010 Keynote Speaker, Juvenile Idiopathic Arthritis Symposium, Milan 2010 Massachusetts Eye and Ear Infirmary Resident Lecture Series 2010 Lancaster Course in Ophthalmology 2010 The Fifth Annual Ocular Immunology and Uveitis Foundation Physician Education Conference: Summit on Anterior Segment Therapy, Director 2010 Uveitis Subspecialty Day, American Academy of Ophthalmology – Organizer and Speaker 2010 University of California, Los Angeles, Symposium on Juvenile Idiopathic Arthritis Associated Uveitis – Invited Speaker 2010 West Virginia Academy of Ophthalmology, Featured Guest 2010 Symposium on childhood uveitis, Ocular Immunology and Uveitis Foundation, Director 2010 Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course, Guest Lecturer 2011 Current Concepts on ophthalmology, State University of New York, Brooklyn, Featured Speaker 2011 New Orleans Academy of Ophthalmology, Featured Speaker 2011 Anterior Segment Summit, University of Barcelona, Featured Speaker
11 2011 Guest of Honor, 9th Annual Meeting of the Spanish Society of Ocular Surface and Cornea Barcelona 2011 Harvard Medical School/Massachusetts Eye and Ear Infirmary Resident Lecture Series 2011 Brigham & Women’s Hospital, Allergy and Immunology Lecturer 2011 Lancaster Course in Ophthalmology, Lecturer 2011 C. Stephen and Frances Foster Lecture, Duke University School of Medicine, Inaugural Lecturer 2011 Kuwait, Ministry of Health, Guest Lecturer 2011 Kuwait, Kuwait Oil Company Consultant and Lecturer 2011 Lebanon, American University of Beirut, Guest Lecturer 2011 Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course, Guest Lecturer 2011 Allergy Grand Rounds, Massachusetts General Hospital, Invited Lecturer 2011 The Sixth Annual Ocular Immunology and Uveitis Foundation Physician Education Conference; Summit on Anterior Segment Therapy, Director 2012 Harvard Medical School/Massachusetts Eye and Ear Infirmary Resident Lecture Series 2012 Lancaster Course in Ophthalmology, Lecturer 2012 New York Ophthalmic Laser Society, Guest Lecturer 2012 Irving Leopold Memorial Lecture, Guest of Honor 2012 Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course, Guest Lecturer 2012 Brigham & Women’s Hospital, Allergy and Immunology Lecturer 2012 Squaw Valley VitreoRetinal Symposium, Guest Lecturer 2012 Paris Societe Francaise D'Ophtalmologie, Guest of Honor 2012 University of California, Los Angeles, Symposium on Juvenile Idiopathic Arthritis Associated Uveitis, Part II – Invited Speaker 2012 Greater New York Resident Lecture Series, Invited Speaker 2012 The Seventh Annual Ocular Immunology and Uveitis Foundation Physician Education Conference; Summit on Childhood Uveitis, Director 2012 Uveitis Subspecialty Day, American Academy of Ophthalmology – Organizer and Speaker 2012 New England Ophthalmological Society: 739th Meeting – Guest Speaker 2013 New Age of Medical Management of Pediatric Non-Infectious Uveitis; AAPOS Annual Meeting, Invited Speaker 2013 Boston University School of Medicine, Grand Rounds Invited Speaker 2013 Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course, Guest Lecturer 2013 Brigham & Women’s Hospital, Allergy and Immunology Lecturer 2013 LEXUM ACADEMIE First International Scientific and Training Conference, Wroclaw, Poland – Guest of Honor 2013 The White Nights Congress of Ophthalmology, St. Petersburg, Russia, Invited Guest Speaker 2013 Second International Symposium on Birdshot Retinochoroidopathy, Boston – Organizer and Speaker 2013 American Uveitis Society, Guest Presenter 2013 Rheumatology Grand Rounds, Massachusetts General Hospital, Invited Lecturer
12 2013 New England Ophthalmological Society: 740th Meeting – Guest Speaker 2014 Harvard Medical School, “New Frontiers in Corneal Research” – Guest Lecturer 2014 Boston Children’s Hospital Allergy Lecture Series, Invited Lecturer 2014 12th International Ocular Inflammation Society Congress, Valencia, Spain - Guest Lecturer 2014 New York Eye and Ear Infirmary Grand Rounds Visiting Professor 2014 Advanced Cornea Conference, Ft. Lauderdale, FL – Guest Lecturer 2014 George Washington University, School of Medicine, Invited Visiting Professor 2014 Riga, Latvia – Guest of Honor, Guest Lecturer 2014 Irish College of Ophthalmologists Annual Conference, The Mooney Lecturer 2014 Lancaster Course in Ophthalmology, Lecturer 2014 Brigham & Women’s Hospital, Allergy and Immunology Lecturer 2014 Gifford Truhlsen Conference at the Truhlsen Eye Institute, University of Nebraska, Gifford Lecturer 2014 AAO Uveitis Subspeciality Day – Extinguishing the Great Fire, Organizer and Speaker 2015 Department of Ophthalmology, College of Medicine, University of Saskatchewan Saskatoon, SK, Canada, Visiting Professor 2015 Massachusetts Eye and Ear Uveitis Instruction Course, Guest Lecturer 2015 7th French American Ophthalmology Symposium, Monte Carlo, Guest Lecturer 2015 International Ocular Inflammation Society 13th Congress, San Francisco, CA, Guest Lecturer 2015 AAO Cornea Subspeciality Day – Show Me the Evidence! Back to Basics and Beyond, Speaker 2015 Advanced Cornea Conference, Ft. Lauderdale, FL – Guest Lecturer 2015 Lancaster Course in Ophthalmology, Lecturer 2015 Brigham & Women’s Hospital, Allergy and Immunology Lecturer 2016 Mallinckrodt Pharmaceuticals National Meeting, Diagnosis and Therapy of Uveitis, Orlando, FL, Guest Lecturer 2016 Lancaster Course in Ophthalmology, Lecturer 2016 Brigham & Women’s Hospital, Allergy and Immunology Lecturer 2016 David Easty Lecture, Bowman Club, Royal College of Surgeons, Edinburgh, Scotland 2016 Lebanese Ophthalmological Society, Annual Meeting Honored Guest Lecturer 2016 The Bowman Club XVIII, Invited Speaker the David Easty Lecture 2016 Beirut for the 24th Lebanese Ophthalmological Society (LOS) congress, Invited speaker 2016 AAO Uveitis Subspeciality Day 2016 Uveitis Symposium, Korean Uveitis Society, Severance Hospital, Yonsei University, Seoul, Korea 2016 Hong Kong Eye Hospital, Guest Lecture 2017 Sonoma Eye Conference 2017 Lancaster Course in Ophthalmology, Lecturer 2017 Brigham & Women’s Hospital, Allergy and Immunology Lecturer 2017 The Tessler Lecture, University of Illinois, Chicago 2017 AAO Glaucoma Subspeciality Day 2017 AAO Learning Lounger 2017 AAO Breakfast with the Experts
13 2017 AAO Uveitis Course 2017 Ocular Immunology and Uveitis Conference 2017 International Ocular Inflammation Society, Laussane, Switzerland 2017 Stephen and Frances Foster Endowed Lecture 2017 American Uveitis Society, lecture on pediatric uveitis 2017 Mexican Society of Ophthalmolgoy 2017 New England Opthalmological Society, lecturer
2018 Harvard Medical School, lecture to ophthalmology residents on ocular surface inflammatory diseases 2018 Lancaster Course in Ophthalmology, Lecturer 2018 AAO Subspecialty Day, Invited Lecturer 2018 Sonoma Eye Conference, Invited Lecturer 2018 Massachusetts General Hospital Allergy, Invited Lecturer 2018 AAO Uveitis Course 2018 AAO Chronic Conjunctivitis Course 2018 MEEI Resident lecture 2018 NY State Ophthalmological Society, Invited Lecture 2018 Duke University Foster Lecturer
2019 Lancaster Course in Ophthalmology 2019 Sonoma Eye Lecturer 2019 AAO Uveitis course 2019 AAO Chronic Conjunctivitis Course 2019 Venice Ocular Immunology Course 2019 Paris Congress on Rheumatology, Symposium Director 2019 Berlin German Society of Ophthalmology, Aurel von Szily Lecture
AWARDS AND HONORS:
1960 Bausch and Lomb Science Prize 1960 National Merit Scholar 1961 Beta Omega Sigma Leadership Honorary 1965 Phi Beta Kappa 1965 Graduation with Highest Distinction in Chemistry 1965 Chemistry Prize 1969 Alpha Omega Alpha 1979 Sigma XI 1985 Hippocrates Medal, Swedish Royal Academy of Medicine 1986 American Ophthalmological Society 1994 The Best Doctors in America: Town and Country Magazine 1995 Research to Prevent Blindness Senior Scientific Investigator Award 1996 The Best Doctors in America: American Health Magazine 1996 The Best Doctors in America: Ophthalmology Times 2000 America’s Top Doctors: Castle Connolly Medical Ltd. 2001 America’s Top Doctors: Castle Connolly Medical Ltd. 2002 America’s Top Doctors: Castle Connolly Medial Ltd.
14 2002 Kingston’s National Registry of Who’s Who – Life Member 2002 America’s Registry of Outstanding Professionals 2002 The Best Doctors in America 2003 America’s Top Doctors: Castle Connolly Medical Ltd. 2003 The Diaz Caneja Medal 2003 The International Ocular Inflammation Society Award 2004 The Clinical Uveitis Research Award 2004 America’s Top Doctors: Castle Connolly Medical Ltd. 2004 America’s Top Ophthalmologists: Consumer Research Council of America 2005 Mildred Weisenfeld Award for Outstanding Performance: ARVO 2005 Top Doctors: Boston Herald 2005 America’s Top Doctors: Castle Connolly Medical Ltd. 2005 The Marquis Who’s Who Publication Board 2005 America’s Top Ophthalmologists: Consumer Research Council of America 2006 America’s Top Doctors: Castle Connolly Medical Ltd. 2006 The Best Doctors in America 2006 America’s Top Ophthalmologists: Consumer Research Council of America 2007 American Academy of Ophthalmology Life Achievement Award 2007 America’s Top Doctors: Castle Connolly Medical Ltd. 2007 The Best Doctors in America 2007 America’s Top Ophthalmologists: Consumer Research Council of America 2008 America’s Top Doctors: Castle Connolly Medical Ltd. 2008 The Best Doctors in America 2008 Top Doctors: Boston Magazine 2008 America’s Top Ophthalmologists: Consumer Research Council of America 2008 European Uveitis Patient Interest Association, 1st Prize, Best 2008 Paper in Clinical Uveitis 2008 Top Five Most Cited Papers published by Ophthalmic Epidemiology during 2008 2009 Top Doctors: Boston Magazine 2009 The Clinical Uveitis Research Award 2009 America’s Top Doctors: Castle Connolly Medical Ltd. 2009 The Best Doctors in America 2009 America’s Top Ophthalmologists: Consumer Research Council of America 2009 McLean Medal 2009 Patients’ Choice Award, American Registry 2009 Editors’ Choice Symposium, 2009 American Academy of Ophthalmology Annual Meeting 2009 European Uveitis Patient Interest Association, 2nd Prize, Best 2009 Paper in Clinical Uveitis 2009 Inclusion of Three Papers within the Top 10 Uveitis Papers published in 2009, as recommended by the American Academy of Ophthalmology 2010 America’s Top Doctors Award 2010 Top Doctors: Boston Magazine 2010 The Clinical Uveitis Research Award 2010 Association for Research in Vision and Ophthalmology Silver Fellow Award 2010 Highest Grade Within Subject Area; 2010 American Academy of Ophthalmology Annual Meeting (Free Poster #PO 404)
15 2010 Best Paper of Session, 2010 American Academy of Ophthalmology Annual Meeting (Free Paper #PA 039) 2010 Inclusion of Four Papers within the Top 10 Uveitis Papers published in 2010, as recommended by the American Academy of Ophthalmology 2011 America’s Top Doctors: Castle Connolly Medical Ltd. 2011 America’s Top Ophthalmologists: Consumer Research Council of America 2011 Patients’ Choice Award, American Registry 2011 America’s Top Doctors Award 2011 Top Doctors: Boston Magazine 2012 America’s Top Doctors: Castle Connolly Medical Ltd. 2012 America’s Top Ophthalmologists: Consumer Research Council of America 2012 Patients’ Choice Award, American Registry 2012 America’s Top Doctors Award 2012 Top Doctors: Boston Magazine 2012 Academy of Ophthalmology, Life Fellow Award 2012 Vitals, Most Compassionate Doctor Award 2013 America’s Top Doctors: Castle Connolly Medical Ltd. 2013 Patients’ Choice Award, American Registry 2013 America’s Top Doctors Award 2013 Top Doctors: Boston Magazine 2014 America’s Top Doctors: Castle Connolly Medical Ltd. 2014 Patients’ Choice Award, American Registry 2014 America’s Top Doctors Award 2014 Top Doctors: Boston Magazine 2015 America’s Top Doctors: Castle Connolly Medical Ltd. 2015 Best Mentor: Foster Ocular Immunology Society 2016 America’s Top Doctors: Castle Connolly Medical Ltd. 2016 Patients’ Choice Award, American Registry 2016 America’s Top Doctors Award 2017 America’s Top Doctors: Castle Connolly Medical Ltd. 2017 Patients’ Choice Award, American Registry 2017 America’s Most Honored Professionals Award 2018 Albert Nelson Marquis Lifetime Award
MAJOR COMMITTEE ASSIGNMENTS:
International 1999 – Present International Society of Ocular Pharmacology and Pharmaceutics – Organizing Executive Committee 1999 – Present International Ocular Inflammation Society – Executive International Council 2003 – Present International Uveitis Study Group
National 1980 American Academy of Ophthalmology - Continuing Education Committee, Subcommittee of Planning in Continuing Education in Ophthalmology 1983 – Present Corneal Dystrophy Society 1989 – Present American Behçet's Disease Association 1991 – Present Board of Directors, Castroviejo Cornea Society
16 1992 – Present American Uveitis Society, Executive Committee 1994 Ad Hoc Grant Application Reviewer, National Eye Institute 1994 – 1997 American Uveitis Society, Director, AUS Course on Uveitis, American Academy of Ophthalmology 1994 – Present American Uveitis Society, Executive Committee 1998 – Present American Uveitis Society, Chairman, Committee on Investments 1999 – Present American Uveitis Society, Director, Scientific Meeting 1999 – 2000 American Uveitis Society, Subcommittee on Immunomodulatory Therapy for Ocular Inflammtory Diseases 2000 – Present Medical Advisory Board, Stevens-Johnson Syndrome Foundation 2003 – Present American Academy of Ophthalmology- Director- Uveitis Subspecialty Day 2004 – 2008 American Academy of Ophthalmology, Basic and Clinical Science Course – Faculty 2011 – 2013 President Elect American Uveitis Society 2013 – 2015 President American Uveitis Society
Local 1975 – 1981 Teaching Committee, Massachusetts Eye and Ear Infirmary 1975 – 1981 Resident Selection Committee, Massachusetts Eye and Ear Infirmary 1981 – 1987 Infection Control Committee, Massachusetts Eye and Ear Infirmary 1983 – 1987 Pharmacy Committee, Massachusetts Eye and Ear Infirmary 1985 – 2005 Patent Committee, Massachusetts Eye and Ear Infirmary 1985 – 1987 Ambulatory Services Reorganization Task Force, Massachusetts Eye and Ear Infirmary 1985 – 1987 Marketing Task Force, Massachusetts Eye and Ear Infirmary 1986 – 1988 Overhead Task Force, Massachusetts Eye and Ear Infirmary 1993 – 1996 Board of Surgeons, Massachusetts Eye and Ear Infirmary 1994 – 2005 Executive Committee, Department of Ophthalmology Massachusetts Eye and Ear Infirmary 2005 – Present Ocular Immunology and Uveitis Foundation – Director- Annual Physician Education Conference 2006 – Present Ocular Immunology and Uveitis Foundation, President of the Board of Trustees 2006 – Present Ocular Immunology and Uveitis Foundation, Board Development Committee
EDITORIAL BOARDS:
Editorial Board, CME Series of Ophthalmology Editorial Board, Cornea Editorial Board, Herpes Editorial Board, Digital Journal of Ophthalmology (DJO) Editor-in-Chief, Contemporary Ophthalmology Editor-in-Chief, Massachusetts Eye Research & Surgery Institute, World Wide Web Site Editor-in-Chief, www.uveitis.org World Wide Web Site Editorial Board, Ocular Immunology and Inflammation
17 Editorial Advisory Board, WebMD Editorial Board, Topics in Ocular Antiinfectives Advisory Board, Medscape Ophthalmology Editorial Board, Allergy and Immunology
EDITORIAL BOARDS, AD HOC REVIEW:
American Journal of Ophthalmology Archives of Ophthalmology Ophthalmology Investigative Ophthalmology Current Eye Research Experimental Eye Research Survey of Ophthalmology New England Journal of Medicine Journal of Immunology Survey of Immunology
MEMBERSHIPS, OFFICES, AND COMMITTEE ASSIGNMENTS IN PROFESSIONAL SOCIETIES:
General Medicine: American Medical Association Massachusetts Medical Society Royal Society of Medicine, London Lupus Foundation of America, Inc. American Behçet’s Disease Association American College of Rheumatology, Fellow American College of Surgeons, Fellow
Clinical Ophthalmology: American Academy of Ophthalmology, Fellow American Association of Ophthalmology Massachusetts Society of Eye Physicians & Surgeons New England Ophthalmological Society Contact Lens Society of America
Immunology Research: Ocular Microbiology and Immunology Group American Association of Immunology American Society of Ophthalmologic and Otolaryngologic Allergy American Uveitis Society, Board of Directors American Federation for Clinical Research Federation of American Societies for Experimental Biology
18 International Society of Immunopharmacology American Society for Microbiology Association of Medical Laboratory Immunologists American Society of Clinical Immunologists International Uveitis Study Group International Ocular Inflammation Society
Ophthalmic Research: Association for Research in Vision & Ophthalmology Association for Eye Research – Amsterdam International Society for Eye Research
MAJOR RESEARCH INTERESTS:
1. General and Ocular Immunology - Autoimmune Ocular Disease - Corneal Transplantation Immunology - Immune Response to Ocular Herpes Simplex Infection - Immunomodulatory Therapy
2. Ocular Microbiology - Bacterial, Fungal and Viral Ocular Infections - Ocular Penetration of Antibiotics
3. Corneal Wound Healing
4. Surgical Therapy of Ocular Inflammatory Disease
5. Uveitis Diagnosis and Therapy
TEACHING EXPERIENCE:
Current Annual Teaching Activities:
Resident Lecture Series, Massachusetts Eye and Ear Infirmary
Lancaster Course in Ophthalmology
American Academy of Ophthalmology Course on: Uveitis Course on: Scleritis Course on: Peripheral Corneal Disease Course on: Chronic Conjunctivitis Course on: Cornea
19 Ocular Immunology and Uveitis Foundation Annual Physicain Education Conference Anterior Segment, 2006, 2008 , 2010 International Symposium on Birdshot Choroidopathy, 2008 Posterior Segment Conference, 2007, 2009 Ocular Immunology and Uveitis Foundation Symposium on Juvenile Idiopathic Arthritis Associated Uveitis – Organizer and Speaker
Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course
CONSULTANT POSITIONS:
Consultant, Baxter Laboratories, Travenol Div. Design and Conduct of Clinical Trials: 1972-1974
Consultant, Fisons Corporations Design and Conduct of Clinical Trials: 1985-1995
Consultant, Sandoz Pharmaceuticals Design and Conduct of Clinical Trials: 1990
Consultant, Alcon Pharmaceuticals Design and Conduct of Clinical Trials: 1990-1995 Basic Research on Inflammation Speakers’ Bureau
Consultant, Centocor Pharmaceuticals Immunomodulatory Therapy: 2003 – 2006
Consultant, Inspire Pharmaceuticals Clinical Research on Uveitic Macular Edema 2004 – 2011 Speakers’ Bureau
Consultant, Inotek 2003-2015
Consultant, Bausch & Lomb 1997- present Speakers’ Bureau
Consultant, Genetech 2004-present
Consultant, Sirion 2006-2010
Consultant, Therakine 2006-2015
Consultant, Ista 2006-2012
Consultant, Allergan 2005-present
20 Sponsored Research Speakers’ Bureau
Consultant, EyeGate 2005-present
Consultant, Novartis Sponsored Research 2007-Present
Consultant, Merrimack 2006-2009
Consultant, Lux BioSciences 2008-2011 Sponsored Research 2007-2009
Consultant, Abbott Laboratory 2009-2012
Consultant, XOMA Corporation 2012-2015
Consultant, Mallinckrodt Ocular Inflammation Expert Panel, 2015-Present
PRINCIPAL CLINICAL AND HOSPITAL SERVICE RESPONSIBILITIES:
Director – Ocular Immunology and Uveitis Service Massachusetts Eye and Ear Infirmary Director – Hilles Immunology Laboratory Massachusetts Eye and Ear Infirmary Director – Rhodes Molecular Immunology Laboratory Massachusetts Eye and Ear Infirmary (Ended in 2005 with the establishment of the Massachusetts Eye Research & Surgery Institute) Founder & President - Massachusetts Eye Research & Surgery Institution President & CEO – Ocular Immunology & Uveitis Foundation
GRANTS RECEIVED:
1966 NSF Summer Research Fellowship 1973 Southern Medical Association Fellowship 1975 & 1976 NIH Research Fellowship 1979 NIH (National Eye Institute) R01 Grant EY-03063,01, “Immunopathology of an Animal Model of Peripheral Ulcerative Keratitis.” 1981 Milton Fund, Harvard University “Autoimmune Corneal Disease” 1982 NIH (National Eye Institute) R01 Grant EY-04092-01 “Regulation of Immune Responses in the Eye.”In collaboration with Mark I. Greene, M.D., Dept. of Pathology, Harvard Medical School 1982 NIH R01 Grant CA20822 “Cell Interaction and the Clotting System.”In conjunction with Robert B. Colvin, M.D., Immunopathology Dept., Mass. General Hospital 1983 Fight for Sight: “Ocular Immune Responses”
21 1985 NIH “Immunology and Genetics of Herpes Simplex Keratitis.” Grant RO1-EY-06008-01 1985 NIH Institutional Training Grant, Massachusetts Eye and Ear Infirmary 1985 NIH “Case Control Study of Selective Eye Disorders: Uveitis.” In conjunction with Dr. Johanna Seddon, Massachusetts Eye and Ear Infirmary 1987 NIH R01CA-20822 “Cell Interaction and the Clotting System.” In collaboration with Robert Colvin, M.D., Mass. Gen. Hospital 1988 NIH T32-EY07097-02 “Multidisciplinary Training in Ophthalmic Science.” Massachusetts Eye and Ear Infirmary 1989 & 1994 NIH EY08379-01 “Ocular Pemphigoid Mechanism of Pathogenesis.” In conjunction with A. Razzaque Ahmed, M.D., Center for Blood Research 1989 & 1996 NIH R01 EY06008 “Molecular Genetics of Herpes Simplex-mediated Ocular Pathology” Massachusetts Eye and Ear Infirmary 1998 NIH EY08379-04 “Ocular Cicatricial Pemphigoid: Mechanism of Pathogenesis. with A. Razzaque Ahmed, MD, Center for Blood Research 2001 Bausch & Lomb Fluocinolone Implant Study Grant 2005 Inspire Pharmaceuticals Denufosol Uveitic Macular Edema Study Grant 2005 NIH EY 014655-02 “Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study” (SITE) 2006 NIH Multi-Centre Uveitis Steroid Treatment Trial (MUST) 2006 Allergan Posurdex for Intermediate Uveitis 2007 Lux Biosciences Studies on LX 211 (x3) 2007 Merrimack Pharmaceuticals Study Grant 2007 Lux Biosciences Studies on PK 2007 Merrimack Pharmaceuticals: Alphafetoprotein Therapy for Uveitis 2008 Cerimon Pharmaceuticals: Basilixumab Therapy for Uveitis 2008 Sirion Therapeutics: Difluprednate Therapy for Uveitis 2008 Novartis Phamaceuticals: Anti-IL-17 Antibody Therapy for Uveitis 2008 Eyegate Pharma: Iontophoresis of Dexamethasone Therapy for Uveitis 2008 ISTA Phamaceuticals: Bromfenac Therapy for Uveitis 2008 Novartis Phamaceuticals: AEB071 as a therapy for Uveitis in patients with Macular Edema 2008 Novartis Phamaceuticals: RKI983 as a therapy for Uveitis in patients with Glaucoma 2009 Novartis Phamaceuticals: Anti-IL-17 Antibody Therapy for Uveitis 2009 Novartis Pharmaceuticals: Anti-IL-17 Antibody Therapy for Behcet’s 2010 Abbott: Adalimumab Therapy for Active Uveitis 2010 Abbott: Adalimumab Therapy for Inactive Uveitis 2010 Alcon: Durezol for Anterior Uveitis 2011 NIH EY 014655-02 “Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study” (SITE) renewed 2011 NIH Multi-Centre Uveitis Steroid Treatment Trial (MUST) renewed 2011 Eyegate Pharma: Iontophoresis of Dexamethasone Therapy for Uveitis 2011 Lux Biosciences Studies on Voclosporin for Posterior Uveitis 2011 Santen Sirolimus DE-109 Injectable Study
22 2011 Novartis Pharmaceuticals: LFG316 for Active Multifocal Choroiditis and Panuveitis 2012 NIH EY 014655-02 “Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study” (SITE) renewed 2012 NIH Multi-Centre Uveitis Steroid Treatment Trial (MUST) renewed 2012 XOMA X052130 Gevokizumab Study 2012 XOMA X052131 Gevokizumab Study 2013 NIH EY 014655-02 “Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study” (SITE) renewed 2013 NIH Multi-Centre Uveitis Steroid Treatment Trial (MUST) renewed 2013 Santen Sirolimus DE-109 Injectable Study 2013 Novartis Pharmaceuticals: LFG316 for Active Multifocal Choroiditis and Panuveitis 2013 NIH EY 014655-02 “Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study” (SITE) renewed 2013 XOMA X052130 Gevokizumab Study 2013 XOMA X052131 Gevokizumab Study 2013 XOMA X052132 Gevokizumab Study 2013 PSV-FAI-001 pSivida Study 2013 sanofi aventis ACT13480 Study 2014 NIH EY 014655-02 “Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study” (SITE) renewed 2014 NIH Multi-Centre Uveitis Steroid Treatment Trial (MUST) renewed 2014 Santen Sirolimus DE-109 Injectable Study 2014 Novartis Pharmaceuticals: LFG316 for Active Multifocal Choroiditis and Panuveitis 2014 NIH EY 014655-02 “Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study” (SITE) renewed 2014 XOMA X052130 Gevokizumab Study 2014 XOMA X052131 Gevokizumab Study 2014 XOMA X052132 Gevokizumab Study 2014 XOMA X052133 Gevokizumab Study 2014 PSV-FAI-001 pSivida Study 2014 sanofi aventis ACT13480 Study 2014 CLS1001-201 Clearside Biomedical Study 2014 DSP-Visulex System Aciont Study 2014 NS2-02 Aldeyra Study 2014 192371-023 Allergan Study 2014 NFG0214 Dompé Study 2015 NIH Multi-Centre Uveitis Steroid Treatment Trial (MUST) renewed 2015 Santen Sirolimus DE-109 Injectable Study 2015 Novartis Pharmaceuticals: LFG316 for Active Multifocal Choroiditis and Panuveitis 2015 NIH EY 014655-02 “Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study” (SITE) renewed 2015 XOMA X052130 Gevokizumab Study 2015 XOMA X052131 Gevokizumab Study 2015 XOMA X052132 Gevokizumab Study
23 2015 XOMA X052133 Gevokizumab Study 2015 PSV-FAI-001 pSivida Study 2015 CLS1001-201 Clearside Biomedical Study 2015 DSP-Visulex System Aciont Study 2015 NS2-02 Aldeyra Study 2015 192371-023 Allergan Study 2015 NFG0214 Dompé Study
2016 NIH Multi-Centre Uveitis Steroid Treatment Trial (MUST) renewed 2016 Santen Sirolimus DE-109 Injectable Study 2016 Novartis Pharmaceuticals: LFG316 for Active Multifocal Choroiditis and Panuveitis 2016 PSV-FAI-001 pSivida Study 2016 PSV-FAI-006 pSivida Study 2016 DSP-Visulex System Aciont Study 2016 EGP-437-006 EyeGate Study 2016 440 B+L Study 2016 853 B+L Study 2016 091 Allergan Bimatoprost SR Study
PHILANTHROPIC SOCIETIES:
1. Davison Society, Duke University School of Medicine 2. Phillips Society, Massachusetts General Hospital 3. Founder Society, Massachusetts General Hospital 4. Braxton Craven Fellow – Duke University 5. James B Duke Society – Duke University 6. Pinnacle Society- Duke Univeristy
BIBLIOGRAPHY:
Original Reports
In Print
1. Waltman SR, Buerk K, Foster CS. Effects of Ophthalmic Ointment on Intraocular Penetration of Topical Fluorescein in Rabbits and Man. Am J Ophthalmol 1974;78:262-4.
2. Foster CS, Brennan L. The Oculocardiac and the Oculorespiratory Reflex. Am Assoc Nurse Anesthetists J 1974;42:317-22.
3. Bohigian GM, Foster CS. Treatment of Pseudomonas keratitis in the rabbit with antibiotic- steroid combinations. Invest Ophthalmol Vis Sci 1977;16:553-556.
24
4. Foster C, Pavan-Langston D. Corneal Wound Healing and Antiviral Medication. Arch Ophthalmol 1977;95:2062-7.
5. Pavan-Langston D, Foster CS. Trifluorothymidine and Idoxuridine Therapy of Ocular Herpes. Am J Ophthalmol 1977;84:818-25.
6. Mobilia EF, Foster CS. The Management of Recurrent Corneal Erosions with Ultra-Thin Lenses. Cont Intraoc Lens Med J 1978;4:25-9.
7. Donshik PC, Collin HB, Foster CS, Cavanagh HD, Boruchoff SA, Magee AJ. Conjunctival Resection Treatment and Ultrastructural Histopathology of Superior Limbic Keratoconjunctivitis. Am J Ophthalmol 1978;85:101-10.
8. Cannon DJ, Foster CS. Collagen crosslinking in keratoconus. Invest Ophthalmol Vis Sci 1978;17:63-5.
9. Collin HB, Donshik PC, Boruchoff SA, Foster CS, Cavanagh HD. The Fine Structure of Nuclear Changes in Superior Limbic Keratoconjunctivitis. Invest Ophthalmol Vis Sci 1978;17:79-84.
10. Foster CS, Goetzl EJ. Ascorbate Therapy in Impaired Neutrophil and Monocyte Chemotaxis With Atopy, Hyperimmunoglobulinemia E, and Recurrent Infection. Arch Ophthalmol 1978;96:2069-72.
11. Kenyon KR, Foster CS. Thermal Denaturation of Donor Cornea: An Unusual Complication of Penetrating Keratoplasty. Ophth Surg 1978;9:47-51.
12. Collin HB, Donshik PC, Foster CS, Boruchoff SA, Cavanaugh HD. Keratinization of the Bulbar Conjunctival Epithelium in Superior Limbic Keratoconjunctivitis in Humans. Acta Ophthalmol 1978;56:531-43.
13. Foster CS, Yamamoto GK. Ocular Rigidity in Keratoconus. Am J Ophthalmol. 1978;86:802-6.
14. Foster CS, Allansmith MR. Chronic Unilateral Blepharoconjunctivitis Caused by Sebaceous Carcinoma. Am J Ophthalmol 1978;86:218-20.
15. Foster CS, Kenyon KR, Greiner J, Greineder DK, Friedland B, Allansmith MR. The Immunopathology of Mooren’s Ulcer. Am J Ophthalmol 1979;88:149-59.
25 16. Foster CS, Allansmith MR. Lack of Blood Group Antigen A on Human Corneal Endothelium. Am J Ophthalmol 1979;87:165-70.
17. Mobilia EF, Foster CS. A One-Year Trial of Polycon Lenses in the Correction of Keratoconus. Cont Intraoc Lens Med J 1979;5:37-42.
18. Lamberts DW, Foster CS, Perry HD. Schirmer Test After Topical Anesthesia and the Tear Meniscus Height in Normal Eyes. Arch Ophthalmol 1979;97:1082-5.
19. Foster CS, English J. Coping with Blindness: The Importance of the Ophthalmologist in Referral. J Vis Impair Blind 1979:193-6.
20. Foster CS, Stefanyszyn M. Intraocular Penetration of Miconazole in Rabbits. Arch Ophthalmol 1979;97:1703-6.
21. Lamberts DW, Foster CS. Chronic Unilateral External Ocular Inflammation. Surv Ophthalmol 1979;24:157-66.
22. Foster CS. Ocular Surface Manifestations of Neurological and Systemic Disease. Int Ophthalmol Clin 1979;19:207-42.
23. Foster CS. Vernal Keratoconjunctivitis. Perspectives Ophthalmol 1980;1:35-8.
24. Fogle JA, Kenyon KR, Foster CS. Tissue Adhesive Arrests Stromal Melting in the Human Cornea. Am J Ophthalmol 1980;89:795-802.
25. Foster CS. Immunosuppressive Therapy for External Ocular Inflammatory Disease. Ophthalmology 1980;87:140-9.
26. Foster CS, Duncan J. Randomized Clinical Trial of Topically Administered Cromolyn Sodium for Vernal Keratoconjunctivitis. Am J Ophthalmol 1980;90:175-81.
27. Eliason J, Foster CS. Insect Contamination of a Cornea Stored in M-K Medium. Ophthalmol Surg 1980;11:611-3.
28. Foster CS, Lass JH, Moran-Wallace K, Giovanoni R. Ocular Toxicity of Topical Antifungal Agents. Arch Ophthalmol 1981;99:1081-4.
29. Lass JH, Campbell RC, Rose J, Foster CS, Dohlman CH. Medroxyprogesterone on Corneal Ulceration: Its Effects After Alkali Burns on Rabbits. Arch Ophthalmol 1981;99:673-6.
26 30. Lass JH, Haaf J, Foster CS, Belcher C. Visual Outcome in Eight Cases of Serratia Marcescens Keratitis. Am J Ophthalmol 1981;92:384-90.
31. Foster CS, Dubey DP, Stux S, Yunis E. Natural Killer (NK) Cytotoxicity and HLA-A, -B, -C, and DR Profile in a Group of Patients with Recurrent Versus Non-recurrent Herpes Simplex Keratitis (HSK). The Cornea in Health and Disease. (VIth Congress of the European Society of Ophthalmology). Royal Society of Medicine International Congress and Symposium 1981;49:733-737.
32. Foster CS, Lass J. Antifungal Ocular Toxicity. The Cornea in Health and Disease. (Vith Congress of the European Society of Ophthalmology). Royal Society of Medicine International Congress and Symposium 1981;40:671-675.
33. Foster CS, Duncan J. Prognostic Factors in Penetrating Keratoplasty for Herpes Simplex Keratitis. The Cornea in Health and Disease. (Vith Congress of the European Society of Ophthalmology). Royal Society of Medicine International Congress and Symposium 1981;40:797-800.
34. Foster CS, Dubey DP, Stux S, Yunis E.. Natural Killer Activity and HLA Phenotypes in Patients with Herpes Simplex Keratitis. Herpetische Augenerkrankungen Munich 1981;85- 9.
35. Foster CS. Immunosuppressive Therapy for Experimental Corneal Ulceration. Immunology of the Eye: Workshop II. Autoimmune Phenomena and Ocular disorders. Special Supplement Immunology Abstracts, 1981;91-102.
36. Foster CS, Duncan J. Penetrating Keratoplasty for Herpes Simplex Keratitis. Am J.Ophthalmol 1981;92:336-43.
37. Foster CS. Miconazole Therapy for Keratomycosis. Am J Ophthalmol 1981;91:622-9.
38. Fujikawa LS, Foster CS, Harrist TJ, Lanigan JM, Colvin RB. Fibronectin in Healing Rabbit Corneal Wounds. Lab Invest 1981;45:120-9.
39. Nash IS, Greene PR, Foster CS. Comparison of Mechanical Properties of Keratoconus and Normal Corneas. Exp Eye Res 1982;35:413-24.
40. Mobilia EF, Foster CS. A Comparison of Various Extended Wear Lenses for Use in Aphakia. Contact Intraoc Lens Med J 1982;8:12-5.
27 41. Foster CS, Zelt RP, Phan T-MM, Kenyon KR. Immunosuppressive and Selective Inflammatory Cell Depletion: Studies on a Guinea Pig Model of Corneal Ulceration After Ocular Alkali Burning. Arch Ophthalmol 1982;100:1820-4.
42. Bhan AK, Fujikawa LS, Foster CS. T-cell Subsets and Langerhans Cells in Normal and Diseased Conjunctiva. Am J Ophthalmol 1982;94:205-12.
43. Foster CS, Wetzig RP, Greene MI. Ocular Immune Responses I. Priming of A/J Mice in the Anterior Chamber with Azobenzenearsonate-Derivatized Cells Induces Second- order- like Suppressor T Cells. J Immunol 1982;128:1753-7.
44. Fujikawa LS, Colvin RB, Bhan AK, Fuller TC, Foster CS. Expression of HLA-A/B/C and –DR Locus Antigens on Epithelial, Stromal, and Endothelial Cells of the Human Cornea. Cornea 1982;1:213-22.
45. Foster CS, Wilson LA, Ekins MB. Immunosuppressive Therapy for Progressive Ocular Cicatricial Pemphigoid. Ophthalmology 1982;89:340-53.
46. Foster CS, Wetzig R. Immune Reactions in the Eye. Surv Immunol Res 1982;1:93-108.
47. Tolentino FI, Foster CS, Lahav M, Luke HS, Liu LHS, Rabin AR. Toxicity of Intravitreous Miconazole. Arch Ophthalmol 1982;100:1504-9.
48. Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endothalmitis: Review of 36 cases. Ophthalmol 1982;89:921-9.
49. Foster CS. Diagnosis and Therapy of Central Corneal Ulcers I. Differential Diagnosis and Diagnostic Procedures. NY Eye Ear Inf J 1982;3:16-9.
50. Foster CS. Diagnosis and Therapy of Central Corneal Ulcers II: Initial Therapy: Bacterial and Fungal Keratitis. NY Eye Ear Inf J 1982;3:20-4.
51. Foster CS. Immunomodulation in Ophthalmology. Int Ophthalmol Clin 1983;23:183-196.
52. Foster CS, Yee M. Corneoscleral Manifestations of Graves’ Disease and the Acquired Connective Tissue Disorders and Systemic Vasculitis. Int Ophthalmol Clin 1983;23:131- 57.
53. Cintron C, Fujikawa LS, Covington H, Foster CS, Colvin RB. Fibronectin in Developing Rabbit Cornea. Curr Eye Res 1983;3:489-99.
54. Foster CS. Herpes Simplex Keratitis. Clinical Ophthalmology Update. 1983;1:2-8.
28
55. Foster CS. Herpes Zoster Ophthalmicus. Clinical Ophthalmology Update. 1983;1:2-6.
56. Foster CS. Cicatricial Pemphigoid. Clinical Ophthalmology Update. 1983;1:2-6.
57. Tuberville AW, Foster CS, Wood TO. The Effect of Donor Corneal Epithelium Removal on the Incidence of Allograft Rejection Reactions. Ophthalmology 1983;90:1351-6.
58. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis: Effects of systemic immunosuppression. Ophthalmology 1984;91:1253-63.
59. Thoft RA, Friend J, Kinoshita S, Nikoli L, Foster CS. Ocular Cicatricial Pemphigoid Associated with Hyperproliferation of the Conjunctival Epithelium. Am J Ophthalmol 1984;98:37-42.
60. Lass JH, Langston RHS, Foster CS, Pavan-Langston D. Antiviral Medications and Corneal Wound Healing. Antiviral Res 1984;4:143-57.
61. Foster CS. Review of uveitis book by Smith and Nozik. New Engl J Med 1984;310:1063.
62. Fujikawa LS, Foster CS, Gipson IK, Colvin RB. Basement Membrane Components in Healing Rabbit Corneal Epithelial Wounds: Immunofluorescence and Ultrastructural Studies. J Cell Biol 1984;98:128-38.
63. Borodic GE, Beyer-Machule CK, Millin J, Conte J, Foster CS. Immunoglobulin deposition in localized conjunctival amyloidosis. Am J Ophthalmol 1984;98:617-622.
64. Phan T-MM, Zelt RP, Kenyon KR, Chakrabarti B, Foster CS. Ascorbic Acid Therapy in a Thermal Burn Model of Corneal Ulceration in Rabbits. Am J Ophthalmol 1985;99:74-82.
65. Wasson P, Foster CS. Autoimmune Reactions in the Eye. Concepts Immunopathol 1985;2:249-67.
66. Galbavy EJ, Foster CS. Ultrastructural Characteristics of Conjunctiva in Cicatricial Pemphigoid. Cornea 1985;4:127-36.
67. Foster CS, Monroe JG, Campbell R, Kalpaxis J, Wetzig R, Greene MI. Ocular Immune Responses II. Priming of A/J mice in the Vitreous Induces Either Enhancement of or Suppression of Subsequent Hapten-Specific DTH Responses. J Immunol 1985;136:2787- 91.
29 68. Foster CS. Systemic Immunosuppressive Therapy for Progressive Bilateral Mooren’s Ulcer. Ophthalmology 1985;92:1436-9.
69. Pouliquen Y, Patey A, Foster CS, Goichot L, Savoldelli M. Drug-induced Cicatricial Pemphigoid Affecting the Conjunctiva. Ophthalmology 1986;93:775-83.
70. Foster CS, Tsai Y, Monroe JG, Campbell R, Cestari M, Wetzig R, Knipe D, Greene MI. Genetic Studies on Murine Susceptibility to Herpes Simplex Keratitis. Clin Immunol Immunopathol 1986;40:313-25.
71. Sandstrom IK, Foster CS, Wells PA, Knipe D, Caron L, Greene MI. Previous Immunization of Mice with Herpes Simplex Virus Type-1 (HSV-1) Strain MP Protects Against Secondary Corneal Infection. Clin Immunol Immunopathol 1986;40:326-34.
72. Regan CDJ, Foster CS. Retinal Vascular Diseases: Clinical Presentation and Diagnosis. Int Ophthalmol Clin 1986;26:25-53.
73. Foster CS, Regan CDJ. Retinal Vascular Diseases: Management. Int Ophthalmol Clin 1986;26:55-71.
74. Singh G, Guthoff R, Foster CS. Observations on Long-Term Follow-up of Posterior Scleritis. Am J Ophthalmol 1986;101:570-5.
75. Wells PA, Ashur ML, Foster CS. SDS-Gradient Polyacrylamide Gel Electrophoresis of Individual Ocular Mucus Samples from Patients with Normal and Diseased Conjunctiva. Curr Eye Res 1986;5:823-31.
76. Foster CS, Shaw CD, Wells PA. Scanning Electron Microscopy of Conjunctival Surfaces in Patients with Ocular Cicatricial Pemphigoid. Am J Ophthalmol 1986;102:584-91.
77. Wagoner MD, Kenyon KR, Foster CS. Management Strategies in Peripheral Ulcerative Keratitis. Int Ophthalmol Clin 1986;26:147-57.
78. Millin JA, Golub BM, Foster CS. Human Basement Membrane Components of Keratoconus and Normal Corneas. Invest Ophthalmol Vis Sci 1986;27:604-7.
79. Foster CS. Cicatricial Pemphigoid. Thesis for the American Ophthalmological Society. Trans Am Ophthalmol Soc 1986;84:527-663.
80. Morgan CM, Foster CS, D’Amico DJ, Gragoudas ES. Retinal Vasculitis in Polyarteritis Nodosa. Retina 1986;6:205-9.
30 81. Foster CS. Basic Research and Clinical Aspects of Pseudomonas aeruginosa. Eye and Immunity 1987;39:77-82.
82. Singh G, Foster CS. Epidermal Growth Factor in Alkali-Burned Corneal Epithelial Wound Healing. Am J Ophthalmol 1987;103:802-7.
83. Foster CS, Opremcak EM, Rice B, Wells P, Chung H, Thompson P, Fong LP, Raizman M. Clinical, Pathologic, and Immunopathologic Characteristics of Experimental Murine Herpes Simplex Virus Stromal Keratitis and Uveitis is Controlled by Gene Products from the Igh-1 Locus on Chromosome 12. Trans Am Ophthalmol Soc 1987;85:293-311.
84. Lass JH, Foster CS, Grove AS, Rubenfeld M, Lusk RP, Jenson AB, Lancaster WD. Interferon-Alpha Therapy of Recurrent Conjunctival Papillomas. Am J Ophthalmol 1987;103:294-301.
85. Phan T-MM, Foster CS, Boruchoff SA, Zagachin LM, Colvin RB. Topical Fibronectin in the Treatment of Persistent Corneal Epithelial Defects and Trophic Ulcers. Am J Ophthalmol 1987;104:494-501.
86. Foster CS. Ocular Immunology. Semin Ophthalmol 1988;3:211-20.
87. Opremcak EM, Wells PA, Thompson P, Daigle JA, Rice BA, Millin JA, Foster CS. Immunogenetic Influence of Igh-1 Phenotype on Experimental Herpes Simplex Virus Type-1 Corneal Infection. Invest Ophthalmol Vis Sci 1988;29:749-54.
88. Millin JA, Opremcak EM, Wells PA, Foster CS. Ganglionic Permissivity to HSV-1 Replication and Acyclovir-Induced Latency: An In Vitro Model. Invest Ophthalmol Vis Sci 1988;29:232-8.
89. Foster CS, Fong LP, Azar D, Kenyon KR. Episodic Conjunctival Inflammation after Stevens-Johnson Syndrome. Ophthalmology 1988;95:453-62.
90. Ormerod LD, Foster CS, Paton BG, Haaf J, Baker AS. Ocular Capnocytophaga Infection in an Edentulous, Immunocompetent Host. Cornea 1988;7:218-22.
91. Foster CS. Vitrectomy in the Management of Uveitis. Ophthalmology 1988;95:1011-2.
92. Singh G, Foster CS. 1988. Treatment of Nonhealing Corneal Ulcers and Recurrent Corneal Erosions. The Cornea: Transactions of the World Congress on the Cornea III, (Ed. Cavanagh HD) Raven Press, NY. pp. 45-53.
31 93. Foster CS, Opremcak EM, Rice B, Wells P, Chung H, Thompson P, Fong LP, Raizman M. Immunogenic Control of Ocular Responses to Herpes Simplex Virus. The Cornea: Transactions of the World Congress on the Cornea III 1988;413-420.
94. Wells PA, DeSiena-Shaw C, Rice B, Foster CS. Detection of ocular mucus in normal human conjunctiva and conjunctiva from patients with cicatricial pemphigoid Using Lectin Probes and Histochemical Techniques. Exp Eye Res 1988;46:485-97.
95. Ormerod LD, Fong LP, Foster CS. Corneal infection in mucosal scarring disorders and Sjögren’s syndrome. Am J Ophthalmol 1988;105:512-8.
96. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988;95:813821.
97. Foster CS. Ocular manifestations of sarcoidosis preceding systemic manifestations. Sarcoidosis and other granulomatous disorders. Excerpta Medica 1988;756:177-181.
98. Thompson P, Wells PA, Sandstrom IK, Opremcak EM, Millin JA, Daigle JA, Foster CS. Immunomodulation of experimental murine herpes simplex keratitis: I. UV-HSV protection. Curr Eye Res 1988;7:1043-9.
99. Foster CS, Sandstrom IK, Wells PA, Thompson P, Daigle J, Opremcak EM. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection. Curr Eye Res 1988;7:1051-61.
100. Fong LP, Ormerod DL, Kenyon KR, Foster CS. Microbial keratitis complicating penetrating keratoplasty. Ophthalmology 1988;95:1269-75.
101. Foster CS. Evaluation of topical cromolyn sodium in the treatment of vernal keratoconjunctivitis. Ophthalmology 1988;95:194-201.
102. Raizman MB, Foster CS. Passive transfer of anti-HSV-1 IgG protects against stromal keratitis in mice. Curr Eye Res 1988;7:823-9.
103. Sainz de la Maza M, Tauber J, Foster CS. Cataract surgery in ocular cicatricial pemphigoid. Ophthalmology 1988;95:481-6.
104. Tauber J, Melamed S, Foster CS. Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 1989;96:33-7.
105. Singh G, Foster CS. Growth factors in treatment of nonhealing corneal ulcers and recurrent erosions. Cornea 1989;8:45-53.
32
106. Sainz de la Maza M, Tauber J, Foster CS. Scleral grafting for necrotizing scleritis. Ophthalmology 1989;96:306-10.
107. Phan T-MM, Foster CS, Wasson PJ, Fujikawa LS, Zagachin LM, Colvin RB. Role of fibronectin and fibrinogen in healing of corneal epithelial scrape wounds. Invest Ophthalmol Vis Sci 1989;30:377-85.
108. Phan T-MM, Foster CS, Zagachin LM, Colvin RB. Role of fibronectin in the healing of superficial keratectomies in vitro. Invest Ophthalmol Vis Sci 1989;30:386-91.
109. Gudmundsson OG, Ormerod LD, Kenyon KR, Glynn RJ, Baker AS, Haaf J, Lubars S, Abelson MB, Boruchoff SA, Foster CS, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea 1989;8:115-21.
110. Zaltas MM, Ahmed R, Foster CS. Association of HLA-DR4 with ocular cicatricial pemphigoid. Curr Eye Res 1989;8:189-93.
111. Foster CS, Opremcak EM, Tolchin N. Evidence for the potential influence of cyclic nucleotides on maintenance of or reactivation from latency of herpes simplex in trigeminal ganglionic neurons. Acta Ophthalmol 1989;67:142-4.
112. Liu EY, Raizman MB, Rosner B, Ihley TM, Foster CS. Effects of blood transfusion and cyclosporin on rabbit corneal graft survival. Curr Eye Res 1989;8:523-31.
113. Foster CS, Fong LP, Singh G. Cataract surgery and intraocular lens implantation in patients with uveitis. Ophthalmology 1989;96:281-8.
114. Raizman MB, Foster CS. Plasma exchange in the therapy of Behçet’s disease. Graefe’s Arch Clin Exp Ophthalmol 1989;227:360-3.
115. Opremcak EM, Foster CS, Hemady R, Rice BA, Daigle JA, Raizman MB, Chung H, Zaltas M. Chorioretinal disease patterns in congenic mice following intraocular inoculation with HSV-1. Invest Ophthal Vis Sci 1989;30:1041-6.
116. Hoang-Xuan T, Foster CS, Raizman MB, Greenwood B. Mast cells in conjunctiva affected by cicatricial pemphigoid. Ophthalmology 1989;96:1110-4.
117. Foster CS. Herpes simplex virus-induced destructive corneal disease. Eye 1989;3:194-203.
33 118. Ahmed AR, Khan KN, Wells PA, Rice BA, Foster CS. Preliminary serological studies comparing immunofluorescence assay with radioimmunoassay. Curr Eye Res 1989;8:1011-9.
119. Hemady R, Opremcak EM, Zaltas M, Berger A, Foster CS. Herpes simplex virus type-1 strain influence on chorioretinal disease patterns following intracameral inoculation in Igh-1 disparate mice. Invest Ophthalmol Vis Sci 1989;30:1750-7.
120. Sainz de la Maza M, Wells PA, Foster CS. Cyclic nucleotide modulation of herpes simplex virus latency and reactivation. Invest Ophthalmol Vis Sci 1989;30:2154-9.
121. Young LHY, Foster CS, Young JDE. In vivo expression of perforin by natural killer cells during a viral infection: studies on uveitis produced by herpes simplex virus type 1. Am J Pathol 1989;136:1021-30.
122. Sainz de la Maza M, Tauber J, Hoang-Xuan T, Foster CS. Consideraciones sobre la decision terapeutica en la queratitis ulcerativa periferica. Arch Soc Esp Oftal 1989;53:273- 9.
123. Sainz de la Maza M, Foster CS. Posibilidades de manipulacion de las fases de latencia y reactivacion del virus herpes simplex tipo 1. Arch Soc Esp Oftal 1989;2:37-44.
124. Sainz de la Maza M, Foster CS. Nucleotidos ciclicos y reactivacion viral en un modelo de latencia del virus del herpes tipo I en el ganglio trigeminal del raton. Arch Soc Esp Oftal 1989;1:67-72.
125. Foster CS, Ross RN. Giant papillary conjunctivitis: the American experience. Proceedings of the Second Fison’s International Ophthalmology Workshop, Paris 1990;16-24.
126. Foster CS, Calonge MC. Management of severe atopic keratoconjunctivitis. Proceedings of the Second Fison’s International Ophthalmology Workshop, Paris1990;76-89.
127. Hemady R, Zaltas M, Paton B, Foster CS, Baker AS. Bacillus-induced endophthalmitis: new series of 10 cases and review of literature. Br J Ophthalmol 1990;74:26-9.
128. Hoang-Xuan T, Foster CS, Rice BA. Scleritis in relapsing polychondritis. Ophthalmology 1990;97:892-8.
129. Young LHY, Foster CS, Young JDE. In vivo expression of perforin by natural killer cells during a viral infection. Am J Path 1990;136:1021-30.
34 130. Hemady R, Chu W, Foster CS. Keratoconjunctivitis sicca and corneal ulcers. Cornea 1990;9:170-3.
131. Tauber J, Sainz de la Maza M, Hoang-Xuan T, Foster CS. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea 1990;9:66-73.
132. Hersh PS, Rice BA, Baer JC, Wells PA, Lynch SE, McGuigan LJB, Foster CS. Topical nonsteroidal agents and corneal wound healing. Arch Ophthalmol Vis Sci 1990;108:577- 83.
133. Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmol. 1990;97:992-1000.
134. Singh G, Wilson MR, Foster CS. Long-term follow-up study of mitomycin eye drops as adjunctive treatment for pterygia and its comparison with conjunctival autograft transplantation. Cornea 1990;9:331-4.
135. Hoang-Xuan T, Rodriguez A, Zaltas M, Rice B, Foster CS. Ocular rosacea: a histologic and immunopathologic study. Ophthalmology 1990;97:1468-75.
136. Rice BA, Foster CS. Immunopathology of cicatricial pemphigoid affecting the conjunctiva. Ophthalmology 1990;97:1476-83.
137. Baer JC, Raizman MB, Foster CS. Ocular Behçet’s disease in the United States: clinical presentation and visual outcome in 29 patients. Ocul Immunol Today 1990;918:383-6.
138. Foster CS, Tauber J, Sainz de la Maza M. Systemic chemotherapy for ocular cicatricial pemphigoid. Ocul Immunol Today 1990;918:409-13.
139. Tamesis RR, Foster CS. Natural killer cellular cytoxicity against herpes simplex virus- infected cells in Igh-1-disparate mice. Invest Ophthalmol Vis Sci 1990;31:2224-9.
140. Hemady R, Tauber J, Ihley TM, Opremcak EM, Foster CS. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1- disparate congenic murine strains. Invest Ophthalmol Vis Sci 1990;31:2335-41.
141. Opremcak EM, Rice BA, Wells PA, Foster CS. Histology and immunohistology of Igh-1- restricted herpes simplex keratitis in BALB/c congenic mice. Invest Ophthalmol Vis Sci 1990;31:305-12.
142. Hoang-Xuan T, Baer J, Ihley TM, Rice BA, Wells PA, Foster CS. Anti-idiotypic vaccination against HSV-1 keratitis. Ocul Immunol Today 1990;918:115-8.
35
143. Tamesis RR, Foster CS. Natural killing of HSV-1 infected and noninfected target cells in Igh-1 disparate mice. Ocul Immunol Today 1990;918:157-60.
144. Sainz de la Maza M, Foster CS, Tauber J. Value of scleral homografting in necrotizing scleritis management. Ocul Immunol Today 1990;918:455-8.
145. Sainz de la Maza M, Foster CS, Fong LP, Rice BA. Immunohistochemical study of scleritis. Ocul Immunol Today 1990;918:309-12.
146. Hemady RK, Opremcak EM, Zaltas M, Tauber J, Foster CS. Igh-1 influence on development of HSV-1 retinitis in a mouse model. Ocul Immunol Today 1990;918:119- 122.
147. Foster CS, Ihley TM, Hemady R, Tamesis RR, Rice BA, Wells PA. Role of antibody in prevention of herpes simplex stromal keratitis. Ocul Immunol Today 1990;918:111-4.
148. Foster CS. Intraocular lens implants in patients with uveitis. Ophthalmology 1990;97;12:1579.
149. Foster CS, Tauber J., Sainz de la Maza M, Hoang-Xuan T. Investigation and treatment of peripheral corneal ulcers. Fourth Workshop on External Eye Disease & Inflammation 1990;13-21.
150. Sainz de la Maza M, Foster CS, Rodriguez A. Tecnicas immunohistoquimicas en la latencia y reactivacion del virus herpes simplex tipo 1. Arch Soc Esp Oftal Invest 1990;3:17-24.
151. Sainz de la Maza M, Foster CS. Papel de los inmunocomplejos en la escleritis necrotizante. Arch Soc Oftal 1990;59:265-70.
152. Foster CS, Baer JC, Raizman MB. Therapeutic responses to systemic immunosuppressive chemotherapy agents in patients with Behçet’s syndrome affecting the eyes. Fifth International Symposium on Behçet’s Disease 1990;581-588.
153. Phan TM, Foster CS, Shaw CD, Zagachin LM, Colvin RB. Topical fibronectin in an alkali burn model of corneal ulceration in rabbits. Arch Ophthalmol 1991;109:414-9.
154. Hemady R, Tauber J, Foster CS. Immunosuppressive drugs in immune and inflammatory ocular disease. Surv Ophthalmol 1991;35:369-85.
36 155. Fong LP, Sainz de la Maza M, Rice BA. Kupferman AE, Foster CS. Immunopathology of scleritis. Ophthalmology 1991;98:472-9.
156. Tauber J, Sainz de la Maza M, Foster CS. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea 1991;10:185-95.
157. Zierhut M, Foster CS. Multiple sclerosis, sarcoidosis, and other diseases in patients with pars planitis. Dev Ophthalmol 1991;23:41-7.
158. Hoang-Xuan T, Foster CS, Jakobiec FA, Tauber J, Sainz de la Maza M, Krebs W. Romberg’s progressive hemifacial atrophy: an association with scleral melting. Cornea 1991;10:361-6.
159. Raizman MB, Sainz de la Maza M, Foster CS. Tectonic keratoplasty for peripheral ulcerative keratitis. Cornea 1991;10:312-6.
160. Neumann R, Tauber J, Foster CS. Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. Ophthalmology 1991;98:858-62.
161. Lee SJ, Rice BA, Foster CS. HLA class II expression in normal and inflamed conjunctiva. Regional Immunology 1991;3:177-85.
162. Foster CS, Rice BA, Dutt J. Immunopathology of atopic keratoconjunctivitis. Ophthalmology 1991;98:1190-6.
163. Sainz de la Maza M, Foster CS, Raizman MB. Queratoplastia tectonica en queratitis ulcerativa periferica. Arch Soc Esp Oftal 1991;60:189-92.
164. Sainz de la Maza M, Foster CS. The diagnosis and treatment of peripheral ulcerative keratitis. Semin Ophthalmol 1991;6:133-41.
165. Rodriguez A, Sainz de la Maza M, Missry J, Foster CS. The role of cyclic nucleotide mediators in latency and reactivation of HSV-1 infected neuroblastoma cells. Eye 1991;5:627-35.
166. Sainz de la Maza M, Foster CS. Necrotizing scleritis after ocular surgery: A clinopathologic study. Ophthalmology 1991;98:1720-6.
167. Zierhut M, Tamesis R, Foster CS. Herpes-simplex-Virus-Retinitis. Fortchr Ophthalmol 1991;88:740-7.
37 168. Foster CS. Cataract surgery and intraocular lens implantation in patients with intermediate uveitis. Dev Ophthalmol 1992;23:212-8.
169. Foster, CS. Medical treatment of intermediate uveitis. Dev Ophthalmol 1992;23:156-7.
170. Zaltas MM, Opremcak EM, Hemady R, Foster CS. Immunohistologic findings in herpes simplex virus chorioretinitis in the Von Szily mModel. Invest Ophthalmol Vis Sci 1992;33:68-77.
171. Chan LS, Soong HK, Foster CS, Hammerberg C, Cooper KD. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome. J Am Med Assoc 1991;266:1543-6.
172. Ahmed AR, Foster CS, Zaltas M, Notani O, Awdeh Z, Alper CA, Yunis EJ. Association of DQw7 (DQB1*0301) with OCP. Proc Nat Acad Sci 1991;88:11579-82.
173. Baer JC, Foster CS. Corneal laser photocoagulation for treatment of neovascularization: Efficacy of 577 nm yellow dye laser. Ophthalmology 1992;99:173-9.
174. Soukiasian SH, Foster CS, Niles JL, Raizman MB. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener’s granulomatosis. Ophthalmology 1992;99:125-32.
175. Soukiasian SH, Rice BA, Foster CS, Lee SJ.. The T cell receptor in normal and inflamed human conjunctiva. Invest Ophthalmol Vis Sci 1992;33:453-9.
176. Foster CS, Zierhut M, Wu H, Tamesis R, Jabbur N. Murine acute retinal necrosis. Trans Am Ophthalmol Soc 1992;251-268.
177. Calonge M, Foster CS, Rice BA, Baer JC. Management of corneal complications in xeroderma pigmentosum. Cornea 1992;11:173-82.
178. Shore JW, Foster CS, Westfall CT, Rubin PA. Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology 1992;99:383-95.
179. Hemady RK, Baer JC, Foster CS. Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis. Int Ophthalmol Clin 1992;32:2410-52.
180. Okada AA, Foster CS. Posterior uveitis in the pediatric population. Int Ophthalmol Clin.1992;32:121-52.
38
181. Hemady RK, Sainz de la Maza M, Raizman MB, Foster CS. Six cases of scleritis associated with systemic infection. Am J Ophthalmol 1992;114:55-62.
182. Hemady RK, Chu W, Foster CS. Intraocular penetration of ketoconazole in rabbits. Cornea 1992;11:329-33.
183. Tauber J, Jabbur N, Foster CS. Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea 1992;11:446-51.
184. Elner VM, Dutt J, Pavilack MA, Sugar A, Foster CS, Elner SG. Intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigens in herpes keratitis. Ophthalmology 1992;99:1400-7.
185. Filipec M, Mai Phan T, Zhao T, Rice BA, Merchant A, Foster CS. Topical cyclosporine A and corneal wound healing. Cornea 1992;11:546-52.
186. Zierhut M, Soukiasian S, Zhao T, Tamesis RR, Foster CS. Depletion of T-lymphocyte subsets in murine herpes-simplex-virus retinitis. German J Ophthalmol 1992;1:145-50.
187. Sainz de la Maza M, Jabbur NS, Foster CS. Esclero-uveitis. Arch Soc Esp Oftal 1992;63:1-8.
188. Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, Talley AR, Speaker MG. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99:1647-54.
189. Foster CS, Barney NP. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis. Documenta Ophthalmologica 1992;80:363-9.
190. Haider N, Neumann R, Foster CS, Ahmed AR. Report on the sequence of DQB1*0301 gene in ocular cicatricial pemphigoid patients. Curr Eye Res 1992;11:1233-8.
191. Foster CS, Neumann R, Tauber J. Long term results of systemic chemotherapy for ocular cicatricial pemphigoid. Documenta Ophthalmologica 1993;82:223-9.
192. Pavilack MA, Foster CS, Kowal VO, Dutt JE, Albert DM. Peripseudophakic membrane: pathologic features. Arch Ophthalmol 1993;111:240-4.
193. Foster CS, Vitale AT. Cataract surgery in uveitis. Ophthalmol Clin North Am 1993;6:139- 46.
39 194. Neumann R, Dutt J, Foster, CS. Immunohistopathologic features and therapy of conjunctival lichen planus. Am J Ophthalmol 1993;115:494-500.
195. Hemady RK, Baer JC, Foster CS. Biomicroscopic and histopathologic observations after corneal laser photocoagulation in a rabbit model of corneal neovascularization. Cornea 1993;12:185-90.
196. Zierhut M, Foster CS. Role of T-lymphocyte subsets in murine herpes simplex virus retinitis. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis1993;29-32.
197. Foster CS, Baer J. Behçet’s disease in America: ocular manifestations and response to treatment. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis 1993;185-189.
198. Foster CS, Hunter D. Isolated ocular sarcoidosis: Late development of systemic manifestations in uveitis patients. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis. 1993;377-9.
199. Zierhut M, Foster CS. Uveitis and relapsing polychondritis. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis 1993;487-9.
200. Foster CS, Hemady RK, Baer JC. Cytotoxic agents in the management of juvenile theumatoid arthritis (JRA) associated uveitis. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis 1993;525-8.
201. Foster CS. Cataract surgery and intraocular lens implantation in patients with pars planitis. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis 1993;593-5.
202. Foster CS, Wu HK, Merchant A. Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients. Documenta Ophthalmologica 1993;83:83-90.
203. Neumann R, Jabbur NS, Vickers F, Foster CS. Topical diclofenac sodium, dexamethasone and placebo compared in a model of immunogenic uveitis in rabbits. Ocul Immunol Inflamm 1993;1:87-97.
204. Barney NP, Foster CS. Atopic ocular disease. Int Ophthalmol Clin 1993;33:87-92.
205. Foster CS, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology 1993;100:809-17.
40 206. Kaufman AH, Foster CS. Cataract extraction in patients with pars planitis. Ophthalmology 1993;100:1210-7.
207. Sainz de la Maza M, Jabbur NS, Foster CS. An analysis of therapeutic decision for scleritis. Ophthalmology 1993;100:1372-6.
208. Heiligenhaus A, Shore JW, Rubin PAD, Foster CS. Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid: Implications for patient selection and surgical considerations. Ophthalmology 1993;100:1283-8.
209. Akova YA, Jabbur NS, Neumann R, Foster CS. Atypical ocular atopy. Ophthalmology 1993;100:1367-71.
210. Tamesis RR, Rodriguez AG, Hoang-Xuan T, Foster CS. Antibody-dependent cellular cytoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice. German J Ophthalmol 1993;2:218-23.
211. Sainz de la Maza M, Hemady RK, Foster CS. Infectious scleritis: Report of four cases. Documenta Ophthalmologica 1993;33-41.
212. Mohimen A, Neumann R, Foster CS, Ahmed AR. Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines. Curr Eye Res 1993;12:741-52.
213. Soukiasian SH, Foster CS. Mooren’s ulcer. Diagnostic problems in clinical ophthalmology 1994;220-227.
214. Foster CS. Author’s Reply: Cataract surgery in patients with juvenile rheumatoid arthritis. Ophthalmology 1993;100:1597.
215. Akova YA, Dutt J, Rodriguez A, Jabbur N, Foster CS. The Role of Igh-1 Disparate congenic mouse T lymphocytes in the pathogenesis of herpetic stromal keratitis. Curr Eye Res 1993;12:1093-101.
216. Jayaraman S, Heiligenhaus A, Rodriguez A, Soukiasian S, Dorf ME, Foster CS. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J Immunol 1993;151:5777-89.
217. Foster CS. Pars planitis. American Academy of Ophthalmology: Uveitis Module: Focal Points 1993;11:8-10.
41 218. Akova YA, Foster CS. Cataract surgery in patients with sarcoidosis-associated uveitis. Ophthalmology 1993;101:473-9.
219. Foster CS, Rodriguez-Garcia A, Pedroza-Seres M, Berra A, Heiligenhaus A, Soukiasian
SH, Jayaraman S. Murine herpes simplex virus keratitis is accentuated by CD4+, Vß 8.2+
Th2 T cells. Trans Am Ophthalmol Soc 1993;91:325-350.
220. Berra A, Dutt JE, Nouri M, Foster CS. Heat shock protein expression in human conjunctiva. Invest Ophthalmol Vis Sci 1994;35:352-7.
221. Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology 1994;101:389-96.
222. Foster CS, Soukiasian SH. Anti-neutrophil cytoplasmic antibodies (ANCA) scleritis. Documenta Ophthalmologica 1993.
223. Sainz de la Maza M, Jabbur NS, Foster CS. Tratamiento de la escleritis (scleritis therapy). Arch Soc Españ Oftalmol 1993;64:261-26.
224. Santos CI, Huang AJ, Abelson MB, Foster CS, Friedlander M, McCulley JP. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis. Am J Ophthalmol 1994;117:488-97.
225. Barney NP, Foster CS. A prospective randomized trial of oral acyclovir following penetrating keratoplasty for herpes simplex keratitis. Cornea 1994;13:232-6.
226. Holland GN, Executive Committee of American Uveitis Society. Perspective: standard diagnostic criteria for the acute retinal necrosis syndrome. Am J Ophthalmol 1994;117:663-7.
227. Sainz de la Maza M, Dutt JE, Foster CS. Comparacion de los componentes de la Matriz extracellular entre la esclera normal y la esclera con inflamacion necrotizante. Arch Soc Esp Oftal 1994;66:59-64.
228. Vitale AT, Rodriguez A, Foster CS. Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy. Ophthalmology 1996;103:365-73.
229. Espaillat A, Lee SJ, Arrunategui-Correa V, Foster CS, Vitale A, Dimeo S, Colvin RB. Expression of fibronectin isoforms in a rat cornea after an epithelial-scrape wound. Curr Eye Res 1994;13:325-30.
42 230. Sainz de la Maza M, Foster CS. Peripheral ulcerative keratitis and malignancies. Cornea 1994;13: 364-7.
231. Cai X, Foster CS, Lui JJ, Filipec M, Kupferman AE, Colvin RB, Lee SJ. Alternatively spliced fibronectin molecules in the wounded cornea: analysis by polymerase chain reaction. Invest Ophthalmol Vis Sci 1993;34:3585-92.
232. Lee SJ, Li Z, Sherman B, Foster CS. Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1993;34:3522-5.
233. Akova Y, Jabbur N, Foster CS. Ocular presentation of polyarteritis nodosa: clinical course and management with steroid and cytotoxic therapy. Ophthalmology 1993;100:1775-81.
234. Zierhut M, Hemady R, Zhao T, Ihley TA, Merchant A, Foster CS. Herpes simplex virus type 2 induced retinal necrosis in BALB/c mice. Acta Ophthalmologica 1993;72:211-7.
235. Berra A, Rodriguez A, Heiligenhaus A, Pazos B, Van Rooijen N, Foster CS. The role of macrophages in the pathogenesis of HSV-1 induced chorioretinitis in BALB/c mice. Invest Ophthalmol Vis Sci 1994;35:2990-8.
236. Tamesis RR, Messmer EM, Rice BA, Dutt JE, Foster CS. The role of natural killer cells in the development of herpes simplex virus type-1 induced stromal keratitis. Eye 1994;8:298- 306.
237. Neumann R, Foster CS. Experimental Uveitis. Ocul Immunol Inflamm1993;1:87-97.
238. Lane L, Ayliffe W, Foster CS. Management strategies in peripheral ulcerative keratitis and necrotizing scleritis. Proceedings, New Orleans Academy of Ophthalmology 1993;39-47.
239. Ayliffe W, Foster CS. High risk keratoplasty. Proceedings, New Orleans Academy of Ophthalmology 1993;57-69.
240. Foster CS. Cataract surgery in the patient with uveitis. American Academy of Ophthalmology Module: Focal Points 1994;12:1-6.
241. Foster CS, Dutt JE, Rice BA, Kupferman AE, Lane L. Conjunctival epithelial basement membrane zone immunohistology: normal and inflamed conjunctiva. Int Ophthalmol Clin 1993;34:209-14.
242. Kaufman AH, Niles JL, Foster CS. ANCA test in ophthalmic inflammatory disease. Int Ophthalmol Clin 1994;34:215-27.
43 243. Park SS, D’Amico DJ, Foster CS. The role of invasive diagnostic testing in inflammatory eye diseases. Int Ophthalmol Clin 1994;34:229-38.
244. Akova YA, Rodriguez A, Foster CS. Atopic keratoconjunctivitis. Ocul Immunol Inflamm1994;2:125-44.
245. Vitale AT, Pedroza-Seres M, Arrunategui-Correa V, Lee SJ, Dimeo S, Foster CS, Colvin RB. Differential expression of alternatively spliced fibronectin in normal and wounded rat corneal stroma and epithelium. Invest Ophthalmol Vis Sci 1994;35:3664-72.
246. Yunis JJ, Mobini N, Yunis EJ, Alper CA, Deulofeut R, Rodriguez A, Foster CS, Marcus- Bagley D, Good RA, Ahmed AR. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci 1994;91:7747-51.
247. Zierhut M, Tamesis RR, Neumann R, Hemady R, Ihley TM, Dutt JE, Zhao T, Foster CS. Herpes-simplex-Virus-Retinitis: Rolle des Immunsystems im Tierversuch (Natural killer cells do not influence the von Szily model of herpes simplex virus type-1 induced contralateral retinitis). Ger J Ophthalmol 1991;88:740-7.
248. Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology 1994;101:1267-74.
249. Merayo-Lloves J, Foster CS. Murine model of seasonal allergic conjunctivitis (SAC) to ragweed. Excerpta Medica 1994;107-10.
250. Pedroza-Seres M, Goei S, Merayo-Lloves J, Arrunategui-Correa V, Foster CS.. Expression of Vß T cell receptor transcripts in experimental murine keratitis. Excerpta Medica 1994;293-6.
251. Neves RA, Rodriguez A, Power WJ, Pedroza-Seres M, Foster CS. The value of combined serum angiotensin converting enzyme and gallium scan in the diagnosis of ocular sarcoidosis. Excerpta Medica 1994;353-6.
252. Power WJ, Rodriguez A, Neves RA, Lane L, Foster CS. Prognostic value of antineutrophil cytoplasmic antibodies in limited ocular Wegener’s granulomatosis. Excerpta Medica 1994;365-8.
253. Sainz de la Maza M, Foster CS. Ocular prognosis of scleritis and systemic vasculitic diseases. Excerpta Medica 1994;373-6.
44 254. Foster CS, Drake M, Turner FD, Crabb JL, Santos CI, et al.. Efficacy and safety of 1% rimexolone ophthalmic suspension vs. 1% prednisolone acetate (Pred Forte). Excerpta Medica 1994;411-5.
255. Neves RA, Dutt JE, Rodriguez A, Merayo-Lloves J, Belfort R, Foster CS. Immunohistopathology of the lacrimal gland in AIDS-related sicca syndrome. Excerpta Medica 1994;453-6.
256. Rodriguez A, Power WJ, Neves RA, Foster CS. Long-term systemic acyclovir in the management of recurrent herpes simplex keratouveitis. Excerpta Medica 1994;465-8.
257. Arrunategui-Correa VR, Dutt JE, Foster CS. The role of B lymphocytes in experimental herpes simplex viral retinitis. Scand J Immunol 1994;40:299-307.
258. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmology 1994;101:1281-6.
259. Heiligenhaus A, Berra A, Foster CS. CD4+ Vß8+ T cells mediate herpes stromal keratitis. Curr Eye Res 1994;13:711-6.
260. Soukiasian SH, Foster CS, Raizman MB. Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. Am J Ophthalmol 1994;118:601-11.
261. Power WJ, Rodriguez A, Neves RA, Lane L, Foster CS. Disease relapse in patients presenting with ocular manifestations of Wegener’s granulomatosis. Ophthalmology 1995;102:154-60.
262. Power WJ, Foster CS. Update on sympathetic ophthalmia. Int Ophthalmol Clin 1995;35:127-37.
263. Ayliffe W, Foster CS, Marcoux P, Upton M, Finkelstein M, Kuperwaser M, Legmann A. Relapsing acute myeloid leukemia presenting as hypopyon uveitis. Am J Ophthalmol 1995;119:361-4.
264. Bhol K, Udell I, Haider N, Yunis JJ, Mohimen A, Neumann R, Grasso C, Ahmed AR, Foster CS. Ocular cicatricial pemphigoid: A case report of monozygotic twins discordant for the disease. Arch Ophthalmol 1995;113:202-7.
265. Foster CS. The pathophysiology of ocular allergy: current thinking. Allergy 1995;50:6-9.
266. Tugal-Tutkun I, Akova YA, Foster CS. Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 1995;102:576-85.
45
267. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology 1995;102:687-92.
268. Foster CS. Round Table: The chronic red eye. Proceedings, New Orleans Academy of Ophthalmology 1993;143-11.
269. Foster CS, Ledoux D. Types and management of ophthalmic herpes simplex virus infections. Herpes 1995;2:27-32.
270. Merayo-Lloves J, Calonge M, Foster CS. Experimental model of allergic conjunctivitis to ragweed in guinea pig. Curr Eye Res 1995;14:487-94.
271. Messmer EM, Foster CS. Destructive corneal and scleral disease associated with rheumatoid arthritis: Medical and surgical management. Cornea 1995;14:408-17.
272. Sainz de la Maza M, Foster CS. Asociationes sistémicas de la escleritis. Arch Soc Espan Oftalmol 1995;68:581-6.
273. Talamo JH, Siebert K, Wagoner MD, Yeh E, Telfair W. VISX moderate myopia study group. Multicenter study of photorefractive keratectomy for myopia of 6.00 to 8.00 diopters. J Refract Surg 1995;11:238-47.
274. Rodriguez Garcia A, Foster CS. Infecciones oculares en pacientes con el síndrome de immunodeficiencia adquirida. Enfermedades Infecciosas y Microbiologia; 1995;14:407-15.
275. Power WJ, Neves RA, Rodriguez A, Dutt JE, Foster CS. Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid. Ophthalmology 1995;102:1158-63.
276. Lane L, Tamesis R, Rodriguez A, Christen W, Akova YA, Messmer E, Pedroza-Seres M, Barney N, Foster CS. Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease. Ophthalmology 1995;102:1530-5.
277. Tugal-Tutkun I, Urgancioglu M, Foster CS. Immunopathologic study of the conjunctiva in patients with Behçet’s disease. Ophthalmology 1995;102:1660-8.
278. Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology 1995;102:1669-76.
46 279. Avery AC, Zhao Z, Rodriguez A, Bikoff E, Soheilian M, Foster CS, Cantor H. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature 1995;376:431-4.
280. Foster CS. Clinician’s corner (contributor). American Academy of Ophthalmology Module: Focal Points 1995;13:10-4.
281. Neumann RR, Foster CS. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematous patients. Retina 1995;15:206-12.
282. Correa VA, Dutt JE, Foster CS. Variable region usage in B cell deficient mice in the model of experimental herpes simplex retinitis. Scand J Immunol 1995;42:387-95.
283. Ghoraishi M, Akova YA, Tutkun IT, Foster CS. Penetrating keratoplasty in atopic keratoconjunctivitis. Cornea 1995;14:610-3.
284. Heiligenhaus A, Jayaraman S, Soukiasian S, Dorf M, Foster CS. Glykoprotein D (5-23) spezifische Th2 T-Zell Linie induziert HSV-1 Keratitis. Der Ophthalmologe 1995;92:484- 91.
285. Heiligenhaus A, Foster CS. Histological and immunopathological analysis of T-cells mediating murine HSV-1 keratitis. Graefe’s Arch Clin Exp Ophthalmol 1994;232:628-34.
286. Heiligenhaus A, Wells PA, Foster CS. Immunization against HSV 1 keratitis with a synthetic gD peptide. Eye 1995;9:89-95.
287. Sainz de la Maza M, Foster CS. Inflamación escleral. Inflamaciones oculares. Official report of the Spanish Ophthalmological Society 1995;213-234.
288. Rodriguez A, Power WJ, Neves RA, Foster CS. Recurrence rate of herpetic keratouveitis in patients on long-term oral acyclovir. Documenta Ophthalmologica 1995;90:331-40.
289. Power WJ, Neves RA, Rodriguez A, Pedroza-Seres M, Foster CS. The value of combined serum angiotensin converting enzyme and gallium scan in the diagnosis of ocular sarcoidosis. Ophthalmology 1995;102:2007-11.
290. Rodriguez-Garcia A, Foster, CS. Valor diagnóstico y terapéutico de la biopsia conjunctival en las enfermedades inflamatorias oculares externas. Rev Mex Oftalmol 1995;69:221-8.
291. Power WJ, Kaufman AH, Merayo-Lloves J, Arrunategui-Correa V, Foster CS. Expression of collagens I, III, IV and V mRNA in excimer wounded rat cornea: analysis by semi- quantitative PCR. Curr Eye Res 1995;14:879-86.
47 292. Tugal-Tutkun I, Havrlikova K, Power WJ, Foster CS. Changing patterns in uveitis of childhood. Ophthalmology 1996;103:375-83.
293. Pedroza-Seres M, Goei S, Merayo-Lloves J, Arrunategui-Correa V, Dutt J, Foster CS. T- cell receptor Vß gene expression in experimental herpes stromal keratitis. Eye 1995;9:599- 604.
294. Talamo JH, Siebert K, Wagoner MD, et al. Multicenter study of photorefractive keratectomy for myopia of 6.00 to 8.00 Diopters. J Refractive Surg 1995;11:238-47.
295. Berra A, Dutt JE, Foster CS. Detection of herpes simplex virus type 1 by an in situ polymerase chain reaction technique. Cornea 1996;15:55-61.
296. Rodriguez A, Calonge M, Pedroza-Seres M, Akova YA, Messmer E, D’Amico DJ, Foster CS. Referral patterns of uveitis in a tertiary care center: An epidemiologic study. Arch Ophthalmol 1996;114:593-600.
297. Merayo-Lloves J, Dutt JE, Zhao T, Foster CS. A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium. J All Clin Immunol 1996;97:1129- 40.
298. Sainz de la Maza M, Bujan A, Foster CS, Ayliffe W. Sequedad ocular en pacientes con la enfermedad crónica del injerto contra el huésped. Arch Soc Espan Oftalmol 1996;70:57- 64.
299. Chow CYC, Foster CS. Mooren’s ulcer. Int Ophthalmol Clin 1996;36:1-13.
300. Gregory JK, Foster CS. Peripheral ulcerative keratitis in the collagen vascular diseases. Int Ophthalmol Clin 1996;36:21-30.
301. Nguyen QD, Foster CS. Cicatricial pemphigoid: diagnosis and treatment. Int Ophthalmol Clin 1996;36:41-60.
302. Legmann A, Foster CS. Noninfectious necrotizing scleritis. Int Ophthalmol Clin 1996;36:73-80.
303. Ceisler EJ, Foster CS. Juvenile rheumatoid arthritis and uveitis: Minimizing the blinding complications. Int Ophthalmol Clin 1996;36:91-107.
304. Smith JA, Foster CS. Sarcoidosis and its ocular manifestations. Int Ophthalmol Clin 1996;36:109-25.
48 305. Bhisitkul RB, Foster CS. Diagnosis and ophthalmological features of Behçet’s disease. Int Ophthalmol Clin 1996;36:127-34.
306. Samiy N, Foster CS. The role of nonsteroidal antiinflammatory drugs in ocular inflammation. Int Ophthalmol Clin 1996;36:195-206.
307. Tamesis RR, Rodriguez A, Christen WG, Akova YA, Messmer E, Foster CS. Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. Ophthalmology 1996;103:768-75.
308. Bhol K, Mohimen A, Neumann R, Yunis J, Foster CS, Yunis EJ, Ahmed AR. Difference in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid. Curr Eye Res 1996;15:521-32.
309. Foster CS. Revoluntionary discoveries lead to diagnosis and cure. Ophthalmol World News 1995;17.
310. Buhac J, Bhol K, Padilla T, Foster CS, Ahmed AR. Coexistence of pemphigus vulgaris and ocular cicatricial pemphigoid. J Am Acad Dermatol 1996;34:884-6.
311. Soheilian M, Markomichelakis N, Foster CS. Intermediate uveitis and retinal vasculitis: New ocular manifestations of cat scratch disease. Am J Ophthalmol 1996;122:582-4.
312. Foster CS, Alter G, Crabb JL, DeBarge LR, Feiler L, Friedlander MH, Raizman MB, Santos CI. Efficacy and safety of rimexolone 1% ophthalmic suspension versus Pred Forte 1% in the treatment of uveitis. Am J Ophthalmol 1996;122:171-82.
313. Power WJ, Saidman SL, Zhang DS, Vamvakas EC, Merayo-Lloves JM, Kaufman AH, Foster CS. HLA typing in patients with ocular manifestations of Stevens-Johnson syndrome. Ophthalmology 1996;103:1406-9.
314. Dutt JE, Ledoux D, Baer H, Foster CS. Collagen abnormalities in conjunctiva of patients with cicatricial pemphigoid. Cornea 1996;15:606-11.
315. Neves RA, Rodriguez A, Power WJ, Muccioli C, Lane L, Belfort R, Foster CS. Herpes zoster peripheral ulcerative keratitis in patients with the acquired immunodeficiency syndrome. Cornea 1996;15: 446-50.
316. Dana MR, Merayo-Lloves J, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 1996;103:1846-53.
49 317. Heiligenhaus A, Dutt JE, Foster CS. Histology and immunopathology of systemic lupus erythematosus affecting the conjunctiva. Eye 1996;10:425-32.
318. Rojas B, Foster CS. Cataract surgery in patients with uveitis. Curr Opin Ophthalmol 1996;7:11-6.
319. Berra A, Heiligenhaus A, Foster CS. T cell subsets and T cell receptor Vß utilization by Igh-1 congenic mice in herpetic retinal necrosis. Graefe’s Arch Clin Exp Ophthalmol 1996;234:583-8.
320. Zierhut M, Bieber T, Bröcker E, Forrester J, Foster CS, Streilein W. Trends in immunology. Immunol Today 1996;17:448-50.
321. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis-associated uveitis. Ophthalmology 1996;104:58-63.
322. Foster CS. Juvenile rheumatoid arthritis-associated uveitis: The continuing saga of preventable blindness. Ophthalmology Times 1996.
323. Foster CS. Rimexolone is the first new corticosteroid for ophthalmic use in 20 years – Its use controls inflammation without significantly raising intraocular pressure. Ocul Surg News 1996;14:124-5.
324. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcome prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 1997;104:236-44.
325. Power WJ, Hogan RN, Hu S, Foster CS. Primary varicella keratitis: diagnosis by PCR. Am J Ophthalmol 1996;123:252-4.
326. Abad JC, Foster CS. Fungal keratitis. Int Ophthal. Clin 1996;36:1-15.
327. Rojas B, Zafirakis P, Foster CS. Cataract surgery in patients with uveitis. Curr Opin Ophthalmol 1996;8:6-12.
328. Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Hemler M, Foster CS, Ahmed AR. Ocular cicatricial pemphigoid antigen: Partial sequence and characterization. Proc Natl Acad Sci USA 1996;93:14714-9.
329. Sainz de la Maza M, Tarrus S, Foster CS. Tratamiento de la episcleritis recurrente. Arch Soc Esp Oftalmol 1997;72:17-22.
330. Sangwan VS, Zafirakis P, Foster CS. Mooren’s ulcer. Ind J Ophthalmol 1997;45:7-17.
50
331. Rodriguez A, Yood RA, Condon TJ, Foster CS. Recurrent uveitis in a patient with adult- onset cyclic neutropenia associated with increased large granular lymphocytes. Br J Ophthalmol 1997;81:415.
332. Nussenblatt RB, Gery I, Ferris F, Weiner H, Shiloach J, Ramaley N, Perry C, Caspi R, Hafler D, Foster CS, Whitcup SM. Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/II randomized masked trial. Am J Ophthalmol 1997;123:583- 92.
333. Yang J, Foster CS. Rimexolone: A new ophthalmic corticosteroid with low intraocular pressure raising potenital. Drugs of Today 1997;33:123-9.
334. Foster CS. The role of ocular immunology in the twenty-first century. Arch Soc Esp Oftalmol 1997;72:4.
335. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea. Patient characteristics and follow-up. Ophthalmology 1998;04:1863-7.
336. Taravella MJ, Johnson DW, Petty JG, Keyser RB, Foster CS, Lundberg BE. Infectious posterior scleritis vaused by Pseudallescheria boydii: Clinicopathologic findings. Ophthalmology997;04:1312-6.
337. Hu S, Dutt J, Zhao T, Foster CS. Tetrandrine potently inhibits herpes simplex virus type-2- induced keratitis in BALB/C mice. Oculmmunol Inflamm 1997;:173-180.
338. Arrunatequi-Correa V, Dutt JE, Foster CS. Analysis of T cell receptor V gene expression in B cell deficient mice after experimental herpes simplex virus keratitis. Acta Virologica 1997;1:145-52.
339. Foster CS. Topical steroid treatment of ocular inflammation. Ophthalmol Clin North Am 1997;10:389-403.
340. Reza Dana M, Chatzistefanou K, Schaumberg DA, Foster CS. Posterior capsule opacification after cataract surgery in patients with uveitis. Ophthalmology 1997;104:1387- 94.
341. Foster CS. A new steroid for treating postoperative ophthalmic inflammation and uveitis. Ophthalmic Practice 1997;15:117-8.
342. Foster CS. Necrology of Dr. Garrett Sullivan. Trans Am Ophthalmol Soc 1996;94:15-6.
51 343. Merchant A, Foster CS. Primary intraocular lymphoma (CNC-NHL). Int Ophthalmol Clin 1997;37:101-16.
344. Yang J, Foster CS. Squamous cell carcinoma of the conjunctiva. Int Ophthalmol Clin 1997;37:73-86.
345. Merchant A, Fletcher J, Medina CA, Hemady R, Foster CS. Pharmacomanipulation of HSV-1 induced chorioretinitis in mice. Eye 1997;11:504-5.
346. Hu S, Merayo-Lloves J, Zhao T, Foster CS. Potent inhibitory effect of tetrandrine on experimental allergic conjunctivitis in mice. J Ocul Pharmacol Therapeut 1997;13:435-44.
347. Abad JC, An B, Power WJ, Foster CS, Azar DT, Talamo JH. A prospective evaluation of alcohol-assisted vs. mechanical epithelial removal before photorefractive keratectomy (PRK). Ophthalmology 1997;104:1566-75.
348. Foster CS. Systemic lupus erythematosus, discoid lupus erythematosus, and progressive systemic sclerosis. Int Ophthalmol Clin 1998;37: 93-116.
349. Harper S, Foster CS. The ocular manifestations of Rheumatoid disease. Int Ophthalmol Clin 1998;38:1-19.
350. Shiuey Y, Foster CS. Peripheral ulcerative keratitis and collagen vascular disease. Int Ophthalmol Clin 1998;38:21-32.
351. Nguyen QD, Foster CS. Systemic lupus erythematosus and the eye. Int Ophthalmol Clin 1998;38:33-60.
352. Krzystolik M, Power WJ, Foster CS. Ocular manifestations of sarcoidosis. Int Ophthalmol Clin 1998;38:61-76.
353. Chatzistefanou K, Markomichelakis N, Christen W, Soheilian M, Foster CS. Characteristics of uveitis presenting for the first time in the elderly. Ophthalmology 1998;105:347-52.
354. Power WJ, Tugal-Tutkun I, Foster CS. Long-term follow-up of patients with atopic keratoconjunctivitis. Ophthalmology 1998;105:637-42.
355. Heiligenhaus A, Schaller J, Mauß S, Engelbrecht S, Dutt JE, Foster CS, Steuhl K. Eosinophil granule proteins expressed in acute ocular cicatricial pemphigoid. Br J Ophthalmol 1998;82:312-7.
52 356. Foster CS. Recognizing the ocular manifestations of rheumatoid arthritis. Women’s Health 1998;1:247-57.
357. Hu S, Merayo-Lloves J, Zhao T, Foster CS. Comparative effectiveness and molecular pharmacological mechanisms of antiallergic drugs on experimental conjunctivitis in mice. J Ocul Pharmcol Therapeut 1998;14:67-74.
358. Tesavibul N, Dorfman D, Sangwan V, Christen W, Zafirakis P, Rojas B, Foster CS. Costimulatory molecules in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1998;39:982-8.
359. Akpek EK, Kalayci D, Hasitipi A, Foster CS. Behçet’s disease and ocular involovement. Br Med J Turkey 1997;2:11-3.
360. Halpern MT, Palmer CS, Foster CS, Pal A, Battista C. A pharmacoeconomic analysis of rimexolone for the treatment of ophthalmic inflammatory conditions. Am J Managed Care 1998;4:854-62.
361. Merchant A, Zhao T, Foster CS. Chronic keratoconjunctivitis associated with congenital dyskeratosis and erythrokeratodermia variabilis – two rare genodermatoses. Ophthalmology 1998;105:1286-91.
362. Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Outcomes in anterior uveitis sssociated with the HLA-B27 haplotype. Ophthalmology 1998;105:1646-51.
363. El-Shabrawi Y, Livir-Rallatos C, Christen W, Foster CS. High levels of IL-12 in the aqueous humor and vitreous of uveitis patients. Ophthalmology 1998;105:1659-63.
364. Nguyen QD, Foster CS. Saving the vision of children with juvenile rheumatoid arthritis- associated uveitis. J Am Med Assoc 1998;280:1133-4.
365. Livir-Rallatos C, El-Shabrawi Y, Zafirakis P, Pellett PE, Stamey FR, Foster CS. Recurrent nodular scleritis associated with varicella zoster virus. Am J Ophthalmol 1998;126:594-7.
366. Foster CS. Ocular manifestations of childhood arthritis. Women’s Health 1998;1:823-33.
367. Messmer EM, Foster CS. Lepromatous uveitis. Graefe’s Arch Clin Exp Ophthalmol 1998;236:717-9.
368. Yang J, Baltatzis S, Foster CS. Peripheral ulcerative keratitis following Salmonella gastroenteritis. Cornea 1998;17:672-4.
53 369. Sangwan V, Merchant A, Sainz de la Maza, Foster CS. Leukocyte adhesion molecule expression in scleritis. Arch Ophthamol 1998;116:1476-80.
370. Nguyen Q, Foster CS. Ciliary body melanoma masquerading as chronic uveitis. Ocul Immunol Inflamm 1998;6:253-6.
371. Sainz de la Maza, Serra M, Tarrus S, Foster CS. Actitud terapeutica freente a las ulceras corneales no infecciosas asociadas a la artritis reumatolde. Arch Soc Esp Oftalmol 1998;73:477-82.
372. Akpek E, Foster CS. Bilateral acute retinal necrosis caused by cytomegalovirus in an immunocompromized patient. Am J Ophthalmol 1999;127:93-5.
373. Uy H, Nguyen QD, Durand ML, Paton B, Foster CS. Infectious crystalline keratopathy and endophthalmitis secondary to Mycobacterium abscessus in a monocular patient with Stevens-Johnson syndrome. Am J Ophthalmol 1999;127:209-10.
374. Akpek EK, Foster CS. Limbal stem-cell transplantation. Int Ophthalmol Clin 1999;39:71- 82.
375. Chan R, Foster CS. A step-wise approach to ocular surface rehabilitation in patients with ocular inflammatory disease. Int Ophthalmol Clin 1999;39:83-108.
376. Nguyen QD, Foster CS. Scleral patch graft in the management of necrotizing scleritis. Int Ophthalmol Clin 1999;39:109-32.
377. Da Mata A, Foster CS. Ahmed valve and uveitic glaucoma. Int Ophthalmol Clin 1999;39:155-68.
378. Uy H, Foster CS. Diagnostic pars plana vitrectomy and uveitis. Int Ophthalmol Clin 1999;39:223-36.
379. Akpek EK, Uy SH, Christen W, Gurdal C, Foster CS. Severity of episcleritis and systemic disease association. Ophthalmology 1999;106:729-31.
380. Akpek EK, Polcharoen W, Foster CS. Conjunctival lymphoma masquerading as chronic conjunctivitis. Ophthalmology 1999;106:757-60.
381. Uy H, Jakobiec F, Pineda R, Shore J, Polcharoen W, Foster CS. Hypertrophic discoid lupus erythematosus of the conjunctiva. Am J Ophthalmol 1999;127:604-5.
54 382. The Loteprednol Etabonate US Uveitis Study Group. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Am J Ophthalmol 1999;127:537-44.
383. Messmer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999;43:379-96.
384. Akpek EK, Polcharoen W, Chan R, Foster CS. Ocular surface neoplasia masquerading as chronic blepharoconjunctivitis. Cornea 1999;18:282-8.
385. Foster CS. Ocular manifestations of systemic lupus erythematosus. Women’s Health 1999;2:379-89.
386. Strauss EC, Larson KA, Brenneise I, Foster CS, Larsen GR, Lee MA, Lee JJ. Soluble P- selectin glycoprotein ligand-1 inhibits inflammation in a murine model of allergy. Invest Ophthalmol Vis Sci 1999;40:1336-41.
387. Foster CS, Stavrou P, Zafirakis P, Rojas B, Tesavibul N, Baltatzis S. Intraocular Lens Explantation in Patients with Uveitis. Am J Ophthalmol 1999;128:31-7.
388. Akpek EK, Ahmed I, Jakobiec FA, Hochberg HF, Sohelian M, Foster CS. Intraocular- central nervous system lymphoma: Clinical features, diagnosis and outcomes. Ophthalmology 1999;106:1805-10.
389. Chan RY, Bhol K, Tesavibul N, Letko E, Simmons RK, Foster CS, Ahmed AR. The role of antibody to human 4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1999;40:2283.
390. Merayo-Lloves J, Power WJ, Rodriguez A, Pedroza M, Baltatzis S, Foster CS. Secondary glaucoma in patients with uveitis. Ophthalmologica 1999;213:300-4.
391. Letko E, Bhol K, Pinar V, Foster CS, Ahmed R. Tacrolimus (FK 506). Ann Allergy Asthma Immunol 1999;83:179-89.
392. Foster CS, Ahmed R. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid. Ophthalmology 1999;106:2136-43.
393. Da Mata A, Burk SE, Netland PA, Baltatzis S, Christen W, Foster CS. Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 1999;106:2168-72.
55 394. Akpek EK, Maca S, Christen WG, Foster CS. Elevated vitreal interleukin-10 level is not diagnostic of intraocular-CNS lymphoma. Ophthalmology 1999;106:2291-5.
395. Sangwan V, Akpek AK, Voo I, Zhao TZ, Pinar V, Yang J, Christen W, Baltatzis S, Foster CS. Krill protease effects on wound healing following corneal alkali burn. Cornea 1999;18:707-11.
396. Foster CS, Samson CM. Peripheral corneal ulcer. Canadian Ophthalmic Case Consultations 1999;3:5-6.
397. Hu S, Dutt J, Arrunategui-Correa, Baltatzis S, Foster CS. Cytokine mRNA expression in BALB/c mouse corneas infected with herpes simplex virus. Eye 1999;13:309-13.
398. Rojas B, Zafirakis P, Christen W, Markomichelakis NN, Foster CS. Medical treatment of macular edema in patients with uveitis. Doc Ophthalmol 1999;97:399-407.
399. Arrunategui-Correa V, Baltatzis S, Foster CS. The role of cytokines in experimental herpes simplex keratitis. Acta Virologica 1999;43:325-30.
400. Samson CM, Foster CS. Chronic postoperative endophthalmitis. Int Ophthalmol Clin 2000;40:57-68.
401. Gasch AT, Foster CS, Grosskreutz CL, Pasquale LR. Postoperative sympathetic ophthalmia. Int Ophthalmol Clin 2000;40:69-84.
402. Harper SL, Foster CS. Intraocular lens explantation in uveitis. Int Ophthalmol Clin 2000;40:107-16.
403. Gion N, Stavrou P, Foster CS. Immunomodulatory therapy for chronic tubulointerstitial nephritis associated uveitis (TINU). Am J Ophthalmol 2000;129:764-8.
404. Foster CS. Discussion: Shimazaki et al. – Ocular surface reconstruction for Stevens- Johnson syndrome. Ophthalmology 2000;107:1523.
405. Letko E, Bhol K, Foster CS, Ahmed AR. Linear IgA bullous disease (LABD) limited to the eye. Ophthalmology 2000;107:1524-8.
406. El-Shabrawi Y, Foster CS. Correlation of metalloproteinase –2 and –9 with proinflammatory cytokines interleukin-1, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis. Curr Eye Res 2000;20:211-4.
56 407. Bhol KC, Simmons RK, Dans MJ, Foster CS, Giancotti FG, Ahmed AR. The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4. J Immunol 2000;165:2824-9.
408. Romero-Rangel T, Stavrou P, Cotter J, Rosenthal P, Baltatzis S, Foster CS. Gas- permeable scleral contact lens therapy in ocular surface diseases. Am J Ophthalmol 2000;130:25-32.
409. Foster CS, Havrlikova K, Tugal-Tutkun I, Merayo-Lloves J, Christen W. Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmologica 2000;78:576-9.
410. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, Van Gelder RN, Whitcup SM, Yocum D. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000;130:492-513.
411. Foster CS. American Uveitis Society Meeting Summary October 1999. Oc Immunol Inflamm 2000;8.
412. Letko E, Bhol K, Foster CS, Ahmed AR. Influence of intravenous immunoglobulin therapy on serum levels of anti-β4 antibodies in ocular cicatricial pemphigoid: A correlation with disease activity. Curr Eye Res 2000;21: 646-54.
413. Akpek EK, Foster CS. Primary intraocular lymphoma with a low interleukin-10 to interleukin-6 ratio and heterogenous IgH gene arrangement. Arch Ophthalmol 2000;118:731.
414. Nguyen QD, Uy HS, Akpek EM, Harper S, Zacks D, Foster CS. Choroidopathy in systemic lupus erythematosus. Lupus 2000;9:288-98.
415. Perez VL, Foster CS. Uveitis with neurological manifestations. Int Ophthalmol Clin 2001;41:41-59.
416. Kumari S, Bhol KC, Simmons RK, Razzaque MS, Letko E, Foster CS. Identification of ocular cicatricial pemphigoid antibody binding site(s) in human 4 integrin. Invest Ophthalmol Vis Sci 2001;42:379-85.
417. Miserocchi E, Baltatzis S, Foster CS. Ocular features associated with anticardiolipin antibodies: A descriptive study. Am J Ophthalmol 2001;131:451-6.
57 418. Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH. Endophthalmitis after keratoprosthesis. Incidence, bacterial causes and risk factors. Arch Ophthalmol 2001;119:484-9.
419. Uy H, Nguyen QD, Arbour J, Gravel M, D’Amico DJ, Jakobiec FA, Foster CS. Sclerosing inflammatory pseudotumor of the eye. A case report. Arch Ophthalmol 2001;119:603-7.
420. Miserocchi E, Foster CS. Cheratite da herpes simplex virus. Riv Trime Oftalomol 2001;2:5-10.
421. Letko E, Stechschulte S, Kenyon KR, Sadeq N, Romero TR, Samson CM, Nguyen QD, Harper SL, Primack JD, Azar DT, Gruterich M, Dohlman CD, Baltatzis S, Foster CS. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol 2001;119:659-63.
422. Akpek EK, Foster CS. Interleukin-10 and intraocular-central nervous system lymphoma – Author’s reply. Ophthalmology 2001;108:426-7.
423. Foster CS. The Conrad Berens Lecture: Chronic cicatricial conjunctivitis. J Contact Lens Assoc Ophthalmol 2001;27:61-7l.
424. Miserocchi E, Baltatzis S, Foster CS. A case of atypical Cogan’s syndrome with uncommon corneal findings. Cornea 2001;20:540-2.
425. Ocampo VVD, Foster CS, Baltatzis S. Surgical excision of iris nodules in the management of sarcoid uveitis. Ophthalmology 2001;108:1296-9.
426. Sippel KC, Ma JJK, Foster CS. Amniotic membrane surgery. Curr Opin Ophthalmol 2001;12:269-81.
427. Meldrum ML, Kurban RS, Foster CS, Albert DM, O’Brien JM. Collagen vascular diseases: cutaneous manifestations in ophthalmology. Ophthal Plas Recon Surg 2000;16:459-70.
428. Harper SL, Letko E, Samson CM, Zafirakis P, Sangwan V, Nguyen QD, Uy H, Baltatzis S, Foster CS. Wegener’s granulomatosis: The relationship between ocular and systemic disease. J Rheumatol 2001;28:1025-32.
429. Foster CS. Immunomdulatory therapy for chronic tubulointerstitial nephritis-associated uveitis – Author’s reply. Am J Ophthalmol 2001;132:447.
58 430. Samson CM, Waheed NK, Baltatzis S, Foster CS. Methotrexate treatment of uveitis. Ophthalmology 2001;108:1134-9.
431. Nguyen Q, Uy HS, Merchant A, Medina C, Zhao T, Zhao Z, Cantor H, Baltatzis S, Foster CS. Fas-fas ligand and HSV uveitis and keratitis. Invest Ophthalmol Vis Sci 2001;42:2505-9.
432. Afshari NA, Afshari MA, Foster CS. Inflammatory conditions of the eye associated with rheumatic diseases. Curr Rheumatol Rep 2001;3:453-63.
433. Sami N, Bhol KC, Beutner EH, Plunkett RW, Leiferman KM, Foster CS, Ahmed AR. Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: molecular characterization of both autoantibodies. Clin Immunol 2001;100: 219-27.
434. Samson CM, Ekong A, Foster CS. Uveitis in children: diagnosis and management. Int Ophthalmol Clin 2001;41:199-216.
435. Yao L, Foster CS. Tubulointerstitial nephritis and uveitis syndrome. Int Ophthalmol Clin 2001;41:217-32.
436. Waheed NK, Miserocchi E, Foster CS. Ocular concerns in juvenile rheumatoid arthritis. Int Ophthalmol Clin 2001;41:223-34.
437. Sainz de la Maza Serra M, Escobar Barranco JL, Foster CS. [Characteristics of scleritis in patients older than 60 years]. Arch Soc Esp Oftalmol 2001;76:425-30.
438. Kumari S, Bhol KC, Rehman F, Colon J, Foster CS, Ahmed AR. Interleukin-1 components in ocular cicatricial pemphigoid. Role in intravenous immunoglobulin therapy. Cytokine 2001;14:218-24.
439. Letko E, Ahmed AR, Foster CS. Treatment of ocular cicatricial pemphigoid with tacrolimus (FK506). Graefes Arch Clin Exp Ophthalmol 2001;239:441-4.
440. Razzaque MS, Foster CS, Ahmed AR. Tissue and molecular events in human conjunctival scarring in ocular cicatricial pemphigoid. Histol Histopathol 2001;16:1203-12.
441. Chan R, Yannuzzi LA, Foster CS. Ocular Whipple’s disease: Earlier effective diagnosis Ophthalmol 2001;108:2225-31.
442. Stavrou P, S Baltatzis, Letko E, Samson CM, Christen W, Foster CS. Pars plana vitrectomy in patients with intermediate uveitis. Ocul Immunol Inflamm 2001;9:141-52.
59 443. Akpek EK, Baltatzis S, Yang J, Foster CS. Long-term immunosuppressive treatment in serpiginous choroiditis. Ocul Immunol Inflamm 2001;9:153-68.
444. Uy H, Christen W, Foster CS. HLA-B27 associated uveitis and macular edema. Ocul Immunol Inflamm 2001;9:177-84.
445. Merayo-Lloves J, Baltatzis S, Foster CS. Epstein-Barr virus dacryoadenitis resulting in keratoconjunctivitis sicca in a child: diagnosis and treatment. Am J Ophthalmol 2001;132:922-3.
446. Miserocchi E, Waheed NK, Baltatzis S, Foster CS. Chronic cicatrizing conjunctivitis in a patient with ocular cicatricial pemphigoid and fatal Wegener’s granulomatosis. Am J Ophthalmol 2001;132:923-4.
447. Sainz de la Maza M, Foster CS, Jabbur NS, Baltatzis S. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol 2002;120:15- 9.
448. Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology 2002;109:111-8.
449. Miserocchi E, Baltatzis S, Ekong A, Roque MR, Foster CS. The efficacy and safety of chlorambucil in intractable non-infectious uveitis. The Massachusetts Eye and Ear Infirmary experience. Ophthalmology 2002;109:137-42.
450. Ekong A, Foster CS, Roque M. Eye involvement in autoimmune blistering disease. Clin Dermatol 2001;19:742-9.
451. Michel SS, Ekong A, Baltatzis S, Foster CS. Multifocal choroiditis and panuveitis (MCP): Immunomodulatory therapy. Ophthalmology 2002;109:378-83.
452. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtschig G, Korman NJ, Lightman S, Lozada-Nur F, Marinkovich MP, Mondino BJ, Prost C, Rogers RS. The first international concensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic factors. Arch Dermatol 2002;138:370-9.
453. Foster CS. Understanding mast cell heterogeneity. Rev Ophthalmol 2002;9:86-7.
454. Abelson M, Foster CS, Gupta G. Diagnosing and managing anterior uveitis. Rev Ophthalmol 2002;110-4.
60
455. Foster CS. Book Review – Drug-Induced Ocular Side Effects, 5th Edition (Frauenfelder FT, Frauenfelder FW). Arch Ophthalmol 2002;120:1002.
456. Foster CS, Papadaki TG. Diagnostic evaluations to guide therapy for anterior uveitis. Contemp Opthalmol 2002;1:1-8.
457. Samson CM, Nduaguba C, Baltatzis S, Foster CS. Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology 2002;109:862-8.
458. Akpek EK, Jabs DA, Tessler HH, Joondeph BC, Foster CS. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology 2002;109:1506-13.
459. Miserocchi E, Waheed NK, Dios E, Christen W, Merayo-Lloves J, Roque M, Foster CS. Visual outcomes in HSV and VZV uveitis: A clinical evaluation and comparison. Ophthalmology 2002;109:1532-7.
460. Razzaque MS, Foster CS, Ahmed AR. Role of enhanced expression of m-CSF in conjunctiva affected by cicatricial pemphigoid is associated with increased accumulation of macrophages. Invest Ophthalmol Vis Sci 2002;43:2977-83.
461. Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS. Relapsing polychondritis – A clinical review. Semin Arthritis Rheum 2002;31:384-95.
462. Zacks DM, Samson CM, Loewenstein J, Foster CS. Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy. Graefes Arch Clin Exp Ophthalmol 2002;240:601-7.
463. Letko E, Bhol K, Colon J, Foster CS, Ahmed AR. Biology of interleukin-5 in ocular cicatricial pemphigoid. Graefes Arch Clin Exp Ophthalmol 2002;240:565-9.
464. Chu DS, Foster CS. Sympathetic ophthalmia. Int Ophthalmol Clin 2002;42:179-85.
465. Strauss EC, Foster CS. Atopic ocular disease. Ophthalmol Clin North Am 2002;15:1-5.
466. Miserocchi E, Modorati G, Foster CS, Brancato R. Ocular and extracutaneous involvement in Pyoderma gangrenosum. Ophthalmology 2002;109:1941-3.
467. Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. NY Sight – NY State Ophthalmologic Society 2002;Summer:28-35.
61 468. Alio JL, Chipont E, BenEzra D, Fakhry MA, Foster CS, Baarsma GS, Beekhuis WH, Ohno S, Burtin T, Belfort R, Muccioli C, Uusitalo R, Juhas R, Garcia PH, Attia HE, Shalash R, Sainz de la Maza M. Comparative performance of intraocular lenses in eyes with cataract and uveitis. J Cataract Refract Surg 2002;28:2096-108.
469. Perez VL, Azar DT, Foster CS. Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol 2002;17:124-30.
470. Yu EN, Foster CS. Chronic post-operative endophthalmitis due to Pseudomonas oryzihabitans. Am J Ophthalmol 2002;134:613-4.
471. Foster CS. Ocular Whipple’s disease. Ophthalmology 2002;109:1952-3.
472. Papaliodis GN, Nguyen QD, Samson CM, Foster CS. Intraocular lens tolerance in surgery for cataracta complicata: Assessment of four implant materials. Semin Ophthalmol 2002;17:120-3.
473. Levinson RD, Park MS, Rikkers SM, Reed EF, Smith JR, Martin TM, Rosenbaum JT, Foster CS, Sherman MD, Holland GN. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci 2003;44:653-7.
474. Baltatzis S, Romero-Rangel T, Foster CS. Sectorial keratitis and uveitis: differential diagnosis. Graefes Arch Clin Exp Ophthalmol 2003;241:2-7.
475. Batchelor TT, Del Checcolol G, Ciordial R, Foster CS, Henson JW. High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 2003;9:711-5.
476. Argüeso P, Tisdale A, Mandel U, Letko E, Foster CS, Gipson IK. The cell-layer – and cell-type – specific distribution of GalNAc-transferase in the ocular surface epithelia is altered during keratinization. Invest Ophthalmol Vis Sci 2003;44:86-92.
477. Foster CS, Rashid S. Management of coincident cataract and uveitis. Curr Opin Ophthalmol 2003;14:1-6.
478. Foster CS, Tufail F, Waheed NK, Chu D, Miserocchi E, Baltatzis S, Vredeveld CM. Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol 2003;121:437-40.
479. Papaliodis GN, Chu DS, Foster CS. Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology 2003;110:786-9.
62
480. B. Iaccheri, Fiore T, Papadaki T, Androudi S, Foster CS. Adverse Reactions with Antitoxoplasma Therapy. Invest. Ophthalmol. Vis. Sci. 44: E-Abstract 1415.
481. Razzaque MS, Foster CS, Ahmed AR. Role of collagen-binding heat shock protein 47 in ocular cicatricial pemphigoid conjunctival scarring. Invest Ophthalmol Vis Sci 2003;44:1616-21.
482. Razzaque MS, Foster CS, Ahmed AR. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003;44:1998-2003.
483. Thakker MM, Perez VL, Moulin A, Cremers SL, Foster CS. Multifocal nodular episcleritis and scleritis in a patient with undiagnosed Hodgkin’s lymphoma. Ophthalmology 2003;110:1057-60.
484. Baltatzis S, Tufail F, Yu EN, Vredeveld CM, Foster CS. Mycophenolate mofetil as an immunodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology 2003;110:1061-5.
485. Stavrou P, Tufail F, Baltatzis S, Foster CS. Immunomodulatory treatment in patients with severe sympathetic ophthalmia. Middle East J Ophthalmol 2003;10:73-6.
486. Miserocchi E, Modorati G, Azzolini C, Foster CS, Brancato R. Herpes simplex virus type 2 acute retinal necrosis in an immunocompetent patient. Eur J Ophthalmol 2003;13:99-102.
487. Cunha RNP, Campos M, Dulley FL, Rojas B, Foster CS. Dry eye evaluation and immunohistochemical study of the conjunctiva and lacrimal gland of bone marrow transplantation patients. Arquivos Brasileiros de Oftalmologia 2003.
488. Trocme SD, Leiferman KM, George T, Bonini S, Foster CS, Smit EE, Sra SK, Grabowski WR, Dohlman CH. Neutrophil and eosinophil participation in atopic and vernal keratoconjunctivitis. Curr Eye Res 2003;26:319-25.
489. Razzaque MS, Kumari S, Foster CS, Ahmed AR. Expression profiles of collagens, HSP47, TGF-beta1, MMPs and TIMPs in epidermolysis bullosa acquisita. Cytokine 2003;21:207-13.
490. Razzaque MS, Ahmed BS, Foster CS, Ahmed AR. Effects of IL-4 on conjunctival fibroblasts: possible role in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003;44:3417-23.
63 491. Ahmed AR, Dahl MV, Consensus Development Group. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol 2003;139:1051-9.
492. Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster CS. Long-term progression, prognosis and treatment of patients with recurrent ocular manifestations of Reiter’s syndrome. Ophthalmology 2003;110:1764-9.
493. Yao L, Baltatzis S, Zafirakis P, Livir-Rallatos C, Voudouri A, Markomichelakis N, Zhao T, Foster CS. Human mast cell subtypes in conjunctiva of patients with atopic keratoconjunctivitis, ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Ocul Immunol Inflamm 2003;11:211-22.
494. Androudi S, Brazitikos P, Iaccheri B, Fiore T, Christen W, Meniconi M, Foster CS. Outcomes of early and late immunomodulatory treatment in patients with HLA-B27- associated chronic uveitis. Graefes Arch Clin Exp Ophthalmol 2003;241:1000-5.
495. Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol 2003;14:395-8.
496. Androudi S, Iaccheri B, Brazitikos P, Papadaki T, Foster CS. Bilateral chronic anterior uveitis & neuroophthalmologic manifestations in a patient with Churg-Strauss syndrome: an unusual ocular presentation. Ocul Immunol Inflamm 2004;12:59-63.
497. Razzaque MS, Foster CS, Ahmed AR. Role of macrophage migration inhibitory factor in conjunctival pathology in ciciatricial pemphigoid. Invest Ophthalmol Vis Sci 2004;45:1174-81.
498. Durrani K, Papaliodis G, Foster, CS. Pulse IV Cyclophosphamide in Ocular Inflammatory Disease. Ophthalmology 2004;111(5):960-5.
499. Durrani K, Hynes A, Foster CS. The White Dot Syndromes. Contemporary Ophthalmology 2004 Pt I & II; 3(6):1-7, (7):1-6.
500. Holland GN, Stiehm ER, Additional participants in the workshop “Evaluation . Special Considerations in the Evaluation and management of Uveitis in Children. Am J Ophthalmology 2003;135(6):867-78.
501. Kump L, Paredes I, Foster CS. Treatment of ocular toxoplasmosis in pregnancy. Philippine Journal of Ophthalmology 2004;29(2): 88-93.
64 502. Markomichelakis N, Chatzisefanou K, Dafni U, Christen WG, Zafirakis P, Rojas B, Foster CS. Characteristics of Systemic Disease-Associated and Idiopathic Arthritis-associated Uveitis. Middle East Journal of Ophthalmology 2004;12(1):5-12.
503. Stavrou P, Yu EN, Baltatzis S, Gion N, Zein G, Foster CS. Cataract Surgey in Patients with Scleritis. Middle East Journal of Ophthalmology 2004;12(1):13-17.
504. Papadaki T, Papaliodis G, Zacharopoulos I, Christen W, Soheilian M, Foster CS. Infectious Uveitis and the Role of Diagnostic Vitrectomy. Middle East Journal of Ophthalmology 2004;12(1):33-39.
505. Stavrou P, Yu E, Baltatzis S, Foster CS. Par Plana Vitrectomy in Juvenile Idiopathic Arthritis-Associated Uveitis. Middle East Journal of Ophthalmology 2004;12:2:117-121.
506. Daoud YJ, Letko E, Nguyen QD, Soukiasian SH, Samson CM, Sangwan V, Harper SL, Michel S, Schuman JS, Foster CS. Aqueous humour outflow facility in OCP. Middle East Journal of Ophthalmology 2004;12:102-107.
507. Markomichelakis NN, Iaccheri B, Fiore T, Chatzistefanou KI, Dafni U, Christen W, Rojas B, Sohelian M, Baltatzis S, Foster CS. Intermediate uveitis: prognostic factors and course of disease. Middle East Journal of Ophthalmology 2004;12:2:83-88.
508. Letko E, Miserocchi E, Daoud YJ, Christen W, Foster CS, Ahmed AR. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol. 2004 ;111(3):303-10.
509. Vavvas D, Foster CS. Immunomodulatory Medications in Uveitis. International Ophthalmology Clinics 2004;4(3): 187-203.
510. Perez V, Chavala S, Ahmed M, Chu D, Zafirakis P, Baltatzis S, Ocampo V, Foster CS. Ocular Manifestations and Concepts of Systemic Vasculitudes. Survey of Ophthalmology 2004;49(4):399-418.
511. Sami N, Letko E, Androudi S, Foster CS, Ahmed AR. Intravenous immunoglobulin therapy in patients with ocular cicatricial pemphigoid: A long-term follow-up. Ophthalmology 2004;111(7):1380-2.
512. Cervantes RA, Kump LI, Foster CS. Glucocorticoid-induced osteoporosis: considerations in ophthalmology. Ophthalmology 2004;111(8):1437-8.
65 513. El Shabrawi Y, Walch A, Hermann J, Egger G, Foster CS. Inhibition of MMP –dependent Chemotaxis and Amelioration of Experimental Autoimmune Uveitis with a Selective Metalloproteinase-2 and -9 Inhibitor. J Neuroimmunol. 2004 155: 13-20.
514. Foster CS, Sainz De La Maza M. Ocular cicatricial pemphigoid review. Curr Opin Allergy Clin Immunol. 2004 Oct;4(5):435-9.
515. Perez VL, Papaliodis GN, Chu D, Christen W, Foster CS. Elevated IL-6 in the vitreous fluid of patients with pars planitis and posterior uveitis. Ocular Immunology Inflammation. 2004;12(3):205-14.
516. Ahmed M, Zein G, Khawaja F, Foster CS. Ocular Cicatrial Pemphigoid: Pathogenesis, Diagnosis and Treatment. Progress in Retinal & Eye Research 2004;23:579-592.
517. Thadani SM, Foster CS . Treatment of ocular inflammation in children. Paediatr Drugs. 2004;6(5):289-301.
518. Havrlikova K, Mellott M, Kaufman AH, Loredo GA, Peters JH, Colvin RB, Foster CS. Expression of fibronectin isoforms bearing the alternatively spliced EIIB, and V segments in corneal alkali burn and keratectomy wound models in the Rat. Cornea 2004 ;23(8):812- 8.
519. Iaccheri B, Roque M, Fiore T, Papadaki T, Mathew B, Baltatzis S, Emara B, Tokarewicz AC, Foster CS. Ocular Cicatricial Pemphigoid, Keratomycosis and Intravenous Immunoglobulin Therapy. Cornea. 2004;23(8):819-22.
520. Zein G, Berta A, Foster CS. Multiple sclerosis associated uveitis. Ocular Immunology Inflammation 2004;12(2): 137-42.
521. Ahmed M, Androudi S, Brazitikos P, Paredes I, Foster CS. 360 degrees iris-ciliary body B-cell lymphoma masquerading as post-cataract uveitis. Semin Ophthalmol. 2004 Sep- Dec;19(3-4):127-9.
522. Rubin PA, Foster CS. Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol. 2004;138(6):1041-3.
523. Topalkara A, Ahmed M, Foster CS. Highlights of Modern Diagnosis in Uveitis – Part 2: Useful imaging and Molecular Diagnostic Studies. Highlights of Ophthalmology, 2005, 33:2: 17-19.
524. Durrani K, Foster CS. Psoriatic Uveitis: A Distinct Clinical Entity? Am J Ophthalmol. 2005;139(1):106-11.
66
525. Androudi S, Foster CS. Valsalva retinopathy. Diagnostic Challenges in a Patient with Pars- Planitis. Acta Ophthalmologica. 2005.83: 256-257.
526. Androudi S, Ahmed M, Foster CS. Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. J Cataract Refract Surg. 2005;31(3):472-8.
527. Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS. Stevens- Johnson syndrome and toxic epidermal necrolysis: A Review of the literature. Ann Allergy Asthma Immunol. 2005;94(4):419-36.
528. Acharya N, Pineda R 2nd, Uy HS, Foster CS. Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis. Ophthalmology. 2005;112(5):e19-23.
529. Nussenblatt RB, Peterson JS, Foster CS, Rao NA, See RF, Letko E, Buggage RR. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology. 2005;112:764-70.
530. Kathiresan S, Kelsey PB, Steere AC, Foster CS, Curvelo MS, Stone JR. Case records of the Massachusetts General Hospital. Case 14-2005. A 38-year-old man with fever and blurred vision. N Engl J Med. 2005;12;352:2003-12.
531. Kump LI, Cervantes-Castaneda RA, Androudi SN, Foster CS. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005;112(7):1287-92.
532. Kiss S, Ahmed M, Letko E, Foster CS. Long-term Follow-up of Patients with Birdshot Retinochoroidopathy Treated with Corticosteroid-Sparing Systemic Immunomodulatory Therapy. Ophthalmol. 2005. 112:1066-1071.
533. Baehring JM, Androudi S, Longtine JJ, Betensky RA, Sklar J, Foster CS, Hochberg FH. Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer. 2005;104(3):591-7.
534. Androudi S, Letko E, Meniconi M, Papadaki T, Ahmed M, Foster CS. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema. . Ocul Immunol Inflamm. 2005;13:205-12.
535. Kafkala C, Hynes A, Choi J, Topalkara A, Foster CS. Ahmed valve implantation for uncontrolled pediatric uveitic glaucoma. J AAPOS. 2005;9(4):336-40.
67 536. Rojas B, Cuhna R, Zafirakis P, Ramirez JM, Lizan-Garcii A M, Zhao T, Foster CS. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. Exp Eye Res. 2005;81(3):313-325.
537. Lima Cabrita FV, Foster CS. Anticardiolipin antibodies and ocular disease. Ocul Immunol Inflamm. 2005;13:265-70.
538. Eschle-Meniconi ME, Ahmad SR, Foster CS. Mucous membrane pemphigoid: an update. Curr Opin Ophthalmol. 2005 Oct;16(5):303-7.
539. Kump LI, Androudi SN, Foster C. Ocular toxoplasmosis in pregnancy. Clin Experiment Ophthalmol. 2005;33:455-60.
540. Paredes I, Ahmed M, Foster CS. Diagnostic Evaluations to Guide Therapy for Adamantiades-Behçet’s Disease. Contemporary Ophthalmology 2005;4;1:1-8.
541. Daoud YJ, Cervantes R, Foster CS, Ahmed AR. Ocular pemphigus. J Am Acad Dermatol. 2005 Oct;53(4):585-90.
542. Hynes AY, Kafkala C, Daoud YJ, Foster CS. Controversy in the use of high-dose systemic steroids in the acute care of patients with Stevens-Johnson syndrome. Int Ophthalmol Clin. 2005;45(4):25-48.
543. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509-16.
544. Rashid S, Foster CS. Intermediate Uveitis. Contemporary Ophthalmology 2005:4:8:1-8.
545. Hatton MP, Rubin PA, Foster CS. Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil. Am J Ophthalmol. 2005 Nov;140(5):916-8.
546. Choopong P, Khan N, Sangwan VS, Zafirakis P, Rallatos CL, Rojas B, Baltatzis S, Foster CS. Eosinophil activation in Wegener's granulomatosis: a harbinger of disease progression? Ocul Immunol Inflamm. 2005 Dec;13(6):439-45.
547. Papadaki T, Zacharopoulos I, Iaccheri B, Fiore T, Foster CS. Somatostatin for Uveitic Cystoid Macular Edema (CME). Ocul Immunol Inflamm. 2005 Dec;13(6):469-70.
548. Kafkala C, Daoud YJ, Paredes I, Foster CS. Masquerade scleritis. Ocul Immunol Inflamm. 2005 Dec;13(6):479-82.
68 549. Yu EN, Meniconi ME, Tufail F, Baltatzis S, Foster CS. Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):353- 60.
550. Daoud YJ, Foster CS, Ahmed R. Eyelid skin involvement in pemphigus foliaceus. Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):389-94.
551. Klisovic DD, Foster CS.Microscopic Polyangiitis and ocular disease. Contemporary Opthalmology 2006;5:2:1-8.
552. Onal S, Foster CS. Retinal vasculitis. Contemporary Opthalmology 2006;5:3:1-8.
553. Sobrin L, Foster CS. Systemic lupus erythematosus. Contemporary Opthalmology 2006;5:4:1-8.
554. Cordero M, Sobrin L, Foster CS. Sympathetic Ophthalmia. Contemporary Opthalmology 2006;5:5:1-8.
555. Anzaar F, Foster CS. Giant Cell Arteritis. Contemporary Ophthalmology 2006;5:6:1-8.
556. Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm. 2006 Apr;14(2):87-90.
557. Kump LI, Cervantes-Castaneda RA, Androudi SN, Foster CS, Christen WG. Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium. Ocul Immunol Inflamm. 2006 Apr;14(2):99-104.
558. Teasley LA, Foster CS. Primary Intraocular Lymphoma : Update on Diagnosis and Treatment. Contemporary Ophthalmology 2006;5:7:1-6.
559. Gamm DM, Harris A, Mehran RJ, Wood M, Foster CS, Mootha VV. Mucous Membrane Pemphigoid With Fatal Bronchial Involvement in a Seventeen-Year-Old Girl.Cornea. 2006 May;25(4):474-478.
560. Foster CS. Uveitis:Serious cause of visual loss in children. Rev Ophthalmol May 2006; 36- 40.
561. Jaffe GJ, Martin D, Callanan D, Pearson A, Leby B, Comstock T & Fluocinolone Acetonide Uveits Study Group. Fluocinolone Acetonide Implant (Retisert) for Noninfectious Posterior Uveitis: thirty four week results of amulticenter randomized clinical study. Ophthalmology 2006;113;6:1020-1027.
69
562. Klisovic DD, Foster CS. Adamantiades-Behcet Disease. Contemporary Ophthalmology 2006; 5:10:1-8.
563. Ceron O, Foster CS. Practical Guide to the Interpretation of Fluorescein Angiography. Contemporary Ophthalmology 2006; 5:11:1-10.
564. Kiss S, Anzaar F, Foster CS. Birdshot Retinochoroidopathy. Int Ophth Clin 2006;46:2:39- 55.
565. Andreoli CM, Foster CS. Vogt-Koyanagi-Harada Disease. Int Ophth Clin 2006;46:2:111- 122.
566. Hong JE, Foster CS. Spirochetal Uveitis. Int Ophth Clin 2006;46:2:123-139.
567. Kim, EC, Foster CS. Immunomodulatory Therapy for the Treatment of Ocular Inflammatory Disease: Evidence-based Medicine Recommendations for Use. Int Ophth Clin 2006;46:2:141-164.
568. Foster CS. Cataract Surgery and Uveitis. Current Insight, American Academy of Ophthalmology, Summer 2006.
569. Yu EN, Jurkunas U, Rubin PA, Baltatzis S, Foster CS. Obliterative Microangiopathy Presenting as Chronic Conjunctivitis in a Patient With Relapsing Polychondritis. Cornea. 2006 Jun;25(5):621-622.
570. Kafkala C, Choi J, Zafirakis P, Baltatzis S, Livir-Rallatos C, Rojas B, Foster CS. Mooren Ulcer: An Immunopathologic Study. Cornea. 2006 Jul;25(6):667-673.
571. Choi JY, Kafkala C, Foster CS. Primary intraocular lymphoma: a review. Semin Ophthalmol. 2006 Jul-Sep;21(3):125-33.
572. Khan N, Huang JJ, Foster CS. Cancer Associated Retinopathy (CAR): An Autoimmune- Mediated Paraneoplastic Syndrome. Semin Ophthalmol. 2006 Jul-Sep;21(3):135-41.
573. Ocampo J, Yu E, Zhao TZ, Feroze K, Foster CS. Toxicity of 0.2% Chlorhexidine Gluconate to the Cornea and Adjacent Structures. Philippine Journal of Ophthalmology, 2006 Jul-Sep; 30(3): 119-123.
574. Ahmed M, Foster CS. Steroid Therapy for Ocular Inflammatory Disease. Focal Points, American Academy of Ophthalmology 2006 Sep; 24:7:1-13.
70 575. Kafkala C, Choi JY, Choopong P, Foster CS. Octreotide as a Treatment for Uveitic Cystoid Macular Edema. Arch Ophthalmol 2006 Sep;124(9):1353-5.
576. Kump LI, Castaneda RA, Androudi SN, Reed GF, Foster CS. Visual Outcomes in Children with Juvenile Idiopathic Arthritis-Associated Uveitis. Ophthalmology. 2006 Oct;113(10):1874-7.
577. Fortuna ES, Hinkle D, Foster CS. Management of anterior uveitis: Immunomodulatory Therapy is gaining acceptance. Ophthalmology Management 2006 Oct; 61-101.
578. Papadaki TG, Kafkala C, Zacharopoulos IP, Seyedahmadi B J, Dryja T, Foster CS. Conjunctival Non-Caseating Granulomas in a Human Immunodeficiency Virus (HIV) Positive Patient Attributed to Sarcoidosis. Ocul Immunol Inflamm. 2006 Oct;14(5):309-11.
579. Yilmaz T, Foster CS. Indocyanine Green Angiography. Contemporary Ophthalmology 2006 Oct 15; 5:19:1-8.
580. Iaccheri B, Fiore T, Papaliodis G, Papadaki T, Androudi S, Foster CS. Cyclosporine and Mycophenolate Mofetil: The Massachusetts Eye and Ear Infirmary Experience in the Treatment of Birdshot Retinochoroidopathy. Middle East Journal of Ophthalmology. 2006; 13:4:129-135.
581. Kump LI, Foster CS. Intraocular drug delivery in patients with uveitis under special circumstances. Middle East Journal of Ophthalmology. 2006 Oct-Dec; 13:4:136-140.
582. Letko E, Bhol K, Anzaar F, Perez VL, Ahmed AR, Foster CS. Chronic Cicatrizing Conjunctivitis in a Patient With Epidermolysis Bullosa Acquisita.Arch Ophthalmol. 2006 Nov;124(11):1615-1618.
583. Papadaki TG, Zacharopoulos IP, Papaliodis G, Iaccheri B, Fiore T, Foster CS. Plasmapheresis for lupus retinal vasculitis. Arch Ophthalmol. 2006 Nov;124(11):1654-6.
584. Onal S, Foster CS, Ahmed AR. Efficacy of intravenous immunoglobulin treatment in refractory uveitis. Ocul Immunol Inflamm. 2006 Dec;14(6):367-74.
585. Choopong P, Nielsen PG, Perlman EM, Huang JJ, Dryja TP, Foster CS. Solitary myofibroma of the sclera. Cornea. 2007 Jan;26(1):114-6.
586. Yu EN, Paredes I, Foster CS. Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):11-7.
71 587. Borboli S, Afshari NA, Watkins L, Foster CS. Presumed Oculoglandular Syndrome from Bartonella quintana. Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):41-3.
588. Teasley LA, Foster CS, Baltatzis S. Sclerokeratitis and Facial Skin Lesions: A Case Report of Pyoderma Gangrenosum and its Response to Dapsone Therapy. Cornea. 2007 Feb;26(2):215-219.
589. Tang J, Foster CS. Age-related Macular Degeneration. Contemporary Ophthalmology. 2007 Feb 28;6:4:1-6.
590. Teasley LA, Foster CS. Syphilis: an ophthalmologic update. Int Ophthalmol Clin. 2007 Spring;47(2):133-44.
591. Sobrin L, Foster CS. Cytomegalovirus retinitis after one decade of HAART. Int Ophthalmol Clin. 2007 Spring;47(2):155-64.
592. Cervantes-Castaneda RA, Jawed N, Foster CS. Immunosuppressive Therapy for Noninfectious Uveitis. Retinal Physician 2007 March; 30-37.
593. Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm. 2007 Mar- Apr;15(2):99-104.
594. Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, Jabs DA, Nguyen QD. Punctate Inner Choroidopathy A Survey Analysis of 77 Persons. Ophthalmology. 2007 Apr; 114:1201-1204.
595. Simmons EP, Foster CS. Diabetic Retinopathy and Macular Edema. Contemporary Ophthalmology 2007 Apr 30;6:8:1-8.
596. Wick MR, Foucar E, Allen PW, Alves VA, Bjornsson J, Bosman F, Churg AW, Drut R, Foster CS, Hauptmann S, Hytiroglou P, Kuo TT, Matsubara O, Nappi O, Pervez S, Rosai J, Sasano H, Vielh P, Zelger B. Medicolegal liability in pathology: an international perspective. Semin Diagn Pathol. 2007 May;24(2):65-76.
597. Cordero-Coma M, Anzaar F, Yilmaz T, Foster CS. Herpetic retinitis. Herpes. 2007 Jun;14(1):4-10.
598. Papadaki TG, Zacharopoulos IP, Pasquale LR, Christen WB, Netland PA, Foster CS. Long-term Results of Ahmed Glaucoma Valve Implantation for Uveitic Glaucoma. Am J Ophthalmol. 2007 Jul;144(1):62-69.
72
599. Sobrin L, Kim EC, Christen W, Papadaki T, Letko E, Foster CS. Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol. 2007 Jul;125(7):895-900.
600. Topalkara A, Ben-Arie-Weintrob Y, Ferry JA, Foster CS. Conjunctival Marginal Zone B- cell Lymphoma (MALT Lymphoma) with Amyloid and Relapse in the Stomach. Ocul Immunol Inflamm. 2007 Jul-Aug;15(4):347-50.
601. Durrani K, Ahmed M, Foster CS. Adamantiades-Behcet Disease: Diagnosis and Current Concepts in Management of Ocular Manifestations.Compr Ophthalmol Update. 2007 Jul- Aug;8(4):225-33.
602. Cordero Coma M, Sobrin L, Onal S, Christen W, Foster CS. Intravitreal Bevacizumab for Treatment of Uveitic Macular Edema. Ophthalmology. 2007 Aug;114(8):1574-1579.
603. Sobrin L, Kump LI, Foster CS. Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina. 2007 Sep;27(7):952-7.
604. Foster CS, Korenfeld M. New potent difluprednate advances through Phase III Studies. Ophthalmology Times 2007 Sep 15; 36-37.
605. Gallagher MJ, Quinones K, Cervantes-Castaneda RA, Yilmaz T, Foster CS. Biologic Response Modifier Therapy for Refractory Childhood Uveitis. Br. J. Ophthalmol. 2007 Oct;91(10):1341-4.
606. Coma MC, Yilmaz T, Foster CS. Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid. Acta Ophthalmol Scand. 2007 Nov;85(7):753-5.
607. Teasley LA, Christen WG, Foster CS. Oral Non-Steroidal Anti-Inflammatory Agents in the Treatment of Chronic or Recurrent Non-Infectious Uveitis. Contemporary Ophthalmology 2007;6:11:1-8.
608. Letko E, Gurcan HM, Papliodis GN, Christen W, Foster CS, Ahmed AR. Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit. Clin Exp Dermatol. 2007 Nov;32(6):637-41.
609. Gallagher MJ, Yilmaz T, Cervantes-Castaneda RA, Foster CS. The Characteristic Features of Optical Coherence Tomography in Posterior Uveitis. Br J Ophthalmol. 2007 Dec;91(12):1680-5.
73 610. Levinson RD, Foster CS, Jaffe GJ. Management of chronic uveitis. Focal Points; December 2007, Volume 25, Number 11.
611. Rao V, Gallagher MJ, Bhat P, Foster CS. Sensorineural Hearing Loss In A Patient With HLA-B27 Sclero-Uveitis. Brit Journal Ophthalmol 2008; 92;3.
612. Magee CC, Coggins MP, Foster CS, Muse VV, Colvin RB. Case records of the Massachusetts General Hospital. Case 2-2008. A 38-year-old woman with postpartum visual loss, shortness of breath, and renal failure.N Engl J Med. 2008 Jan 17;358(3):275- 89.
613. Kempen JH, Daniel E, Gangaputra S, et.al. for the Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Methods for Identifying Long-term Adverse Effects of Treatment in Patients with Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiology. 2008 Jan-Feb;15(1):47-55.
614. Ahmed M, Niffenegger JH, Jakobiec FA, Ben-Arie-Weintrob Y, Gion N, Androudi S, Folberg R, Raizman MB, Margo CE, Smith ME, McLean IW, Caya JG, Foster CS. Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Int Ophthalmol. 2008 Feb;23(1): 35-46.
615. Sippel KC, Foster CS. Pearls for limbal stem cell autografting. Ocular Surgery News. Feb 2008: 40.
616. Sobrin L, Huang JJ, Christen W, Kafkala C, Choopong C, Foster CS. Daclizumab for Treatment of Birdshot Chorioretinopathy. Arch Ophthalmol. 2008 Feb;126(2):186-91.
617. Hinkle DM, Foster CS. Tubulointerstitial nephritis and uveitis syndrome. Int Ophth Clin. 2008 Spring;48(2):9-13.
618. Acevedo S, Quinones K, Rao V, Cervantes-Castaneda, RA, Foster CS. Cataract Surgery in children with Juvenile Idiopathic Arthritis associated uveitis. Int Ophth Clin. 2008 Spring;48(2):1-7.
619. Sayegh RR, Ang LP, Foster CS, Dohlman CH. The Boston Keratoprosthesis in Stevens- Johnson Syndrome. Am J Ophthalmol. 2008 Mar;145(3):438-44.
620. Sippel KC, Foster CS. Pearls in amniotic membrane transplantation. Ocular Surgery News. Mar 2008: 44.
74 621. Hatton MP, Raizman M, Foster CS. Exacerbation of Undiagnosed Ocular Cicatricial Pemphigoid After Repair of Involutional Entropion. Ophthal Plast Reconstr Surg. 2008 Mar-Apr;24(2):165-6.
622. Hinkle, DM, Foster CS. Autoimmune Inflammatory Vitreoretinal Disease: Pathogenesis, Progression, and Treatment. Retinal Physician; April 2008.
623. Seth RK, Foster CS, Huang JJ, Scott IU, Fekrat S. Epithelial downgrowth: A new option for an old Adversary. Cornea; May 2008; 45-46.
624. Huynh N, Cervantes-Castaneda RA, Bhat P, Gallagher MJ, Foster CS. Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm. 2008 May-Jun;16(3):89-93.
625. Sobrin L, Christen W, Foster CS. Mycophenolate Mofetil after Methotrexate Failure or Intolerance in the Treatment of Scleritis and Uveitis.Ophthalmology. 2008 Aug;115(8):1416-21, 1421.
626. Gallagher MJ, Cervantes-Castaneda R, Bhat P, Foster CS. Primary Intra-ocular lymphoma: another great masquerader. European Journal of Ophthalmology. 2008; Jul-Aug;18(4): 567-71.
627. Kempen J, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Helzlsouer K. Long-term Risk of Malignancy Among Patients Treated With Immunosuppressive Agents for Ocular Inflammation: A Critical Assessment of the Evidence, Am J Ophthalmol. Volume 146, Issue 6, December 2008, Pages 802-812.
628. Foster CS. Ganciclovir Gel – A New Topical Treatment for Herpetci Keratitis. US Ophthalmic Review (Extract); Touch Briefings. 2008.
629. Callanan, DG, Jaffe, GJ, Martin, DF, Pearson, PA, Comstock, TL. Treatment of Posterior Uveitis With a Fluocinolone Acetonide Implant. Arch ophthalmol. 2008 Sep; 126(9): 1191-1201.
630. Anzaar F, Gallagher MJ, Bhat P, Arif M, Farooqui M, Foster CS. Use of Systemic T- Lymphocyte Signal Transduction Inhibitors in the Treatment of Atopic Keratoconjunctivitis. Cornea 2008 Sep;27(8):884-8.
631. Choopong, P, Tauber, J, Foster, CS. Wegener Granulomatosis. Contemporary Ophthalmology. 2008 Oct 15; 7(19): 1-7.
75 632. Grimm SA, Mccannel CA, Omura AM, et al. Primary CNS Lymphoma with Intraocular Involvement (short review of: Grimm SA et al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology. 2008 Oct 21;71(17):1355-60.
633. Doctor P, Bhat P, Yilmaz T, Foster, CS. Subconjunctival bevacizumab for corneal neovascularization. Cornea 2008 Oct;27(9):992-5.
634. Iaccheri B, Fiore T, Papadaki T, Androudi S, Janjua S, Bahaila I, Foster CS. Adverse drug reactions to treatments for ocular toxoplasmosis: A retrospective chart review. Clinical Therapeutics. 2008 Nov;30(11):2069-74.
635. Kacmaz RO, Kempen JH, Newcomb C, et al.for the Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Ocular Inflammation in Behect’s Disease: Incidence of Ocular Complications and Loss of Visual Acuity. Am J Ophthalmol. 2008 Dec;146(6):828-36.
636. Doctor P, Bhat P, Foster CS. Peripheral Ulcerative Keratitis. Contemporary Ophthalmology. 2008 Dec 15; 7(23): 1-7.
637. Fortuna E, Cervantes-Castañeda R, Bhat, P, Doctor P, Foster CS. Flare-up rates with Bimatoprost Therapy in Uveitic Glaucoma. Am J Ophthalmol. 2008 Dec;146(6):876-82.
638. Kempen JH, Gangaputra S, Daniel E, et.al. Long-term malignancy among patients treated with immunosuprressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol. 2008 Dec; 146(6):802-12.e1.
639. Bhat P, Castañeda-Cervantes R, Doctor P, Foster CS. Intravenous daclizumab for recalcitrant ocular inflammatory disease. 2009 May;247(5):687-92.
640. Hamam R, Bhat P, Foster CS. Conjunctival/Corneal Intraepithelial Neoplasia. International Ophthalmology Clinics. 2009 JAN; 49(1): 63-70.
641. Foster CS. Treatment of herpes simplex keratitis. Refractive Eyecare. 2009 Jan; 13(1).
642. Quiñones K, Cervantes-Castañeda R, Hynes AY, Daoud YJ, Foster CS. Outcomes of Cataract Surgery in Children with Chronic Uveitis. J Cataract Refract Surg. 2009 Apr;35(4):725-31.
643. Doctor P, Bhat P, Foster CS. Intravitreal Bevacizumab for Uveitic Choroidal Neovascularization. Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):118-26.
76 644. Iaccheri B, Papadaki T, Ko C, Fiore T, Zacharopoulos, Thadani S, Christen S, Foster CS. Serum soluble interleukin-2 receptor levels do not correlate with an associated systemic disease in patients with uveitis. Acta Ophthalmol. 2009 Jun 2.
645. Cervantes-Castañeda R, Giuliari GP, Yilmaz T, McDonnell RE, Foster CS. Intravitreal Bevacizumab in Refractory Uveitic Macular Oedema: One year follow up. European Journal of Ophthalmology. 2009 Jul-Aug;19(4):622-9.
646. Gallagher MJ, Yilmaz T, Foster CS. Vogt-Koyanagi-Harada Syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy. Ophthalmic Surgery Lasers & Imaging. 2009 May-Jun;40(3): 345-347.
647. Foster CS. Vernal and Atopic Keratoconjunctivitis. Refractive Eyecare. 2009 Jun 13(6).
648. Khan FH, Quinones K, Foster CS. Ocular Allergy. Contemporary Ophthalmology. 2009 Jul 30; 8(14): 1-8.
649. Cervantes-Castañeda R, Bhat P, Fortuna E, Acevedo, Foster CS. Induction of Durable Remission in Ocular Inflammatory Diseases. European Journal of Ophthalmology. 2009 Jan-Feb;19(1):118-23.
650. Fiore T, Iaccheri B, Androudi S, Anzaar F, D’ Amico DJ, Foster CS. Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. Retina. 2009 Jul- Aug; 29(7):994-1001.
651. Pasadhika S, Kempen JH, Newcomb C, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB. Azathioprine for Ocular Inflammatory Diseases. Am J Ophthalmol. 2009 June30.
652. Bhat P, Cervantes-Castaneda RA, Doctor PP, Anzaar F, Foster CS. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm. 2009 May- June;17(3): 185-90.
653. Mauro J, Foster CS. Pterygia: Pathogenesis and the role of the subconjunctival bevacizumab in treatment. Semin Ophthalmol. 2009 May-June;24(3): 130-4.
654. Kempen JH, Daniel E, Dunn JP, et al. Risk of overall and cancer mortality among patients with ocular inflammation treated with immunosuppressive therapy: retrospective cohort study. Brit Med J. 2009 Jul 3;330.
77 655. Bhat PV, Jakobiec FA, Kurbanyan K, Zhao T, Foster CS. Chronic Herpes Simplex Scleritis: Characterization of 9 Cases of Underrecognized Clinical Entitiy. Am J Ophthalmol. 2009 Aug 10.
656. Giuliari GP, Hinkle DM, Foster CS. Local treatment for lymphoid malignancies of the eye. Anticancer Agents Med Chem. 2009 Dec;9(10): 1123-8.
657. Zakka FR, Chang PY Giuliari GP, Foster CS. Current trends in the management of ocular symptoms in Adamantiades-Behcet’s disease. Clinical Ophthalmology. 2009;3:567-79.
658. Pe’er J, Hochberg FH, Foster CS. Clinical review: Treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm. 2009 Sep-Oct:17(5): 299-306.
659. Doctor P, Sultan A, Syed S, Christen W, Bhat PV, Foster CS. Infliximab for the treatment of refractory scleritis. British Journal of Ophthalmology. 2009 Dec. Epub ahead of print.
660. Papadaki T, Iaccheri B, Fiore T, Zacharopoulos I, Thadani S, Christen W, Androudi S, Foster CS. Serum Soluble interleukin- 2 receptor levels do not correlate with an associated systemic disease in patients with uveitis. Acta Opthalmol. 2010 Mar;88(2):e28-9. Epub 2009 Jun 2.
661. Jancevski M, Foster CS. Cataracts and uveitis. Curr Opin Ophthalmol. 2010 Jan;21(1):10-4.
662. Gangaputra S, Newcomb CW, Liesegang TL, Kacmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Ophthalmology. Methotrexate for ocular inflammatory disease. 2009 Nov;116(11):2188-98.e1.
663. Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS. Cyclosporine for Ocular Inflammatory Diseases. Ophthalmology. 2010 Mar;117(3):576- 84. Epub 2010 Jan 19.
664. Giuliari GP, Chang PY, Thakuria P, Hinkle DM, Foster CS. Pars Plana Vitrectomy for paediatric uveitis: Massachusetts Eye Research and Surgery Institution experience. Eye. 2010 Jan;24(1):7-13.
665. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kacmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS Jabs DA, Kempen JH. Mychophenolate Mofetil for Ocular Inflammation. Am J Ophthalmol. 2010 Mar;149(3):423-32.e1-2. Epub 2009 Dec 30.
78
666. Watkins A, Kempen J, Choi D, Liesegang T, Pujari S, Newcomb C, Nussenblatt R, Rosenbaum J, Thorne J, Foster CS, Jabs D, Levy-Clarke GA, Suhler E, Smith J. Ocular disease in patients with ANCA-positive vasculitis. Journal of Ocular Biology, Diseases, and Informatics, 2010-03-01. Humana Press Inc. 12-19: 3(1).
667. Jancevski M, Foster CS. Cataracts and Uveitis. Discov Med. 2010 Jan;9(44):51-4.
668. Ceron OM, Hinkle DM, Foster CS. Intraocular Inflammatory Disorders Update. Retinal Physician. 2009 Feb:24-8.
669. Foster CS, Chang PY, Ahmed AR. Combination of Rituximab and Intravenous Immunoglobulin for Recalcitrant Ocular Cicatricial Pemphigoid. Ophthalmology. 2010 May;117(5):861-9. Epub 2010 Jan 4.
670. Giuliari GP, Hinkle DM, Foster CS. The spectrum of fundus autofluorescence findings in birdshot chorioretinopathy. Journal of Ophthalmology. 2009 [Epub 2010 Feb 8].
671. Amorese L, Foster CS. Parasitic Keratitis. Contemporary Ophthalmology. 2010 Jan 15.
672. Multicenter Uveitis Steroid Treatment Trial Research Group. The Multicenter Uveitis Steroid Treatment (MUST) Trial: Rationale, Design and Baseline Characteristics. Am J Ophthalmol 2010;149:550-561. e10. Epub 2010 Jan 25.
673. Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 2010 Feb;117(2):356-65.
674. Zaidi AA, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RA, Kempen JH. Hypopyon in Patients with Uveitis. Ophthalmology. 2010 Feb;117(2):366-72.
675. Tumalad M, Mansoor A, Foster CS. Ocular Manifestations of Herpes Simplex Virus Infection. Contemporary Ophthalmology. 2010 Feb 28.
676. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Mycophenolate Mofetil for Ocular Inflammation, American Journal of Ophthalmology, Volume 149, Issue 3, March 2010, Pages 423-432.
79 677. Fiorelli VM, Bhat P, Foster CS. Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm. 2010 Apr;18(2):116-46.
678. Durrani K, Foster CS. Management of Uveitis: Current concepts and modalitites. Contemporary Ophthalmology. 2010 Apr 30.
679. Lee F, Foster CS. Pharmacotherapy of Uveitis. Expert Opinion on Pharmacotherapy. 2010 May;11(7):1135-46.
680. Masood K, Foster CS. Birdshot Retinochoroidopathy: An Updated Review of Diagnosis, Treatment, and Management Options. Contemporary Ophthalmology. 2010 May 15.
681. Siddique SS, Foster CS. Central Serous Chorioretinopathy. Contemporary Ophthalmology. 2010 Jun 15.
682. Galor A, Feuer W, Kempen JH, Kacmaz RO, Liesegang TL, Suhler EB, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Thorne JE. Adverse Effects of Smoking on Patients with Ocular Inflammation. British Journal of Ophthalmology. 2010 Jul;94(7):848-53.
683. Portero-Benito A, Foster CS. Ocular Albinism. Contemporary Ophthalmology. 2010 Jul 15.
684. Mehta M, Foster CS. Histopathologic Differential Diagnosis of Common Eyelid Lesions. Contemporary Ophthalmology. 2010 Jul 30.
685. Giuliari GP, Foster CS. Microperimetry findings in Birdshot chorioretinopathy. Canadian Journal of Ophthalmology. 2010 Aug 1;45(4):1-5.
686. Ciralsky J, Papaliodis GN, Foster CS, Dohlman CH, Chodosh J. Keratoprosthesis in Autoimmune Disease. Ocul Immunol Inflamm. 2010 Aug; 18 (4) 275-80.
687. Villaneuva- Palafox SK, Shaikh M, Foster CS. Neuromyelitis Optica (Devic’s Disease) : An entity distinct from multiple sclerosis. Contemporary Ophthalmology. 2010 Aug 15.
688. Foster CS, Davanzo R, Flynn TE, McLeod K, Vogel R, Crockett RS. Durezol (Difluprednate Opthalmic Emulsion 0.05%) Compared with Pred Forte 1% Opthalmic Suspension in the Treatment of Endogenous Anterior Uveitis. Journal of Ocular Pharmacology and Therapeutics. 2010 Sep 1.
80 689. Mehta M, Dacey M, Foster CS. Recurrent Conjunctivitis and Scleritis Secondary to Coexistent Conjunctival Pemiphigus Vulgaris and Cryptic Herpes Simplex Infection: A Case Report. Ocul Immunol Inflamm. 2010 Sep 2.
690. Siddique SS, Gonzalez LA, Thakuria P, Chang PY, Foster CS. Scleral Necrosis in a patient with congenital erythropoietic porphyria. Cornea. 2010 Sep 15.
691. Quinones K, Choi JY, Yilmaz T, Kafkala C, Letko C, Foster CS. Pars Plana Vitrectomy Versus Immunomodulatory Therapy for Intermediate Uveitis: A Prospective, Randomized Pilot Study. Ocul Immunol Inflamm. 2010 Oct; 18(5):411-7.
692. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH; Psoriasis Study Group, Durez P, Tak PP, Homez-Reino JJ; Rheumatoid Arthritis Study Group, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD; Uveitis Study Group, Rose K, Haider A, Di Padova F. Effects of AIN 457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Science Translation Medicine. 2010 Oct 6; 2(52):52ra72.
693. Krader CG, Foster CS. Dexamethasone Implant an Option For Posterior Segment Uveitis. Ophthalmology Times. 2010 Oct 15; 35 (20): 1, 11.
694. Siddique SS, Gonzalez LA, Amorese L, Shaikh M, Foster CS. Herpes Keratitis in a Patient Undergoing Treatment with Topical Mitomycin C. Cornea. 2011 Jan; 30(1): 97-99.
695. Jancevski M, Foster CS. Anterior Segment Optical Coherence Tomography. Semin Ophthalmology. 2010 Sep-Nov; (5-6): 317-23.
696. Foster CS, Anesi S. The Successful Approach to Ocular Rosacea. Drugs and Disease, Refractive Eyecare. Dec 2010: 11-12, 19.
697. Lowder C, Belfort R Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM; for the Ozurdex HURON Study Group. Dexamethasone Intravitreal Implant for Noninfectious Intermediate and Posterior Uveitis Arch Ophthalmol. 2011 May;129(5):545-53.
698. Palafox SK, Smitha J, Tauber A, Foster CS. Ophthalmia Neonatorum. Journal of Clinical & Experimental Ophthalmology 2:119 (1-5).
699. Peter Y. Chang, Sana S. Siddique, Mehrine Shaikh and C. Stephen Foster. 2010, Topical corticosteroids in ocular diseases, Current Topics in Steroid Research, Vol. 7, 1-10.
81 700. Foster CS. Drug Delivery Mechanisms for the Treatment of Uveitis. Retina Today. 2011 March.
701. Chang PY, Giuliari GP, Shaikh M, Thakuria P, Makhoul D, Foster CS. Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Eye (Lond). 2011 Mar 18. Online.
702. Letko E, Bhol K, Foster CS, Ahmed AR. Possible In Vitro Model of Toxic Epidermal Necrolysis. Arch Ophthalmol. 2011 May; 129 (5): 666-667.
703. Anzaar F, Cabrita F, Ahmed M, Foster CS. Letter to the Editor: The frequency of other autoimmune disorders in patients with ocular cictricial pemphigoid. Acta Ophthalmologica. 2011 May 19.
704. Mulki L, Foster CS. Difluprednate for Inflammatory Eye Disorders. Drugs of Today. 2011 June; 47(5):327-333.
705. Gonzalez-Gonzalez LA, Ridriguez-Garcia A, Foster CS. Pigment Dispersion Syndrome Masquerading as Acute Anterior Uveitis. Ocul Immunol Inflamm. 2011 Jun;19(3):158-66.
706. Gonzalez-Gonzalez LA, Foster CS. Secukinumab. Drugs of the Future. 2011 36(6): 441- 445.
707. Chang P, Foster CS. Stopping the Progression of Uveitic Glaucoma. Uveitis: Journal of the Uveitis Information Group. June 2011, 25-32.
708. Grunwald L, Newcomb CW, Daniel E, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH. Risk of relapse for patients with primary anterior uveitis. Ophthalmology, Volume 118(10):1911- 5.
709. Gangaputra SS, Altaweel MM, Peng Q, Friedman DS, Rao PK, Foster CS, Kim RY, Reed SB, Srivastava SK, Wong IG, Kempen JH, for the MUST Trial Research Group. Morphologic Assessment for Glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocular Immunol Inflamm. 2011, 19: 267-274.
710. Foster CS. Advances in the Prevention of Ocular Herpes Simplex Disease and its Recurrence. Topics in Ocular Antiinfectives, 2011, Issue 16: pps. 1-4.
711. Boughton B, Arevalo JF, Chang P, Davis J, Foster CS. Clinical Update, Pediatrics: Considering PPV in the Treatment of Juvenile Uveitis. Eyenet, July/August 2011.
82 712. Turkcuoglu P, Chang PY, Rentiya ZS, Channa R, Ibrahim M, Hatef E, Sophie R, Sadaka A, Wang J, Sepah YJ, Do DV, Foster CS, Nguyen QD. Mycophenolate Mofetil and Fundus Autofluorescence in the Management of Recurrent Punctate Inner Choroidopathy. Ocul Immunol Inflamm. 2011 Aug;19(4):286-92.
713. The Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group Randomized Comparison of Systemic Anti-Inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial. Ophthalmology, 2011 Oct;118(10):1916-26.
714. Siddique SS, Shah R, Suelves A, Foster CS. Road to remission: a comprehensive review of therapy in uveitis. Expert Opinion on Investigational Drugs, 2011 Nov;20(11):1497-1515.
715. Durrani K, Zakka FR, Ahmed M, Memon M, Siddique SS, Foster CS. Systemic Therapy With Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease. Survey of Ophthalmology, 2011 Nov-Dec;56(6):474-510.
716. Mehta M, Siddique S, Gonzalez-Gonzalez LA, Foster CS. Immunohistochemical Differences Between Normal and Chronically Inflamed Conjunctiva: Diagnostic Features. Am J Dermatopathol 2011 Dec;33(8):786-9.
717. Sugar EA, Jabs DA, Altaweel MM, Lightman S, Acharya N, Vitale AT, Thorne JE, Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Identifying a Clincally Meaningful Threshold for Change in Uveitic Macular Edema Evaluated by Optical Coherence Tomography. Am J Ophthalmol. 2011 Dec;152(6):1044-1052.
718. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor P, Tauber J, Foster CS. Scleritis Therapy, Ophthalmology, 2012 Jan;119(1):51-8.
719. Cohen AE, Assang C, Patane MA, From S, Korenfeld M, Foster CS, et al. Evaluation of Dexamethasone Phosphate Delivered by Ocular Iontophoresis for Treating Noninfectious Anterior Uveitis. Ophthalmology. 2012 Jan;119(1):66-73.
720. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor P, Tauber J, Foster CS. Clinical Characteristics of a Large Cohort of Patients with Scleritis and Episcleritis, Ophthalmology, 2012 Jan;119(1):43-50.
721. Baheti U, Siddique SS, Foster CS, Cataract Surgery in Patients with History of uveitis, Saudi J Ophthalmol. 2012 Jan;26(1):55-60.
722. Anesi SD, Foster CS. Importance of Recognizing and Preventing Blindness from Juvenile Idiopathic Arthritis-Associated Uveitis. Arthritis Care Res (Hoboken). 2012 May;64(5):653-7.
83
723. Hinkle DM, Dacey M, Mandelcorn E, Kalyani P, Mauro J, Bates JH, Soukasian SH, Holland GN, Foster CS, Fraunfelder FT, Davis JL, Fraunfelder FW. Bilateral uveitis associated with fluoroquinolone therapy. Cutaneous and Ocular Toxicology, 2012 Jun;31(2):111-6.
724. Charkoudian LD, Ying GS, Pujari SS, Gangaputra S, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Kempen JH. High-dose intravenous corticosteroids for ocular inflammatory diseases. Ocul Immunol Inflamm. 20:91-99, 2012 (2).
725. Frick KD, Drye LT, Kempen JH, Dunn JP, Holland GN, Latkany P, Rao NA, Sen HN, Sugar EA, Thorne JE, Wang RC, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Associations among visual acuity and vision- and health- related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci 2012;53(3):1169-76. PMID 22247489
726. Capella MJ, Foster CS, Long-Term Efficacy and Safety of Infliximab in the Treatment of Behçet’s Disease. Ocul Immunol Inflamm. 2012 Jun;20(3):198-202.
727. Sheppard JD, Nguyen QD, Usner DW, Comstock TL, Foster CS et. al. Post-Cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant. Clin Ophthalmol. 2012;6:79-85.
728. Taylor SRJ, Lightman SL, Sugar EA, Jaffe GJ, MUST Clinical Tial Research Group. The Impact of Macular Edema on Visual Function in Intermediate, Posterior, and Panuveitis. Ocul Immunol Inflamm. 2012 Jun;20(3):171-81.
729. Rankin JK, Jakobiec FA, Zakka FR, Foster CS. An Improved Approach to Diagnosing and Treating Conjunctival Mucoepidermoid Carcinoma. Surv Ophthalmol. 2012 Jul- Aug;57(4):337-46. 730. Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, Sainz de la Maza MT, Foster CS. Clinical Features and Presentation of Infectious Scleritis from Herpes Viruses: A Report of 35 Cases. Ophthalmology. 2012 Jul;119(7):1460-4.
731. Arcinue CA, Saboo US, Foster CS. Corticosteroids in Uveitis. Retina Today. July/August 2012.
732. Suelves AM, Foster CS. Clinical Care of Uveitis Patients. Advanced Ocular Care. July/August 2012.
733. Udoetuk JD, Dai Y, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, et al. Risk of Corticosteroid-Induced Hyperglycemia Requiring Medical
84 Therapy among Patients with Inflammatory Eye Diseases. Ophthalmology. 2012 Aug;119(8):1569-74.
734. Suelves AM, Kruh JN, Aznar-Peña I, Siddique SS, Foster CS. Long-term safety and visual outcomes of anterior chamber intraocular lens implantation in patients with a history of chronic uveitis. J Cataract Refract Surg. 2012 Oct;38(10):1777-82.
735. Chang PY, Hamam R, Giuliari GP, Foster CS. Cytomegalovirus panuveitis associated with papillitis in an immunocompentent patient. Can J Ophthalmol. 2012 Aug;47(4):e12-3.
736. Yang P, Kruh JN, Foster CS. Antiphospholipid antibody syndrome. Curr Opin Ophthalmol. 2012 Nov;23(6):528-32.
737. Durrani K, Foster CS. Fundus Autofluorescence Imaging in Posterior Uveitis. Semin Ophthalmol. 2012 Sep-Nov;27(5-6):228-35.
738. Daniel E, Pistilli M, Pujari SS, Kaçmaz RO, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. Risk of hypotony in noninfectious uveitis. Ophthalmology. 2012 Nov;119(11):2377-85.
739. Suelves AM, Zhao TZ, Siddique S, Foster CS. Profile of Local Interleukin Expression in a Cohort of Ocular Cicitricial Pemphigoid Patients. Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8112-7.
740. Domalpally A, Altaweel MM, Kempen JH, Myers D, Davis JL, Foster CS, Latkany P, Srivastava SK, Stawell RJ, Holbrook JT, for the MUST Trial Research Group. Optical Coherence Tomography Evaluation in the Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocul Immunol Inflamm. 2012 Dec;20(6):443-7.
741. Carreño E, Portero A, Herreras JM, Calonge M, Foster CS. Distinctive Clinical Features of Idiopathic versus Infectious Serpiginous Choroidopathy. Ocul Immunol Inflamm. 2012 Dec;20(6):448-52.
742. Gregory AC II, Kempen JH, Daniel E, Kaçmaz RO, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, SITE Cohort Study Research Group. Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 2013 Jan;120(1):186-92.
743. Siddique SS, Suelves AM, Baheti U, Foster CS. Glaucoma and Uveitis. Surv Ophthalmol. 2013 Jan-Feb;58(1):1-10.
85 744. Foster CS, Siddique SS, Amorese L, Mulki L, Sulves AM. Regulatory T Cells in Blood of Patients with Birdshot Retinochoroidopathy. Ophthalmology. 2013 Feb;120(2):430.e1.
745. Cervantes-Castañeda RA, Gonzalez-Gonzalez LA, Cordero-Coma M, Yilmaz T, Foster CS. Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: a 12-month follow-up. Br J Ophthalmol. 2013 May;97(5):637-43.
746. Naik RK, Rentz AM, Foster CS, Lightman S, Belfort R, Lowder C, Whitcup SM, Kowalski JW, Revicki DA. Normative Comparison of Patient-Reported Outcomes in Patients With Noninfectious Uveitis. JAMA Ophthalmol. 2013 Feb;131(2):219-25.
747. Artornsombudh P, Gevorgyan O, Payal A, Siddique S, Foster CS. Infliximab Treatment of Patients with Birdshot Retinochoroidopathy. Ophthalmology. 2013 Mar;120(3):588-92.
748. Radwan AE, Arcinue CA, Yang P, Artornsombudh P, Abu Al-Fadl EM, Foster CS. Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema. Graefes Arch Clin Exp Ophthalmol. 2013 Jul;251(7):1801-6.
749. Arcinue CA, Radwan A, Lebanan MO, Foster CS. Comparison of two different combination immunosuppressive therapies in the treatment of Vogt-Koyonagi-Harada syndrome. Ocul Immunol Inflamm. 2013;21(1):47-52.
750. Arcinue CA, Hochberg F, Neumann R, Foster CS. Diagnostic criteria for primary ocular lymphoma. Ophthalmology. 2013 Mar;120(3):646-646.e2.
751. Dick AD, Foster CS. Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology. 2013 Apr;120(4):777-87.
752. Arcinue CA, Ceròn OM, Foster CS. A Comparison Between the Fluocinolone Acetonide (Retisert) and Dexamethasone (Ozurdex) Intravitreal Implants in Uveitis. J Ocul Pharmacol Ther. 2013 Jun;29(5):501-7.
753. Suelves AM, Arcinue CA, Gonazalez-Martin JM, Kruh JN, Foster CS. Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease. Ophthalmology. 2013 Jun;120(6):1201-9.
754. Tauqir MZ, Shulman M, Bittencourt M, Sepah YJ, Ibrahim M, Do DV, Nguyen QD, Foster CS, Vora RA, Albini TA. Diagnostic and Therapeutic Challenges. Retina. 2013 Apr;33(4):883-8.
86 755. Foster CS. Les Manifestations d’Oculaire des Troubles Rhumatologique et Vasculaire Potentiellements Fatals. Journal Français d'Ophthalmologie, Vol. 36(6). June 2013.
756. Lightman S, Belfot R, Naik RK, Lowder C, Foster CS, Rentz AM, Cui H, Whitcup SM, Kowalski JW, Revicki DA. Vision-Related Functioning Outcomes of Dexamethasone Intravitreal Implant in Noninfectious Intermediate or Posterior Uveitis. Invest Ophthalmol Vis Sci. 2013 Jul 18;54(7):4864-70.
757. Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Kaçmaz RO, Levy-Clarke GA, Mills MD, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors. J Rheumatol. 2013 Aug;40(8):1394-403.
758. Radwan A, Metzinger JL, Hinkle DM, Foster CS. Cytomegalovirus Retinitis in Immunocompetent Patients: Case Reports and Literature Review Ocul Immunol Inflamm. 2013 Aug;21(4):324-8.
759. Bajwa A, Foster CS. Diagnostic Testing of Primary Vitreo-Retinal Lymphoma. Journal of Analytical Oncology, Vol. 2(3). August 2013.
760. Yang P, Foster CS. Interleukin-21, Interleukin-23, and Transforming Growth Factor-β1 in HLA-A29-Associated Birdshot Retinochoroidopathy. Am J Ophthalmol. 2013 Aug;156(2):400-406.e2.
761. Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, Katz J, Thorne JE, Lightman SL, Kempen JH; MUST Research Group. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology. 2013 Aug;120(8):1571-9.
762. Baxter SL, Pistilli M, Pujari SS, Liesegang TL, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Kempen JH. Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol. 2013 Sep;156(3):468-77.e2.
763. Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM, for the MUST Trial Research Group. Fluorescein Angiography versus Optical Coherence Tomography for Diagnosis of Uveitic Macular Edema. Ophthalmology. 2013 Sep;120(9):1852-9.
764. Sarup V, Foster CS. HLA Associations in Chronic Vision Threatening Uveitis. Semin Ophthalmol. 2013 Sep-Nov;28(5-6):333-6.
765. Metzinger JL, Foster CS. Emerging therapies for the treatment of uveitis: clinical trial observations. Clin Investigation. 2013 Oct; 3(10):951-66.
87 766. Saboo US, Metzinger JL, Radwan A, Arcinue CA, Parikh R, Mohamed A, Foster CS. Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report. J AAPOS. 2013 Oct;17(5):460-4.
767. Rodríguez-García A, Foster CS, González-Díaz MP, Larrazabal-Aguerrevere LI. Endoftalmitis Infecciosa Endógena Pediátrica: Reto Diagnóstico y Revisión de la Literatura. Rev Mex Infecc & Infectol. 2013 August ;33(4):174-82.
768. Metzinger JL, Cerón O, Foster CS. Recent Advances in Uveitic Glaucoma. Glaucoma Now, 2013 3.
769. Rashid KA, Foster CS, Ahmed AR. Identification of Epitopes within Integrin β4 for Binding of Autoantibodies in Ocular Cicatricial and Mucous Membrane Pemphigoid – Preliminary Report. Invest Ophthalmol Vis Sci. 2013 Nov 19;54(12):7707-16.
770. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Ophthalmology, English Edition, Issue 4. 2013.
771. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Ophthalmology, English – Middle East Edition, Issue 4. 2013.
772. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Ophthalmology, English – Indian Edition, Issue 3. 2013.
773. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Ophthalmology, Italian Edition, Issue 4. 2013.
774. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Ophthalmology, Spanish Edition, Issue 4. 2013.
775. Arcinue CA, Foster CS. Ocular Toxoplasmosis. Highlights of Vitreoretina (Spanish), Issue 3. 2013.
776. Larkin KL, Saboo US, Comer GM, Forooghian F, Mackensen F, Merrill P, Sen HN, Singh A, Essex RW, Lake S, Lim LL, Vasconcelos-Santos DV, Foster CS, Wilson DJ, Smith JR. Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. Br J Ophthalmol. 2014 Jan;98(1):99-103.
777. Arafat SN, Suelves AM, Spurr-Michaud S, Chodosh J, Foster CS, Dohlman CH, Gipson IK. Neutrophil Collagenase, Gelatinase, and Myeloperoxidase in Tears of Patients with Stevens-Johnson Syndrome and Ocular Cicatricial Pemphigoid. Ophthalmology. 2014 Jan;121(1):79-87.
778. Kruh JN, Yang P, Suelves AM, Foster CS. Infliximab for the Treatment of Refractory Noninfectious Uveitis: A Study of 88 Patients with Long-Term Follow-Up. Ophthalmology. 2014 Jan;121(1):358-64.
88 779. Suelves AM, Siddique SS, Schurko B, Foster CS. Anterior chamber intraocular lens implantation in patients with a history of chronic uveitis: Five-year follow-up. J Cataract Refract Surg. 2014 Jan;40(1):77-81.
780. Hu-Torres S, Foster CS. Disease of the Year: Juvenile Idiopathic Arthritis – Differential Diagnosis. Ocul Immunol Inflamm. 2014 Feb;22(1):42-55.
781. Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. Incidence of Visual Improvement in Uveitis Cases with Visual Impairment Caused by Macular Edema. Ophthalmology. 2014 Feb;121(2):588-95.e1.
782. Bajwa A, Foster CS. Ocular Manifestations of Systemic Lupus Erythematosus. J Clin Cell Immunol, 2014 Feb;5(1).
783. Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Factors predictive of remission of new-onset anterior uveitis. Ophthalmology. 2014 Mar;121(3):778-84.
784. Castiblanco C, Foster CS. Review of Systemic Immunosuppression for Autoimmune Uveitis. Ophthalmol Ther. 2014 Mar 18.
785. Sheppard JD, Toyos MM, Kempen JH, Kaur P, Foster CS. Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study. Invest Ophthalmol Vis Sci. 2014 May 6;55(5):2993-3002.
786. Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, Sainz de la Maza M, Foster CS. Clinical Features and Presentation of Posterior Scleritis: A Report of 31 Cases. Ocul Immunol Inflamm. 2014 Jun;22(3):203-7.
787. Wentworth BA, Freitas-Neto C, Foster CS. Management of Pediatric Uveitis F1000Prime Rep. 2014; 6: 41.
788. Foster CS. Ocular Cicatricial Pemphigoid. Ophthalmolog Management, Special Report Cornea. 2014 Aug;18(8):8-9.
789. Lee K, Bajwa A, Freitas-Neto CA, Metzinger JL, Wentworth BA, Foster CS. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I. Expert Opin Pharmacother. 2014 Oct;15(15):2141-54.
790. Lee K, Bajwa A, Freitas-Neto CA, Metzinger JL, Wentworth BA, Foster CS. A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II. Expert Opin Biol Ther. 2014 Nov;14(11):1651-66.
791. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD. Cost-effectiveness of fluocinolone acetonide implant versus systemic
89 therapy for noninfectious intermediate, posterior, and panuveitis. Ophthalmology. 2014 Oct;121(10):1855-62.
792. Bajwa A, Aziz K, Foster CS. Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy. Retina. 2014 Nov;34(11):2259-68.
793. Sen HN, Vitale S, Gangaputra SS, Nussenblatt RB, Liesegang TL, Levy-Clarke GA, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Kempen JH. Periocular Corticosteroid Injections in Uveitis: Effects and Complications. Ophthalmology. 2014 Nov;121(11):2275-86.
794. Freitas-Neto CA, Cerón O, Pacheco KD, Pereira VO, Ávila MP, Foster CS. Optic Neuritis Complicating Herpes Zoster Opthalmicus in an Immunocompetent Patient. Revista Brasileira de Oftalmologia. 2014 Nov-Dec:73(6);386-388.
795. Freitas-Neto CA, Costa RA, Kombo N, Freitas T, Oréfice JL, Oréfice F, Foster CS. Subconjunctival Indocyanine Green Identifies Lymphatic Vessels. JAMA Ophthalmol. 2015 Jan;133(1):102-4.
796. Lou SM, Larkin KL, Winthrop K, Rosenbaum JT, and members of the Uveitis Specialists Study Group. Lack of Consensus in the Diagnosis and Treatment of Ocular Tuberculosis among Uveitis Specialists. Ocul Immunol Inflamm. 2015 Feb;23(1):25-31.
797. Freitas-Neto CA, Boonsopon S, Dhanireddy S, Maghsoudlou A, Silpa-Archa S, Foster CS. Birdshot retinochoroidopathy review. Arq Bras Oftalmol. 2015 Jan-Feb;78(1):56-61.
798. Boonsopon S, Maghsoudlou A, Foster CS. Ocular Manifestations in Systemic Lupus Erythematosus. Rheumatology (Sunnyvale). 2015 Mar; 5(1).
799. Mehta M, Rasheed RA, Duker J, Reichel E, Feinberg E, Husain D, Foster CS, Laver NV. Vitreous Evaluation: A Diagnostic Challenge. Ophthalmology. 2015 Mar;122(3):531-7.
800. Preble J, Foster CS. Uveitic Macular Edema: A Stepladder Treatment Paradigm. Clin Investigation, 2015;5(6):509-17.
801. Letko E, Yeh S, Foster CS, Pleyer U, Brigell M, Grosskreutz CL; AIN457A2208 Study Group. Efficacy and Safety of Intravenous Secukinumab in Noninfectious Uveitis Requiring Steroid-Sparing Immunosuppressive Therapy. Ophthalmology. 2015 May;122(5):939-48.
802. Kruh JN, Kruh-Garcia NA, Foster CS. Evaluation of the Effect of N-Acetylcysteine on Protein Deposition on Contact Lenses in Patients with the Boston Keratoprosthesis Type I. J Ocul Pharmacol Ther. 2015 Jul-Aug;31(6):314-22.
803. Metzinger JL, Foster CS. 'Approved for use in uveitis': drug approval for an orphan disease. Expert Opin Orphan Drugs. 2015 Jul;3(7):799-807.
90 804. Cocho L, Swan RT, Foster CS. Are Patients being treated with immunosuppression for ocular inflammatory disease adequately, Expert Rev Ophthalmol. 2015 Aug;10(4):341-50.
805. Arcinue CA, Durrani KD, Artornsombudh P, Radwan A, Parikh R, Suelves A, Siddique S, Chang I, Preble J, Foster CS. Efficacy and Safety of Adalimumab for Intraocular Inflammation, Orphan Drugs: Research and Reviews. 2015 Aug;5:69-74.
806. Kothari S, Foster CS, Pistilli M, Liesegang TL, Daniel E, Sen HN, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Lawrence SD, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Research Group. The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis. Ophthalmology. 2015 Oct;122(10):1987-2001.
807. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Ophthalmology. 2015 Oct;122(10):1967-75.
808. Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group. Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study. Ophthalmology. 2015 Oct;122(10):1976-86.
809. Tomkins-Netzer O, Lightman S, Drye L, Kempen J, Holland GN, Rao NA, Stawell RJ, Vitale A, Jabs DA, Multicenter Uveitis Steroid Treatment Trial Research Group. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results. Ophthalmology. 2015 Nov;122(11):2351-9.
810. Preble JM, Silpa-Archa S, Foster CS. Ocular Involvement in Systemic Lupus Erythematosus. Curr Opin Ophthalmol. 2015 Nov;26(6):540-5.
811. Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group; Multicenter Uveitis Steroid Treatment MUST Trial Research Group. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Am J Ophthalmol. 2015 Dec;160(6):1133-1141.e9.
812. Freitas-Neto CA, Maghsoudlou A, Dhanireddy S, Payal A, Boonsopon S, Ratwatte MD, Foster CS. Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants. Ocul Immunol Inflamm. 2015 Dec;23(6):425-9.
813. Sharma PK, Markov GT, Bajwa A, Foster CS. Long-term efficacy of systemic infliximab in recalcitrant retinal vasculitis. Retina. 2015 Dec;35(12):2641-6.
91 814. Boonsopon S, Maghsoudlou A, Kombo NE, Foster CS. A Therapeutic Trial of Valganciclovir in Patients with Uveitis and Positive Epstein-Barr Virus Early Antigen D IgG Titers. Eur J Ophthalmol. 2015 Dec 1;26(1):30-5.
815. Silpa-Archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016 Jan;100(1):135-41.
816. Sen HN, Abreu FM, Louis TA, Sugar EA, Altaweel MM, Elner SG, Holbrook JT, Jabs DA, Kim RY, Kempen JH; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group. Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial. Ophthalmology. 2016 Jan;123(1):183-90.
817. Freitas-Neto CA, Cao JH, Oréfice JL, Costa RA, Oréfice F, Lee J, Payal A, Foster CS. Increased Submacular Choroidal Thickness in Active, Isolated, Extramacular Toxoplasmosis. Ophthalmology. 2016 Jan; 123(1):222-224. 818. Foster CS, Kothari S, Anesi SD, Vitale AD, Chu D, Metzinger JL, Cerón O. The Ocular Immunology and Uveitis Foundation (OIUF) Preferred Practice Patterns of Uveitis Management. Surv Ophthalmol. 2016 Jan-Feb;61(1):1-17.
819. Maleki A, Swan RT, Silpa-Archa S, Preble J, He Y, Foster CS. Short-Wavelength Automated Perimetry Parameters at Baseline and Following Remission in Patients with Birdshot Retinochoroidopathy. Am J Ophthalmol. 2016 Mar;163:83-92
820. Castiblanco C, Meese H, Foster CS. Treatment of Pediatric Uveitis with Adalimumab: The MERSI Experience. Journal of the American Association for Pediatric Ophthalmology and Strabismus, J AAPOS. 2016 Apr;20(2):145-7.
821. Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opinon on Drug Safety, Expert Opin Drug Saf. 2016 Apr;15(4):457-65.
822. Queisi M, Zein M, Lamba N, Meese H, Foster CS. Update on Ocular Cicatricial Pemphigoid and Emerging Treatments. Surv Ophthalmol. 2016 May-Jun;61(3):314-7.
823. Cocho L, Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Sainz-de-la-Maza M, Foster CS. Scleritis in patients with granulomatosis with polyangiitis (Wegener). British Journal of Ophthalmology 2016 July;100(8):1062-5
824. Freitas-Neto CA, Oréfice F, Costa RA, Oréfice JL, Dhanireddy S, Maghsoudlou A, Foster CS. Multimodal Imaging Assisting the Early Diagnosis of Cat-Scratch Neuroretinitis. Seminars in Ophthalmology, 2016 August; 31(5):495-8
825. Sainz-de-la-Maza M, Molina-Prat N, Gonzalez-Gonzalez LA, Doctor P, Tauber J, Foster CS. Scleritis Associated with Relapsing Polychondritis. British Journal of Ophthalmology, 2016 August; 100(9):1290-4
92 826. Oray M, Khachatryan N, Ebrahimiadib N, Abu Samra K, Lee S, Foster CS. Ocular morbidities of juvenile idiopathic arthritis-associated uveitis in adulthood: results from a tertiary center study Graefes Arch Clin Exp Ophthalmol, 2016 September; 254(9):1841-9
827. Wolfgang Hueber, Dhavalkumar D. Patel, Thaddeus Dryja, Andrew M. Wright, Irina Koroleva, Gerard Bruin, Christian Antoni, Zoe Draelos, Michael H. Gold, the Psoriasis Study Group, Patrick Durez, Paul P. Tak, Juan J. Gomez-Reino, the Rheumatoid Arthritis Study Group, C. Stephen Foster, Rosa Y. Kim, C. Michael Samson, Naomi S. Falk, David S. Chu, David Callanan, Quan Dong Nguyen, the Uveitis Study Group, Kristine Rose, Asifa Haider, Franco Di Padova1. Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis. Sci. Transl. Med., 2010 October 6;2(52):52ra72
828. Cao JH, Oray M, Cocho L, Foster CS. Rituximab in the Treatment of Refractory Non- Infectious Scleritis. American Journal of Ophthalmology. 2016
829. Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombuth P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Bussenblatt RB, Foster CS. Adalimumab for Ocular Inflammation. Ocular Immunology and Inflammation. 2016 March 22; 25(3): 404- 412
830. Cao JH, Silpa-Archa S, Freitas-Neto CA, Foster CS. Birdshot Chorioretinitis Lesions on Indocyanine Green Angiography as an Indicator of Disease Activity. Retina. 2016; 36(9):1751-1757
831. Kempen JH, Gewaily DY, Newcomb CW, Liesegang TL, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Payal A, Fitzgerald TD. Remission of Intermediate Uveitis: Incidence and Predictive Factors. American Journal of Ophthalmology. 2016 April; 164:110-117
832. Holbrook JT, Sugar EA, Burke AE, Vitale AT, Thorne JE, Davis J, Jabs DA, for the Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. American Journal of Ophthalmology. 2016 April; 164: 29-36
833. Maleki A, Cao JH, Silpa-Archa S, Foster CS. Visual Outcome and Poor Prognostic Factors in Isolated Idiopathic Retinal Vasculitis. Retina. 2016; 36: 1979-1985
834. Sainz-de-la-Maza M, Molins B, Mesquida M, Llorenc V, Zarranz-Ventura J, Sala- Puigdollers A, Matas J, Adan A, Foster CS. Interleukin-22 serum levels are elevated in active scleritis. Acta Ophthalmologica. 2016; 94:e395-e399
835. Silpa-Archa S, Maleki A, Roohipoor R, Preble J, Foster CS. Analysis of Three-dimensional choroidal volume with enhanced depth imaging findings in patients with birdshot retinochoroidopathy. Retina. 2016; 36:1758-1766
836. Suelves AM, Lamba N, Meese HK, Foster CS, JM González-Martín; M Díaz-Llopis, Christen WM. Nuclear cataract as an early predictive factor for recalcitrant juvenile
93 idiopathic arthritis-associated uveitis. Journal of the American Association for Pediatric Ophthalmology and Strabismus. 2016; 20:232-238
837. Robert MC, Črnej A, Shen LQ, Papaliodis GN, Dana R, Foster CS, Chodosh J, Dohlman CH. Infliximab after Boston Keratoprosthesis in Stevens-Johnson Syndrome: An Update. Ocular Immunology and Inflammation. 2017;25(3): 413-417
838. Silpa-Archa S, Oray M, Preble JM, Foster CS. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases. Acta Ophthalmologica. 2016; 94: e400-e406
839. Kubaisi B, Abu Samra K, Foster CS. Granulomatosis with Polyangiitis (Wegener’s disease): An Updated Review of Ocular Disease Manifestations. Intractable and Rare Disease Research. 2016; 5(2):61-69
840. Silpa Archa S, Preble JM, Foster CS. Vogt-Koyanagi-Harada Syndrome: Perspectives for Immunogenetics, Multimodal Imaging and Therapeutic Options. Autoimmunity Reviews. 2016; 15: 809-819
841. Sahawneh H, Maleki A, Foster CS. Efficacy and Safety of intravenous immunoglobulin therapy in refractory uveitis. 2016; 1(1): 1-4
842. Ebrahimiadib N, Mdjtahedi BS, Roohipoor R, Anesi SD, Foster CS. Successful Treatment Strategies in Granulomatosis with Polyangiitis associated Peripheral Ulcerative Keratitis. Cornea. 2016; 35(11): 1459-1465
843. Silpa-archa S, Lee JJ, Boonsopon S, Lizarraga M, Preble JP, Sujirarat D, Patel P, Foster CS. Poor Prognostic factors in patients with birdshot retinochoroidopathy. Retina. 2016; 36: 2220-2226
844. Hinkle DM, Kruh-Garcia NA, Kruh JN, Broccardo C, Doctor P, Foster CS. Moxifloxacin concentration and proteome analysis of aqueous humor in human uveitis associated with oral moxifloxacin therapy. The Open Ophthalmology Journal. 2017; 11: 107-116
845. Maleki A, Swan RT, Lasave AF, Ma L, Foster CS. Selective Laser Trabeculoplasty in Controlled Uveitis with Steroid-Induced Glaucoma. Ophthalmology. 2016; 123(12): 2630- 2632
846. Ahmed AH, Kubaisi B, Foster CS. Serpiginous Choroiditis. JAMA Ophthalmology. 2017 April 1;135(4):e165495
847. Daniel E, Pistilli M, Kothari S, Khachatryan N, Kaçmaz RO, Gangaputra SS, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Bhatt NP, Kempen JH. Risk of Ocular Hypertension in Adults with Noninfectious Uveitis. Ophthalmology. 2017 August; 124(8): 1196-1208 848. You C, Sahawneh HF, Ma L, Kubaisi B, Schmidt A, Foster CS. A review and update on orphan drugs for the treatment of noninfectious uveitis. Clinical Ophthalmology (Auckland, NZ). 2017;11:257-265
94
849. Lee DJ, Preble J, Lee S, Foster CS, Taylor AW. MC5r and A2Ar Deficiencies During Experimental Autoimmune Uveitis Identifies Distinct T cell Polarization Programs and a Biphasic Regulatory Response. Scientific Reports. 2016;6:37790
850. Lamba N, Lee S, Chaudhry H, Foster CS. A review of the ocular manifestations of rheumatoid arthritis. Cogent Medicine. 2016; 3:1243771
851. Patel AK, Newcomb CW, Liesegang TL, Jujari SS, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Nida Sen H, Artornsombudh P, Srishti Kothari, Kempen JH. Risk of Retinal Neovascularization in Cases of Uveitis. American Academy of Ophthalmology. 2016;123:646-654
852. Ebrahimiadib N, Modjtahedi BS, Roohipoor R, Anesi SA, Foster CS. Successful Treatment Strategies in Granulomatosis With Polangiitis-Associated Peripheral Ulcerative Keratitis. Cornea. 2016 November; 35(11):1459-1465
853. Abu Samra K, Oray M, Ebrahimiadib N, Lee S, Anesi SD, Foster CS. Intraocular Lymphoma: Descriptive Data of 26 Patients Including Clinico-pathologic Features, Vitreous Findings, and Treatment Outcomes. Ocular Immunology and Inflammation. 2016; 00(00):1-6
854. Matei VM, Cao JH, Foster CS. Bilateral Hypopyons as a Presenting Symptom. JAMA Ophthalmology. 2016 December; 134(12):1439-1440
855. Payal A, Foster CS. Long-Term Drug-Free Remission and Visual Outcomes in Sympathetic Ophthalmia. Ocular Immunology and Inflammation. 2016; 00(00):1-6
856. Abu Samra K, Maghsoudlou A, Roohipoor R, Valdes-Navarro M, Lee S, Foster CS. Current Treatment Modalities JIA-associated Uveitis and its Complications: Literature Review. Ocular Immunology and Inflammation. 2016; 00(00):1-9
857. Abu Samra K, Valdes-Navarro M, Lee S, Swan R, Foster CS, Anesi SD. A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab. European Journal of Ophthalmology. 2015.
858. Maleki A, Meese H, Sahawneh HF, Foster CS. Progress in the Understanding and Utilization of Biologic Response Modifiers in the Treatment of Uveitis. Expert Review of Clinical Immunology. 2016.
859. Lasave AF, You C, Ma L, Abusamra K, Lamba N, Navarro MV, Meese H, Foster CS. LONG-TERM OUTCOMES OF RITUXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS POSTERIOR UVEITIS REFRACTORY TO CONVENTIONAL IMMUNOSUPPRESSIVE THERAPY. Retina. 2017; 0:1-8
860. De-la-Torre A, Valdes-Camacho J, Foster CS. Bilateral Herpes Simplex Uveitis : Review of the Literature and Own Reports. Ocular Immunolody & Inflammation. 2016;00(00):1-6
95 861. Foster CS. Take the stepladder approach to uveitis. Ophthalmology Management. 2016 August.
862. Ahmed AH, Foster CS, Shields CL. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region. JAMA Ophthalmology. 2017 September 7; doi:10.101/jamaophthalmol.2017.3286
863. You C, Lamba N, Lasave AF, Ma L, Diaz MH, Foster CS. Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017 Feb 3:1-8.
864. You J, Ma L, Anesi S, Foster CS. Long-term Remission of Ocular Cicatricial Pemphigoid off Immunomodulatory Therapy, European Journal of Ophthalmology, 2017 Sep.
865. Jabs DA, Dick A, Doucette JT, Gupta A, Lightman S, McCluskey P, Okada AA, Palestine AG, Rosenbaum JT, Saleem SM, Thorne JE, Trusko B, for the Standardization of Uveitis Nomenclature Working Group. Interobserver agreement among uveitis experts on uveitic diagnoses: The Standardization of Uveitis Nomenclature experience. Am J Ophthalmol 2017 (in press).
866. Lin, Miaoli; Anesi, Stephen; Ma, Lina; Ahmed, Aseef. Characteristics and Visual Outcome of Refractory Retinal Vasculitis Associated With Antineutrophil Cytoplasm Antibody– Associated Vasculitides. American Journal of Ophthalmology , Volume 187 , 21 – 33 867. John D. Sheppard, C. Stephen Foster, Melissa M. Toyos, Kerry Markwardt, Robert Da Vanzo, Thomas E. Flynn & John H. Kempen. Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies. Ocular Immunology and Inflammation. Pages 1-13 | Received 13 Jun 2017, Accepted 16 Nov 2017, Published online: 20 Dec 2017
868. Ahmed A, Foster C. Cyclophosphamide or Rituximab Treatment of Scleritis and Uveitis for Patients with Granulomatosis with Polyangiitis. Ophthalmic Research, Published online: April 10, 2018. DOI: 10.1159/000486791 869. Caceres V, Foster C. Pearls for better diagnosis, treatment of red eye. Ophthalmology Times: Clinical Diagnosis. February 15, 2017. 870. Nazanin Ebrahimiadib, Lina Ma, Bobeck Modjtahedi, Samaneh Davoudi, Safa Rahmani, Sarah Syeda, Andrew Stephenson, Charles Stephen Foster. Atypical Perinuclear Anti- Neutrophil Cytoplasmic Antibodies in Ocular Inflammatory Diseases. Ocular Immunology and Inflammation. Published online 19 Sep 2018. 871. Peter Brown, RELISH Consortium, Yaoqi Zhou. RELISH-DB a large expert-curated database for benchmarking biomedical literature search. Scientific Data. 09 Jan 2019
In Press
1. Abu Samra K, Sahawneh H, Foster CS. The role of biologic response modifiers in the management of Juvenile Idiopathic Arthritis associated Uveitis: a review. Expert Review of Ophthalomology, in press.
96 2. Oray M, Meese H, Foster CS. Diagnosis and Management of Scleritis: Current Status and Future Prospects. Expert Rev. Clin. Immunol, in press.
3. Silpa-archa S, Cao JH, Boonsopon S, Lee J, Preble JM, Foster CS. Birdshot Retinochoroidopathy: Differences in Clinical Characteristics between Patients with Early and Late Age of Onset, Ocul Immunol Inflamm, in press.
4. Dhanireddy S, Kombo NC, Payal AR, Freitas-Neto CA, Preble J, Foster CS. Ex-Press Glaucoma Filtration Device Implantation in Uveitic Glaucoma, Ocul Immunol Inflamm, in press.
5. Ebrahimiadib N, Abu Samra K, Domina AM, Stiles ER, Ewer R, Bocian CP, Foster CS. A novel NOD2-associated mutation and variant Blau syndrome: phenotype and molecular analysis, Ocul Immunol Inflamm, in press.
6. Maleki A, Haitham SF, Ma L, Meese H, Yuchen H, Foster CS. Efficacy and Safety of Infliximab Therapy in Patients with Noninfectious Intermediate Uveitis, Retina, in press.
7. Ebrahimiadib N, Modjtahedi BS, Davoudi S, Foster CS. Treatment of Serpiginous Choroiditis with Chlorambucil: a report of 17 patients, Ocul Immunol Inflamm, in press.
8. Atchara Amphornphruet, Sukhum Silpa-archa, Janine M. Preble, and C. Stephen Foster. Endogenous Cryptococcal Endophthalmitis in Immunocompetent Host: Case Report and Review of Multimodal Imaging Findings and Treatment. Ocular Immunology And Inflammation. Published online: 27 Apr 2017
9. Metzinger JL, Foster CS. Management with Nonsteroidal Anti-inflammatory Agents. InScleritis 2017 (pp. 81-89). Springer International Publishing.
10. Lamba N, Foster CS. Associated Systemic Diseases. InScleritis 2017 (pp. 25-36). Springer International Publishing.
11. Small K, Ferrara M, Schmidt A, Foster CS. Birdshot retinochoroidopathy: pathophysiology, diagnosis and treatment. Expert Opinion on Orphan Drugs. 2017 Apr 3;5(4):321-9.
12. Maleki A, Lamba N, Ma L, Lee S, Schmidt A, Foster CS. Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy. Clinical Ophthalmology (Auckland, NZ). 2017;11:377.
13. Kubaisi B, Syeda S, Schmidt A, Foster CS. Adalimumab for the treatment of non- infectious uveitis: An updated review. Expert Opinion on Orphan Drugs. 2017 Feb 1.
14. Kubaisi B, Kopplin L, Agarwal A, Rosenbaum JT, Foster CS, Nguyen QD. Crohn’s Disease-Associated Uveitis. InThe Uveitis Atlas 2016 (pp. 1-7). Springer India.
97 15. You J, Ma L, Lasave A, Foster CS. Rituximab induction and maintenance treatment in patients with scleritis and granulomatosis with polyangiitis. Ocular Immunology & Inflammation, in press.
16. Lamba N, Lee S, Foster CS. Ocular Manifestations of Rhematoid Arthritis. Cogent Medicine, in press.
17. Syeda S, Abu Samra K, Kubaisi B, Foster CS. Preferred Practice for Ocular Allergy. Journal of Allergy and Immunology, in press.
18. Ahmad A. Diffuse Large B-Cell Lymphoma of the Eye and Periocular Region. JAMA Ophthalmology, in press.
19. Ebrahimiadib N, Hernandez M, Modjtahedi B, Roohipoor R, Foster CS. Atopy in patients with Ocular Cicatricial Pemphigoid. Cornea, in press.
20. Mariantonia Ferrara, Laura Eggenschwiler, Andrew Stephenson, Alyssa Montieth, Nakhoul Nakhoul, Rafael Araùjo-Miranda, C Stephen Foster. The Challenge of Pediatric Uveitis: Tertiary Referall Center experience in USA. Ocular Immunology and Inflammation, in press.
21. Ma L, You C, Hernandez M, Maleki A, Lasave A, Schmidt A, Stephenson A, Zhao T, Anesi S, Foster CS. Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy. Ocular Immunology and Inflammation, in press.
22. Kubaisi B, Maleki A, Ahmed A, Lamba N, Sahawneh H, Stephenson A, Montieth A, Topgi S, Foster CS. Ahmed Glaucoma Valve in Uveitis Patients with Fluocinolone Acetonide Implant-Induced Glaucoma: 3-year Follow-Up. Clinic Opthalmology, in press.
23. Ma L, Lee S, Montieth A, Stephenson A, Foster CS, Anesi S. Cyropyrin-associated Periodic Syndrome-Associated Uveitis and Papillitis. Retinal Cases & Brief Reports, in press.
24. Small K, Stephenson A, Foster CS. Chronic Eye Redness and Pain, After 9 Months of Inflammation Therapy with Recent Hospitalization. JAMA Ophthalmology, in press
25. Caiyun You, Halea Meese, Andrew Stephenson, Alyssa Montieth, Lina Ma, Mikhail Hernandez Diaz, Buraa Kubaisi, Sarah Syeda, C. Stephen Foster. Outcomes of Early Withdrawal of Long-term Immunomodulatory Therapy for Birdshot Retinochoroidopathy. Ocular Immunology and Inflammation, in press.
Book Chapters
1. Foster CS, Allansmith MR. 1979. Lack of Blood Group Antigen A on Human Corneal Endothelium. Immunology and Immunopathology of the Eye. (Eds. Silverstein, A.M., O’Connor, G.R.) Masson & Cie, New York. pp. 151-156.
98
2. Foster CS. 1982. Preocular Tear Film Abnormalities: Diagnosis and Treatment. Current Management in Ophthalmology. (Eds. Koch, D.D., Parke, DW., Paton, D.) Churchill- Livingstone, Inc., NY. pp. 25-55.
3. Foster CS. 1983. Corneal Manifestations of Neurologic Diseases. The Cornea. (Eds. Thoft, R.A., Smolin, G.) Little, Brown and Co., Boston, MA. pp. 315-328.
4. Foster CS. 1983. Ocular Manifestations of the Nonrheumatic Acquired Collagen Vascular Diseases. The Cornea. (Eds. Thoft, R.A., Smolin, G.) Little, Brown and Co., Boston, MA. pp. 264-284.
5. Foster CS. 1984. Wegener’s Granulomatosis. Current Ocular Therapy, 2nd ed. (Eds. Fraunfelder FT and Roy FH) W.B. Saunders Company, Philadelphia, PA. pp. 118-119.
6. Fujikawa LS, Bhan AK, Foster CS. 1984. T-Cell Subsets and Langerhans’ Cells in Conjunctival Lesions. Advances in Immunology and Immunopathology of the Eye (Ed. O’Connor, G.R.), Masson, New York. Chapter 13, pp. 43-47.
7. Foster CS, Wetzig R, Knipe D, Greene MI. 1985. Genetic Influence From Chromosome 12 on Murine Susceptibility to Herpes Simplex Keratitis. Herpetic Eye Diseases. (Eds. Maudgal PC and Missotten L) Dr. W. Junk. Pub., Dordrecht. pp. 67-76.
8. Foster CS. 1985. Systemic Immune Responses After Ocular Antigen Encounter. Herpetic Eye Diseases. (Eds. Maudgal PC and Missotten L) Dr. W. Junk Pub., Dordrecht. pp. 77- 89. 9. Foster CS. 1986. Keratitis. Current Therapy in Infectious Disease. B.C. Decker, Inc., Philadelphia, PA. pp. 281-287.
10. Foster CS, Sonntag HG. 1986. Essentials of Microbiology in Uveitis. Uveitis: Pathophysiology and Therapy. (Eds. Kraus-MacKiw, E. and O’Connor, G.R.) Thieme Medical Publishers, Inc., NY. pp. 29-46.
11. Foster CS. 1987. Nonsteroidal Anti-inflammatory and Immunosuppressive Agents. Clinical Ophthalmic Pharmacology. (Eds. Lambert DW, Potter DE) Little, Brown, Inc., Boston, MA. pp. 173-192.
12. Foster CS, Mark DB. 1987. Corneoscleral Lacerations and Anterior Segment Reconstruction. Atlas of Ophthalmic Surgery Vol. II. (Eds. Heilmann K and Paton D.) Thieme Medical Publishers, Inc., New York. Chapter 5, pp. 1-48.
99 13. Foster CS. 1988. Basic Ocular Immunology. The Cornea. (Eds. Kaufman, H.E., et al.) Churchill Livingston, NY. pp. 85-122.
14. Foster CS, Jacobs DS, Reddy CV. 1992. Ocular Manifestations of Acquired Connective Tissue Disorders. Collagen Pathobiochemistry. Vol. 5. (Ed. Kang, AH., & J.B. Lippincott Co. Philadelphia). 161-180.
15. Foster CS. 1992. Fungal Keratitis. Infectious Disease Clinics of North America: Ocular Infections. (Eds. Michael Barza, M.D. and Jules Baum) 6:4;851-857.
16. Foster CS. 1990. Erythema Multiforme. The Eye in Systemic Disease. (eds. Gold DH, Weingeist TA). pp. 637-8.
17. Neves RA, Foster CS. 1994. Doenças Cicatriciais da Conjuntiva. Cornea. (eds. Belfort R and Kara-José N). Editora Roca, Sáo Paulo, Brazil.
18. Foster CS. 1994. Chapter 70: Syphilis. Duane’s Foundations of Clinical Ophthalmology. (Tasman W and Jaeger EA, eds.) J.B. Lippincott Co., Philadelphia. 2:1-8.
19. Sainz de la Maza M, Foster CS. 1994. Chapter 23: Sclera. Duane’s Foundations of Clinical Ophthalmology (Tasman W Jaeger EA, eds.) J.B. Lippincott. 1:1-17.
20. Ayliffe W, Foster CS. 1995. Immune-Mediated Diseases of the Eye. Surgical Management in External Diseases of the Eye. (Stenson S, Ed) Igaku-Shoin, New York. pp. 239-302.
21. Foster CS. 1995. Chapter 27: The Eye in Skin and Mucous Membrane Disorders. Duane’s Foundations of Clinical Ophthalmology. (Tasman W and Jaeger EA, eds.) 5:1-41.
22. Tauber J, Foster CS. 1995. Cicatricial Pemphigoid. Eye and Skin Disease (Mannis MJ, Macsai MS and Huntley AC, Eds.). Raven Press. pp. 261-271.
23. Brody J, Foster CS. 1996. Vernal Conjunctivitis. Ocular Infection and Immunity. (Eds. Jay S. Pepose, Gary N. Holland and Kirk W. Wilhelmus). pp. 367-375.
24. Haimovici R, Foster CS. 1996. Sarcoidosis. Ocular Infection and Immunity. (Eds. Jay S. Pepose, Gary N. Holland and Kirk R. Wilhelmus). pp. 754-776.
25. Foster CS. 1996. Immunology of Infections. Infections of the Eye, 2nd Edition. (Tabbara KF and Hyndiuk RA, eds.) Little, Brown and Co. pp. 13-34.
100 26. Foster CS, Power WJ. 1996. Basic Ocular Immunology. In: Seminars in Ophthalmology, Uveitis and Ocular Inflammation; ( Friberg TR, Wu HK, eds.) W.B. Saunders, hiladelphia, PA. 11(1):3-9.
27. Foster CS. 1996. Autoimmune Uveitis. Current Therapy in Allergy, Immunology and Rheumatology, 5th Edition (Lichtenstein LM and Fauci AS, eds.). Mosby. Philadelphia, PA. 394-398.
28. Vitale A, Foster CS. 1997. The Pharmacology of Medical Therapy for Uveitis. Textbook of Ocular Pharmacology: Chapter 59: Corticosteroids. (Ed: Zimmerman TJ, Kooner KS, Shariv M, Fechtner RD) Lippincott Raven, Philadelphia p. 681-702.
29. Vitale A, Foster CS. 1997. The Pharmacology of Medical Therapy for Uveitis. Textbook of Ocular Pharmacology: Chapter 60: Mydriatic and Cycloplegic Agents. (Ed: Zimmerman TJ, Kooner KS, Shariv M, Fechtner RD) Lippincott Raven, Philadelphia p. 703-722.
30. Vitale A, Foster CS. 1997. The Pharmacology of Medical Therapy for Uveitis. Textbook of Ocular Pharmacology: Chapter 61: Nonsteroidal Anti-inflammatory Drugs. (Ed: Zimmerman TJ) Lippincott Raven, Philadelphia p. 681-702.
31. Vitale A, Foster CS. 1997. The Pharmacology of Medical Therapy for Uveitis. Textbook of Ocular Pharmacology: Chapter 62: Immunosuppressive Chemotherapy. (Ed: Zimmerman TJ, Kooner KS, Shariv M, Fechtner RD) Lippincott Raven p. 713-722.
32. Power WJ, Foster CS. 1998. Immunologic Diseases Affecting the Cornea. Corneal Diseases, Section IX, Chapter 18, 2nd ed. (Leibowitz HW, ed.).
33. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular Rosacea: Patient Characteristics and Follow-up. 1998. Yearbook of Dermatology (Thiers BH and Lang PG, eds.).
34. Cockerham GC, Foster CS. 1999. Conjunctival Flaps. In: Brightbill FS, editor, Corneal Surgery: Theory, Technique and Tissue, 3rd edition. St. Louis: Mosby, Inc. pp. 135-141.
35. Rojas B, Foster CS. Cataract Surgery in Patients with Uveitis. 1999. The Oxford Textbook of Ophthalmology. (Easty D and Sparrow J, eds.) Oxford University Press.
36. Sainz de la Maza M, Foster CS. Scleritis and Episcleritis. 1999. The Oxford Textbook of Ophthalmology. (Easty D and Sparrow W, eds.) Oxford University Press.
37. Nguyen QD, Foster CS. 1999. Tectonic Procedures. In: Ophthalmic Surgery: Principles and Techniques, Volume 1: Anterior Segment Surgery. (Ed. D.M. Albert, M.D.) Oxford: Blackwell Science Ltd.
101
38. Streilein JW, Foster CS. 1999. Immunology – An Overview. Principles and Practice of Ophthalmology: Section II, Chapter 5, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 47-49.
39. Foster CS. 1999. A Cast of Thousands: The Cells of the Immune System. Principles and Practice of Ophthalmology: Section II, Chapter 6, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 50-60.
40. Foster CS. 1999. B Lymphocyte Responses. Principles and Practice of Ophthalmology:Section II, Chapter 8, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec) Philadelphia: WB Saunders Publishers. pp. 66-73.
41. Foster CS, Streilein JW. 1999. Immune-Mediated Tissue Injury. Principles and Practice of Ophthalmology: Section II, Chapter 9, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec) Philadelphia: WB Saunders Publishers. pp. 74-82.
42. Streilein JW, Foster CS. 1999. Regulation of Immune Responses. Principles and Practice of Ophthalmology Section II, Chapter 10, 2nd Edition (Eds. Daniel M. Albert, Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 83-94.
43. Foster CS. 1999. Pharmacologic Treatment of Immune Disorders. Principles and Practice of Ophthalmology: Section IV, Chapter 34, 2nd Edition.. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 346-353.
44. Foster CS. 1999. Immunologic Disorders of the Conjunctiva, Cornea and Sclera. Principles and Practices of Ophthalmology: Section VIII, Chapter 65, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 803-828.
45. Abad JC, Foster CS. 1999. Fungal Keratitis. Principles and Practice of Ophthalmology: Section VIII, Chapter 69, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 906-914.
46. Merchant A, Foster CS. 1999. Lamellar Keratoplasty. Principles and Practice of Ophthalmology: Section VIII, Chapter 76, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 1020-1026.
47. Foster CS, O’Brien JM. 1999. Anterior Uveitis. Principles and Practice of Ophthalmology: Section IX, Chapter 87, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 1198-1216.
102 48. Hunter DG, Foster CS. 1999. Ocular Manifestations of Sarcoidosis. Principles and Practices of Ophthalmology: Section IX, Chapter 88, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 1217-1224.
49. Tamesis RR, Foster CS. 1999. Toxoplasmosis. Principles and Practice of Ophthalmology: Section XI, Chapter 152, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 2113-2118.
50. Foster CS, Tamesis RR. 1999. Ocular Syphilis. Principles and Practice of Ophthalmology: Section XI, Chapter 156, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 2159-2163.
51. Foster CS, Faris BM. 1999. Adamantiades-Behçet Disease . Principles and Practice of Ophthalmology: Chapter 164, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 2212-2220.
52. Foster CS, O’Brien JM. 1999. Childhood Arthritis and Anterior Uveitis. Principles and Practice of Ophthalmology: Section XVII, Chapter 325, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4542-4554.
53. Dana MR, Reddy CV, Foster CS. 1999. Adult Rheumatoid Arthritis. Principles and Practice of Ophthalmology: Section XVII, Chapter 326, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4555-4562.
54. Foster CS. 1999. Systemic Lupus Erythematosus. Principles and Practice of Ophthalmology: Section XVII, Chapter 327, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec) Philadelphia: WB Saunders Publishers. pp. 4563-4569.
55. Foster CS. 1999. Giant Cell Arteritis. Principles and Practice of Ophthalmology: Section XVII, Chapter 328, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4570-4577.
56. Foster CS, Yang J, 1999. Wegener’s Granulomatosis. Principles and Practice of Ophthalmology: Section XVII, Chapter 329, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4578-4588.
57. Dana MR, Reddy CV, Foster CS. 1999. Scleroderma. Principles and Practice of Ophthalmology: Section XVII, Chapter 330, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4589-4595.
103 58. Foster CS. Nguyen QD. 1999. Adamantiades-Behçet’s Disease. Principles and Practice of Ophthalmology: Section XVII, Chapter 331, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4596-4605.
59. Hunter DG, Foster CS. 1999. Systemic Manifestations of Sarcoidosis. Principles and Practice of Ophthalmology: Section XVII, Chapter 332, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4606-4615.
60. Baltatzis S and Foster CS. 1999. Ocular Candidiasis. Current Ocular Therapy 5 (Eds. Frederick T. Frauenfelder and F. Hampton Roy). Philadelphia: WB Saunders Company. pp. 53-55.
61. Harper S, Foster CS. 1999. Vitiligo. Current Ocular Therapy5 (Eds. Frederick T. Frauenfelder and F. Hampton Roy). Philadelphia: WB Saunders Company. pp. 156-158.
62. Nguyen QD, Foster CS. 2000. The Red Eye. Pediatric Ophthalmology. A Clinical Guide (Ed. Pamela F. Gallin). New York: Thieme. pp. 204-215.
63. Sippel KC, Foster CS. 2001. Five Pearls in Limbal Stem Cell Transplantation. 101 Pearls in Refractive, Cataract and Corneal Surgery (Eds. Melki SA, Azar DT). Thorofare, NJ: Slack Incorporated. pp. 111-120.
64. Sippel KC, Foster CS. 2001. Three Pearls in Amniotic Membrane Grafting. 101 Pearls in Refractive, Cataract and Corneal Surgery (Eds. Melki SA, Azar DT). Thorofare, NJ: Slack Incorporated. pp. 125-130.
65. Stavrou P, Foster CS. 2001. Intraocular Lens Surgery in Uveitis and Scleritis. Intraocular Lenses in Cataract and Refractive Surgery (Ed. Azar DT) Philadelphia: WB Saunders. pp 131-135.
66. Samson CM, Foster CS. 2001. Hypersensitivity: Antibody-Mediated Cytotoxic (Type II). Encyclopedia of Life Sciences. London: Macmillan Reference Limited.
67. Foster CS. 2002. Cicatricial Pemphigoid. The Ocular Adnexa. 827-833.
68. Vitale A, Foster CS. 2005. Chapter 16, Uveitis Affecting Infants and Children: Infectious Causes. Pediatric Retina (Eds. Hartnett ME, Trese M, Capone A, Keats BJB, Steidl S). New York: Lippincott Williams & Wilkins. pp 249-289.
69. Foster CS, Vitale A, Kump L, Ghassan Z. 2005. Chapter 17, Uveitis Affecting Infants and Children: Noninfectious Causes. Pediatric Retina (Eds. Hartnett ME, Trese M, Capone A, Keats BJB, Steidl S). New York: Lippincott Williams & Wilkins. pp 291-313.
104
70. Sippel KC, Foster CS. 2006. Five Pearls in Limbal Stem Cell Transplantation. 101 Pearls in Refractive, Cataract and Corneal Surgery (Eds. Melki SA, Azar DT). Thorofare, NJ: Slack Incorporated. pp. 131-141.
71. Sippel KC, Foster CS. 2006. Three Pearls in Amniotic Membrane Transplantation. 101 Pearls in Refractive, Cataract and Corneal Surgery (Eds. Melki SA, Azar DT). Thorofare, NJ: Slack Incorporated. pp. 145-153.
72. Foster CS. 2008. Uveitis. Risk Prevention in Ophthalmology (Eds Kraushar M). Springer. pp. 237-245.
73. Streilein JW, Foster CS. 2008. Immunology – An Overview. Principles and Practice of Ophthalmology: Section II, Chapter 5, 3rd Edition. (Eds. Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
74. Foster CS. 2008. A Cast of Thousands: The Cells of the Immune System. Principles and Practice of Ophthalmology: Section II, Chapter 6, 3rd Edition. (Eds. Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
75. Foster CS, Anzaar F 2008. B Lymphocyte Responses. Principles and Practice of Ophthalmology:Section II, Chapter 8, 3rd Edition. (Albert DM, Miller JW et al) Philadelphia: WB Saunders Publishers.
76. Foster CS, Streilein JW, Coma MC 2008. Immune-Mediated Tissue Injury. Principles and Practice of Ophthalmology: Section II, Chapter 9, 3rd Edition. (Albert DM, Miller JW et al) Philadelphia: WB Saunders Publishers.
77. Streilein JW, Foster CS. 2008. Regulation of Immune Responses. Principles and Practice of Ophthalmology Section II, Chapter 10, 3rd Edition (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
78. Foster CS. 2008. Pharmacologic Treatment of Immune Disorders. Principles and Practice of Ophthalmology: Section IV, Chapter 34, 3rd Edition.. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
79. Foster CS. 2008. Immunologic Disorders of the Conjunctiva, Cornea and Sclera. Principles and Practices of Ophthalmology: Section VIII, Chapter 65, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
105 80. Kim EC, Hunter DG, Foster CS. 2008. Ocular Manifestations of Sarcoidosis. Principles and Practices of Ophthalmology: Section IX, Chapter 88, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
81. Foster CS, Tamesis RR. 2008. Ocular Syphilis. Principles and Practice of Ophthalmology: Section XI, Chapter 156, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
82. Foster CS, Klisovic DD. 2008. Adamantiades-Behçet Disease . Principles and Practice of Ophthalmology: Chapter 164, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
83. Foster CS, O’Brien JM. 2008. Childhood Arthritis and Anterior Uveitis. Principles and Practice of Ophthalmology: Section XVII, Chapter 325, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
84. Dana MR, Reddy CV, Foster CS. 2008. Adult Rheumatoid Arthritis. Principles and Practice of Ophthalmology: Section XVII, Chapter 326,3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
85. Foster CS, Sobrin L 2008. Systemic Lupus Erythematosus. Principles and Practice of Ophthalmology: Section XVII, Chapter 327, 3rd Edition. (Albert DM, Miller JW et al) Philadelphia: WB Saunders Publishers.
86. Foster CS, Yang J, 2008. Wegener’s Granulomatosis. Principles and Practice of Ophthalmology: Section XVII, Chapter 329, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers.
87. Dana MR, Reddy CV, Foster CS. 2008. Scleroderma. Principles and Practice of Ophthalmology: Section XVII, Chapter 330, 3rd Edition. (Albert DM, Miller JW et al).Philadelphia: WB Saunders Publishers.
88. Foster CS, Anzaar F. 2007. Extraocular Manifestations of Systemic Diseases. Pathobiology of Ocular Diseases. (Eds. Gordon K. Klintworth) 3rd ed. New York: Informa Healthcare.
89. Onal S, Foster CS. Ocular Manifestations of systemic vasculitis. Vasculitis. (Eds. Ball & Bridges) Oxford University Press.
90. Quinones K, Foster CS. Ocular Allergy. Managing the Allergic Patient (Eds. Krouse) Saunders Elsevier.
106 91. JJ Huang, CS Foster. Systemic Immunosuppression in Rheumatologic Diseases. Retinal Vasculitis.
92. Zoumalan C, Cockerham GC, Foster CS. Conjunctival Flaps and Amniotic membrane transplantation. Brightbill, McDonnell, McGhee, eds. Corneal Surgery, 4th edition.
93. Foster CS, Siddique SS. Scleritis. 2011. Corneal and Refractive: Atlas of Clinical Wisdom (Eds Melki & Fava). SLACK Incorporated pp. 125 -129.
94. Foster CS, Gonzalez-Gonzalez LA. 2011. Peripheral Ulcerative Keratits. Corneal and Refractive: Atlas of Clinical Wisdom (Eds Melki & Fava). SLACK Incorporated pp. 131 - 139.
95. Foster CS, Amorese L. 2011. Stevens-Johnson Syndrome.. Corneal and Refractive: Atlas of Clinical Wisdom (Eds Melki & Fava). SLACK Incorporated pp. 141 -148.
96. Foster CS, Hazin R. 2011. Ocular Cicatricial Pemphigoid. Corneal and Refractive: Atlas of Clinical Wisdom (Eds Melki & Fava). SLACK Incorporated pp. 149 -151.
97. Kruh J, Foster CS. 2012. The Philosophy of Treatment of Uveitis: Past, Present, and Future. New Treatments in Noninfectious Uveitis (Eds Miserocchi, Modorati &Foster). KARGER pp. 1-6.
98. Kruh J, Foster CS. 2012. Corticosteroid-Sparing Agents: Conventional Systemic Immunosuppressants. New Treatments in Noninfectious Uveitis (Eds Miserocchi, Modorati &Foster). KARGER pp. 29-46.
99. Vitale AT, Kump LI, Foster CS. 2013. Uveitis Affecting Infants and Children. Pediatric Retina, 2nd edition (Eds Hartnett ME, Trese M, Capone A, et al.) Philadelphia: Lippincott Williams & Wilkins pp. 386-440.
100. Arcinue CA, Pachón Suárez DI, Foster CS. Immunosuppressants and biologic therapy. Ocular Surface Disorders (Eds Benitez-del-Castillo JM, Lemp MA). St. Louis: JP medical publishers pp. 267-273.
101. Dhanireddy S, Metzinger JL, Foster CS. Chapter 1: Clinical Application of Intravenous Immunoglobulins in Autoimmune Mediated Ocular Inflammatory Diseases. Plasmapheresis and Intravenous Immunoglobin: Clinical Uses, Potential Complications and Long-Term Health Effects (Ed Rossana Allegro). Nova Publishers pp. 1-20.
102. González-González LA, Payal AR, Dhanireddy S, Foster CS. Capitulo 6: Immunomodulacion y antiinflamatorios no esteroideos en la patología corneal. La
107 inflamación inmunomoduladores y antiinflamatorios: más allá de los corticoids (Eds Benito AP, Salas EC) Madrid: Sociedad Española de Oftalmologia pp. 94-102.
103. Dhanireddy S, Maghsoudlou A, Preble JM, Ratwatte MD, Foster CS. Ocular Cicatricial Pemphigoid. Autoimmne bullous diseases (Ed Naveed Sami) Cham: Springer International Publishing pp. 75-97. 104. Garcia-Rodriguez A, Foster C. Cataract Surgery. Cataract Surgery in Patients with Uveitis: Preoperative and Surgical Considerations. InTech
On-Line Publications
1. Roque MR, Foster CS. 2000. Vitreous Wick Syndrome. www.Emedicine.com: Ophthalmology – Vitreous.
2. Roque MR, Foster CS. 2000. Actinomycosis in Ophthalmology. www.Emedicine.com: Ophthalmology – Infectious Diseases.
3. Roque MR, Foster CS. 2000. Demodicosis. www.Emedicine.com: Ophtalmology – Infectious Diseases.
4. Roque MR, Foster CS. 2000. Syphilis, Ocular. www.Emedicine.com: Ophthalmology – Infectious Diseases.
5. Roque MR, Foster CS. 2000. Herpes Zoster Ophthalmicus. www.Emedicine.com: Ophthalmology – Infectious Diseases: Hemorrhagic.
6. Roque MR, Foster CS. 2000. Melanoma, Conjunctival. www.Emedicine.com: Ophthalmology – Conjunctiva.
7. Roque MR, Foster CS. 2000. Leiomyoma, Iris. www.Emedicine.com: Ophthalmology – Iris and Ciliary Body.
8. Roque MR, Foster CS. 2000. Chloroquine/Hydroxychloroquine Toxicity. www.Emedicine.com: Ophthalmolgy – Unclassified Disorders.
9. Waheed NK, Foster CS. 2000. Melanoma, Iris. www.Emedicine.com: Ophthalmology – Iris and Ciliary Body.
10. Letko E, Foster CS. 2000. Ophthalmic Manifestations of Cictricial Pemphigoid. www.Emedicine.com: Ophthalmology – Conjunctiva.
108 11. Letko E, Foster CS. 2000. Stevens-Johnson Syndrome. www.Emedicine.com: Ophthalmology – Dermatological Diseases.
12. Samson CM, Foster CS. 2000. Retinopathy, Birdshot. www.Emedicine.com: Ophthalmoloby – Retina: Tractional.
13. Ekong A, Foster CS. 2000. Juvenile Rheumatoid Arthritis. www.Emedicine.com: Ophthalmology – Connective Tissue Disorders.
14. Ekong A, Foster CS. 2000. Dry Eye Syndrome. www.Emedicine.com: Ophthalmology – Lacrimal System.
15. Foster CS. 20001. New Cornea Research www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology 2001 Annual Meeting.
16. Foster CS. 2001. Cornea and External Disease Update. www.medscape.com – Ophthalmology: American Academy of Ophthalmology (AAO) 2001 Annual Meeting.
17. Foster CS, Rashid S. 2002. Juvenile Rheumatoid Arthritis. www.uveitissociety.org - Patient information.
18. Foster CS, Rashid S. 2002. Ocular Cicatricial Pemphigoid. www.uveitissociety.org - Patient information.
19. Foster CS. 20002. Advances in Uveitis. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology 2002 Annual Meeting.
20. Foster CS. 2002. Advances in Cornea Research. www.medscape.com – Ophthalmology: American Academy of Ophthalmology 2002 Meeting.
21. Foster CS. 2003. The Cornea: New Biologic Research. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology – Annual Meeting 2003.
22. Foster CS. 2003. Ocular Inflammatory Disease: The importance of aggressive therapy. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology – Annual Meeting 2003.
23. Foster CS. 2004. Highlights of the association for research in vision and ophthalmology 2004 Annual Meeting. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology – Annual Meeting 2004.
109 24. Zein G, Foster CS. 2004. Management of cataract and Uveitis. www.eyetext.net.
25. Foster CS. 2006 Cataract Surgery and Uveitis. http://aaophp.aao.org/current_insight.
26. Yu, EN, Yao L, Foster CS. 2006. Peripheral Ulcerative Keratitis. www.emedicine.com: Ophthalmology- Cornea.
27. Letko E, Foster CS. 2006. Cictricial Pemphigoid. www.Emedicine.com: Ophthalmology – Conjunctiva.
28. Roque MR, Roque BL, Foster CS. 2006. Herpes Zoster. www.Emedicine.com: Ophthalmology – Infectious Diseases: Hemorrhagic.
29. Roque MR, Roque BL, Foster CS. 2006. Uveitis, Juvenile Idiopathic Arthritis. www.Emedicine.com: Ophthalmology – Iris & Ciliary Body.
30. Letko E, Foster CS. 2005. Stevens-Johnson Syndrome. www.Emedicine.com: Ophthalmology – Dermatological Diseases.
31. Roque MR, Roque BL, Foster CS. 2005. Syphilis, Ocular. www.Emedicine.com: Ophthalmology – Infectious Diseases.
32. Samson CM, Foster CS. 2005. Retinopathy, Birdshot. www.Emedicine.com: Ophthalmoloby – Retina: Tractional.
33. Foster CS. 2005. Latest Advances in Uveitis. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology 2005 Annual Meeting.
34. Foster CS. 2005. Ocular Immunology and Uveitis. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology 2005 Annual Meeting.
35. Roque MR, Foster CS. 2006. Chloroquine/Hydroxychloroquine Toxicity. www.Emedicine.com: Ophthalmolgy – Unclassified Disorders.
36. Foster CS, Arif M. 2006. Uveitis – Fuchs Heterochromic. www.emedicine.com: Ophthalmology – Iris and Ciliary body.
37. Foster CS, Farooqui SZ. 2006. Central Sterile Corneal Ulceration. www.emedicine.com: Ophthalmology – Cornea.
38. Foster CS, Farooqui SZ. 2006. Uveitis Classification. www.emedicine.com: Ophthalmology – Iris and Ciliary body.
110
39. Anzaar F, Foster CS. 2006. Dry Eye Syndrome. www.emedicine.com Ophthalmology – Lacrimal System.
40. Foster CS, Letko E. 2006. Cicatricial Pemphigoid. www.emedicine.com: Ophthalmology – Conjunctiva.
41. Foster CS. 2007. Understanding Uveitis. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting.
42. Afshari NA, Afshari MA, Foster CS. 2008. Inflammatory Conditions of the Eye Associated with Rheumatic Diseases. www.springeronline.com Current Rheumatology Reports.
43. Foster CS. 2008. Advances in the Diagnosis and Treatment of Uveitis. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology (ARVO) 2008 Annual Meeting.
44. Roque MR, Roque BL, Foster CS. 2008. Herpes Zoster. www.emedicine.com eMedicine from WebMD.
45. Roque MR, Roque BL, Miserocchi E, Foster CS. 2008. Giant Cell Arteritis. /www.emedicine.com eMedicine from WebMD.
46. Roque MR, Roque BL, Miserocchi E, Foster CS. Uveitis, Juvenile Idiopathic Arthritis. 2008. www.emedicine.com eMedicine from WebMD.
47. Farooqui SZ, Foster CS, Sheppard JD. Uveitis, Classification. eMedicine from WebMD. Updated November 20, 2008. Available at: http://www.emedicine.com/oph/topic580.htm.
48. Foster CS. 2008. Intraocular Inflammatory Diseases.. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology (ARVO) 2008 Annual Meeting.
49. Ocampo VV, Foster CS. Esotropia, Infantile. eMedicine from WebMD. Updated February 17, 2010. Available at: http://emedicine.medscape.com/article/1198876-overview.
50. Roque MR, Roque BL, Foster CS. Ocular Manifestations of Syphilis. eMedicine from WebMD. Updated February 19, 2010. Available at: http://emedicine.medscape.com/article/1202799-overview.
111 51. Foster CS, Letko E, Ba-Abbad R. Stevens-Johnson Syndrome. eMedicine from WebMD. Updated February 19, 2010. Available at: http://emedicine.medscape.com/article/1197450- overview.
52. Roque MR, Roque BL, Miserocchi E, Foster CS. Uveitis, Juvenile Idiopathic Arthritis. eMedicine from WebMD. Updated September 28, 2010. Available at: http://emedicine.medscape.com/article/1209891-overview.
53. Foster CS, Yuksel E, Anzaar F, Ekong AS. Dry Eye Syndrome. eMedicine from WebMD. Updated November 15, 2010. Available at: http://emedicine.medscape.com/article/1210417-overview.
54. Foster CS, Yuksel E, Anzaar F, Ekong AS. Dry Eye Syndrome. eMedicine from WebMD. Updated November 15, 2010. Available at: http://emedicine.medscape.com/article/1210417-overview.
55. Ocampo VV, Foster CS. Senile Cataract. eMedicine from WebMD. Updated January 05, 2011. Available at: http://emedicine.medscape.com/article/1210914-overview.
56. Roque MR, Roque BL, Foster CS. Chloroquine/Hydroxychloroquine Toxicity. eMedicine from WebMD. Updated January 21, 2011. Available at: http://emedicine.medscape.com/article/1229016-overview.
57. Roque MR, Roque BL, Foster CS. Herpes Zoster. eMedicine from WebMD. Updated January 25, 2011. Available at: http://emedicine.medscape.com/article/1202284-overview.
58. Ocampo VV, Foster CS. Senile Cataract. eMedicine from WebMD. Updated February 04, 2011. Available at: http://emedicine.medscape.com/article/1210914-overview.
59. Boyer DS, Foster CS, Singer MA. The Management of Recurrent Macular Edema in Retina Disease. Interactive Case Series for CME Credit. http://www.dulaneyfoundation.org/login.asp?info=You+must+be+logged+in+to+view+this +course%2E&rUrl=course%2Easp%3Fid%3D156
60. Roque MR, Roque BL, Foster CS. Conjunctival Melanoma. eMedicine from WebMD. Updated May 17, 2011. Available at: http://emedicine.medscape.com/article/1191840- overview.
61. Roque MR, Roque BL, Foster CS. Demodicosis. eMedicine from WebMD. Updated June 29, 2011. Available at: http://emedicine.medscape.com/article/1203895-overview.
62. Arif M, Foster CS, Wong IG. Fuchs Heterochromic Uveitis. eMedicine from WebMD. Updated October 10, 2011. Available at: http://emedicine.medscape.com/article/1208706- overview.
112
63. Foster CS. Ocular Cictricial Pemphigoid. UpToDate, 10 October 2011. Available at: http://www.uptodate.com/contents/ocular-cicatricial-pemphigoid
64. Samson CM, Ali AM, Foster CS. Birdshot Retinopathy. eMedicine from WebMD. Updated November 28, 2011. Available at: http://emedicine.medscape.com/article/1223257-overview.
65. WebMD. Updated December 01, 2011. Available at: http://emedicine.medscape.com/article/1196936-overview.
66. Yu-Keh EN, Foster CS. Peripheral Ulcerative Keratitis. eMedicine from WebMD. Updated January 11, 2012. Available at: http://emedicine.medscape.com/article/1195980- overview.
67. Farooqui SZ, Foster CS, Ma JJ. Central Sterile Corneal Ulceration. eMedicine from Roque MR, Roque BL, Foster CS. Iris Leiomyoma. eMedicine from WebMD. Updated April 10, 2012. Available at: http://emedicine.medscape.com/article/1209782-overview.
68. Ocampo VV, Foster CS. Infantile Esotropia. eMedicine from WebMD. Updated May 30, 2012. Available at: http://emedicine.medscape.com/article/1198876-overview.
69. Foster CS. Uveitis and Macular Edema: A Complex Relationship. June 8, 2012. http://www.medscape.com/viewarticle/765093
70. Foster CS. Corneal Collagen Crosslinking: Still Too Experimental for Keratoconus? June 12, 2012. http://www.medscape.com/viewarticle/765338
71. Foster CS. Pivotal Age-Related Macular Degeneration Treatment Studies Update. July 20, 2012. http://www.medscape.com/viewarticle/767568
72. Foster CS. Neuroprotective Strategies in Glaucoma. July 20, 2012. http://www.medscape.com/viewarticle/767569
73. Waheed NK, Foster CS. Iris Melanoma. eMedicine from WebMD. Updated December 04, 2012. Available at: http://emedicine.medscape.com/article/1208624-overview.
74. Ocampo VV, Foster CS. Senile Cataract. eMedicine from WebMD. Updated January 22, 2013. Available at: http://emedicine.medscape.com/article/1210914-overview.
75. Foster CS, Yuksel E, Anzaar F, Ekong AS. Dry Eye Syndrome. Medscape Reference. Updated April 15, 2013. Available at: http://emedicine.medscape.com/article/1210417- overview.
76. Ocampo VV, Foster CS. Senile Cataract. Medscape Reference. Updated April 22, 2013. Available at: http://emedicine.medscape.com/article/1210914-overview.
113 77. Farooqui SZ, Foster CS, Ma JJ. Central Sterile Corneal Ulceration. eMedicine from Roque MR, Roque BL, Foster CS. Iris Leiomyoma. eMedicine from WebMD. Updated August 7, 2013. Available at: http://emedicine.medscape.com/article/1209782-overview.
78. Roque MR, Roque BL, Foster CS. Chloroquine/Hydroxychloroquine Toxicity. eMedicine from WebMD. Updated August 11,2013. Available at: http://emedicine.medscape.com/article/1229016-overview.
79. Foster CS, Letko E, Ba-Abbad R. Stevens-Johnson Syndrome. eMedicine from WebMD. Updated August 12, 2013. Available at: http://emedicine.medscape.com/article/1197450- overview.
80. Roque MR, Roque BL, Foster CS. Conjunctival Melanoma. eMedicine from WebMD. Updated October 15, 2013. Available at: http://emedicine.medscape.com/article/1191840- overview.
81. Ocampo VV, Foster CS. Senile Cataract. eMedicine from WebMD. Updated January 27, 2014. Available at: http://emedicine.medscape.com/article/1210914-overview.
82. Roque MR, Foster CS. Actinomycosis in Ophthalmology. www.Emedicine.com: Ophthalmology – Infectious Diseases. Updated February 6, 2014.
83. Farooqui SZ, Foster CS, Ma JJ. Central Sterile Corneal Ulceration. eMedicine from Roque MR, Roque BL, Foster CS. Iris Leiomyoma. eMedicine from WebMD. Updated February 6, 2014. Available at: http://emedicine.medscape.com/article/1209782-overview.
84. Ocampo VV, Foster CS. Senile Cataract. eMedicine from WebMD. Updated February 24, 2014. Available at: http://emedicine.medscape.com/article/1210914-overview.
85. Yu-Keh EN, Foster CS. Peripheral Ulcerative Keratitis. eMedicine from WebMD. Updated May 12, 2014. Available at: http://emedicine.medscape.com/article/1195980- overview.
86. Roque MR, Roque BL, Miserocchi E, Foster CS. 2014. Giant Cell Arteritis. http://www.emedicine.com eMedicine from WebMD.
87. Foster CS, Farooqui SZ. 2014. Uveitis Classification. www.emedicine.com: Ophthalmology – Iris and Ciliary body.
88. Ocampo VV, Foster CS. Senile Cataract. eMedicine from WebMD. Updated June 24, 2014. Available at: http://emedicine.medscape.com/article/1210914-overview.
89. Roque MR, Roque BL, Miserocchi E, Foster CS. 13 August 2014. Giant Cell Arteritis. http://www.emedicine.com eMedicine from WebMD.
114 90. Waheed NK, Foster CS. Iris Melanoma. eMedicine from WebMD. Updated September 10, 2014. Available at: http://emedicine.medscape.com/article/1208624-overview.
91. Roque MR, Roque BL, Miserocchi E, Foster CS. 25 September 2014. Giant Cell Arteritis. http://www.emedicine.com eMedicine from WebMD.
92. Ocampo VV, Foster CS. Senile Cataract. eMedicine from WebMD. Updated November 10, 2014. Available at: http://emedicine.medscape.com/article/1210914-overview.
93. Sampson CM, Ali AM, Foster CS. Birdshot Retinopathy. Medscape Reference. Updated March 04, 2015. Available at: http://emedicine.medscape.com/article/1223257-overview.
94. Foster CS. Ocular Cicatricial Pemphigoid. UpToDate. Updated August 05, 2015. Available at: http://www.uptodate.com/contents/ocular-cicatricial-pemphigoid.
95. Foster CS, Meese HK. Unmet Needs in Diagnosis and Treatment of Non-Infectious Uveitis. Medscape Ophthalmology, August 12, 2015. Available at: http://www.medscape.org/viewarticle/848164.
96. Foster CS. Herpetic Anterior Uveitis. Topics in Ocular Antiinfectives. March 2016. Available at: https://cme.sites.medinfo.ufl.edu/files/2009/10/TOA-Issue59-FINweb.pdf.
97. Farooqui SZ, Foster CS. Uveitis Classification. Medscape Drugs & Diseases. June 2016. Available at: http://emedicine.medscape.com/article/1208936-overview.
98. Farooqui SZ, Foster CS. Central Sterile Corneal Ulceration. Medscape Drugs & Diseases. Updated 29 June 2016. Available at: http://emedicine.medscape.com/article/1196936- overview
99. Foster CS. Dry Eye Syndrome. Medscape Drugs & Diseases. Updated 14 July 2016. Available at: http://emedicine.medscape.com/article/1210417-overview
100. Kubaisi B, Foster CS. Iris Melanoma. Medscape Drugs & Diseases. 10 August 2016. Available at: http://emedicine.medscape.com/article/1208624-overview
101. Foster CS. Dry Eye Syndrome. Medscape Drugs & Diseases. Updated 09 October 2017. Available at: http://emedicine.medscape.com/article/1210417-overview
102. Rodríguez-García A, Foster CS. Cataract Surgery in Patients with Uveitis: Perioperative and Surgical Implications. In: Cataract Surgery. Artashes Zilfyan (Editor) eBook InTech, ISBN: 978-953-51-5740-3
103. Small K, Stephenson A, Foster CS. Chronic Eye Redness and Pain After 9 Months of Anti- inflammatory Therapy. JAMA Ophthalmol. Published online December 27, 2018. doi:10.1001/jamaophthalmol.2018.5417
115 104. Foster CS, Ba-Abbad R, Letko E, Parrillo S. Stevens-Johnson Syndrome. Medscape Drugs & Diseases. Updated 17 Jan 2019. Available at: https://emedicine.medscape.com/article/1197450-overview
105. Roque M, Roque B, Foster CS. Iris Leiomyoma. Medscape Drugs & Diseases. Published online February 18, 2019. Available at: https://emedicine.medscape.com/article/1209782-overview
106. Roque M, Roque B, Foster CS. Chloroquine and Hydroxychloroquine Toxicity. Medscape Drugs and Diseases. Published online March 16, 2019. Available at:
https://emedicine.medscape.com/article/1229016-overview
Books
1. Foster CS, et al (Ed). 1972. The Epidemiology of Venous Thrombosis, Milband Memorial Fund Quarterly, Volume 1, Part 2.
2. Foster CS, Sainz de la Maza, M. 1993. The Sclera. Springer-Verlag Publishers, New York.
3. Foster CS, Vitale A. 2001. Diagnosis and Treatment of Uveitis. WB Saunders, Philadelphia.
4. Foster CS, Azar DA, Dohlman CH. 2004. Smolin & Thoft’s The Cornea. Philadelphia: Lippincott, Williams & Wilkins.
5. Pleyer U, Foster CS. 2007. Essentials In Ophthalmology: Uveitis & Immunological Disorders. Springer Verlag, New York.
6. Foster CS, Bhat P, Yilmaz T, Cervantes, R, Mauro J. Atlas of Ocular Inflammatory Diseases. 2009. Andy Grachuck.
7. Foster CS, Amorese L, Dacey M, Rosenbaum R. Birdshot Retinochoroidopathy. 2010. Self-published, C. Stephen Foster.
8. Foster CS, Gonzalez-Gonzalez LA, Anesi SD, Palafox SK. Childhood Uveitis. 2011. Self-published, C. Stephen Foster.
9. Foster CS, Sainz de la Maza, M. 2012. The Sclera, 2nd Edition. Springer-Verlag Publishers, New York.
116 10. Foster, CS. 2012. Cubside Consultation in Uveitis: 49 Clinical Questions. Slack Incorporated, Thorofare, NJ.
11. Miserocchi E, Modorati G, Foster CS. 2012. New Treatments in Noninfectious Uveitis. Karger, Basel, Switzerland.
12. Foster CS, Vitale A. 2013. Diagnosis and Treatment of Uveitis, 2nd Edition. Jaypee Brothers Publishing, New Dehli, India.
13. Foster, CS. 2014. Uvéites: 49 questions cliniques. Slack Incorporated, Thorofare, NJ.
14. Foster CS. Birdshot Retinochoroidopathy, Second Edition. 2014. Self-published, C. Stephen Foster.
15. Anesi SD, Metzinger JL, Ceron O, Foster CS. 2016. Uveitic Glaucoma. Nova Publishers, Hauppauge NY.
117